ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000136.1|Rifamycin_1 # 145 # 720 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0000136.1|Rifamycin_1 	145	720	+	Loose	850	26.1794	OprM	33.33	3000379	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; acridine dye; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGTTGTTGGTGCCGAACAGGGACCGGAAGGCCGGCGTCGTCCAGCCGAGCTCGATCGCGGAGAGCTTCCGCACCAGCTCGGCCACCGTCGTTACCCAGTACACCGGCCTCTCCGTGTCCCAGCTGTCCCAGCTGCGCCGCGCTCTCGGCACCAGTGCCAAGTACCGGGTCGCGAAGAACACCCTGGTCAAGCGGGCGGCCGAGGACGCCGGCATCCAGGGTCTCGAGGACCTGTTCGTCGGCGCGACCGCCATCGCCTTCGTCGAGGGTGAAGCAGTCGACGCCGCCAAGGCGATTCGCGACTTCGCGAAGGACAACAACGCGCTTGTGATCAAGGGCGGCTACATGGACGGCCGAGCGCTGTCCGTGGACGAGATCAACCGGATTGCCGATCTCGACAGCCGTGAGGTCCTGCTCGCCAAGGCGGCGGGCGCGTTCAAGGCGAAGCTTTCCCAGGCCGCCGCGCTGTTCCAGGCGCCGGCGTCCCAGGTCGCCCGCCTGGCTGCCGCGCTGGAGGAGAAGCAGCGCAACGCCGCCGGTACCGAAGCAGCCGAAGCACCCGCCGAGAGCTGA	MPLLVPNRDRKAGVVQPSSIAESFRTSSATVVTQYTGLSVSQLSQLRRALGTSAKYRVAKNTLVKRAAEDAGIQGLEDLFVGATAIAFVEGEAVDAAKAIRDFAKDNNALVIKGGYMDGRALSVDEINRIADLDSREVLLAKAAGAFKAKLSQAAALFQAPASQVARLAAALEEKQRNAAGTEAAEAPAES	MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA	39.38	gnl|BL_ORD_ID|2418|hsp_num:0	1305		
BGC0000136.1|Rifamycin_2 # 770 # 1153 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.682	BGC0000136.1|Rifamycin_2 	770	1153	+	Loose	2000	25.0238	Staphylococcus aureus mupA conferring resistance to mupirocin	26.98	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGGCGAAGCTGAGCACCGCCGAGCTGATCGACGCCTTCAAGGAGCTGACCCTCCTCGAGCTGTCCGAGTTCGTGAAGGAGTTCGAAGAGGTCTTCGACGTGACCGCCGCCGCGCCGGTCGCCGTTGCCGCCGGCCCGGCCGCCGCCGCTGCCGCCCCGGTCGAGGAGCAGGACGAGTTCGACGTCGTCCTCGAGGGCGCCGGCGACAAGAAGATCCAGGTCATCAAGGTCGTCCGCGAGGTCGTCTCGGGCCTGGGCCTGAAGGAGGCCAAGGAGCTGGTCGAGGCCGCTCCCAAGGCCCTCCTGGAGAAGGTCGACAAGGAGGCCGCCGAGGCCGCCAAGGAGAAGCTCGAGGCCGCGGGCGCCAAGATTTCCATCAAGTGA	MAKLSTAELIDAFKELTLLELSEFVKEFEEVFDVTAAAPVAVAAGPAAAAAAPVEEQDEFDVVLEGAGDKKIQVIKVVREVVSGLGLKEAKELVEAAPKALLEKVDKEAAEAAKEKLEAAGAKISIK	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	12.40	gnl|BL_ORD_ID|2125|hsp_num:0	2270		
BGC0000136.1|Rifamycin_3 # 1559 # 2731 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.682	BGC0000136.1|Rifamycin_3 	1559	2731	+	Loose	500	145.976	RanA	32.91	3005091	protein homolog model	n/a	n/a		antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGTGCCGAGGTGGTCATCGAAGGTCTGACGAAGTCCTTCGGTAAGCAGGCCATCTGGCGGGACGTCACGTTGACGCTCCCCCCGGGCGAAGTGTCGGCCATGCTCGGCCCGTCGGGGACCGGCAAGTCGGTCTTCCTGAAGTCGATGATCGGGCTGCTCAAGCCCGACCGCGGCCGCTGCATGATCAACGGGGTGGACATCGTCACCTGCTCCGAGCACAAGCTGTACGAGATCCGGAAGCTCTTCGGTGTCCTCTTCCAGGACGGCGCGCTGTTCGGCTCGATGAACCTCTACGACAACGTCGCCTTCCCGCTGCGTGAGCACACGAAGAAGTCCGAGACGGAAATCCGCCGGATCGTGCTCGAGAAGCTCGACATGACCGGTCTGAACGGCGCCGACAAGAAGCTGCCGGGCGAGATCTCCGGCGGGATGCGCAAGCGCGCCGGCCTGGCCCGCGCCCTGGTGCTCGACCCGGAGATCATCCTGGTCGACGAGCCGGACTCGGGCCTCGACCCGGTCCGCACCACCTACATCTCGCAGCTGTTCCTCGACGTCAACGCGCAGATCGACGCGACGTTCCTGATCGTCACCCACAACATCAACCTGGCCCGCACGGTGCCGGACAACCTGGGCATGCTCTTCCGCAAGGAACTGGTCATGTTCGGCCCGCGCGAGGTGCTGCTGACCAGCGAAGAGCCGGTCGTCAAGCAGTTCCTCAACGGCAAGATGCAGGGCCCGATCGGCATGTCCGAGGAGAAGGACAGCGCCCAGATGGCCGCCGAGCAGGCGATGTTCGAAGCCGGCCACCACGCGGGCGGGGTCGAGGACGTCTCCGGCGTGCCGCCGCAGATGCAGCCGACGCCGGGCGTGCCCACCCGGATGGGTGCCGTCCGCCGCAAGGACCGGGTCATGGAGATCATGCACCGGCTGCCGCCGGCCGCGCAGGAAAGCATCATCGAGTCGCTGAGCCCCGAGGAGCAGCGCCACTACGGTGTGCGGCCGCACCGCGGGCAGCCGCAGCAGGTCGGCGCCCGCCCGCAGGGTGACGGCGTCCCGAACCAGCACCACGGGCAGCTGCCCGCCGACCAGGTGGCGCGGATCCCCGGCGGCCAGCCGCCGAGAACCGGCACGCACCGAATGCCACCGAACAACGGGCCAGGTGGCCGGTGA	MGAEVVIEGLTKSFGKQAIWRDVTLTLPPGEVSAMLGPSGTGKSVFLKSMIGLLKPDRGRCMINGVDIVTCSEHKLYEIRKLFGVLFQDGALFGSMNLYDNVAFPLREHTKKSETEIRRIVLEKLDMTGLNGADKKLPGEISGGMRKRAGLARALVLDPEIILVDEPDSGLDPVRTTYISQLFLDVNAQIDATFLIVTHNINLARTVPDNLGMLFRKELVMFGPREVLLTSEEPVVKQFLNGKMQGPIGMSEEKDSAQMAAEQAMFEAGHHAGGVEDVSGVPPQMQPTPGVPTRMGAVRRKDRVMEIMHRLPPAAQESIIESLSPEEQRHYGVRPHRGQPQQVGARPQGDGVPNQHHGQLPADQVARIPGGQPPRTGTHRMPPNNGPGGR	MIEVKDLRKSFNDVEVLKGITTTFETGKINLVIGQSGSGKTVFLKCLLNVFDPSSGDILFDGRNLSIMGRTEKQEIRSEIGTVFQGSALFDSMTVEENISFPLDMFTNLTYTEKRKRVKEVIGRVHLENANTKFPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPNTAIVIDELIKEITEEYNTTTIINTHDMNSVLTIGEKIVYLRKGVKEWEGNKDLIIKAENEHLIDFVYSSALFKQVRETMLRNNQTNL	151.16	gnl|BL_ORD_ID|2869|hsp_num:0	3825		
BGC0000136.1|Rifamycin_4 # 2728 # 3522 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.691	BGC0000136.1|Rifamycin_4 	2728	3522	+	Loose	450	82.0333	RanB	28.57	3005090	protein homolog model	n/a	n/a		antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAGCTCTCCCGCAACACAGGCGAAGATCCCCGGGATCGGCATGCTCCGCGAGACCGGGAACCTGTTCGCTCTCGGCCTGGACATCGTCCGCGGCCTGTTCCAGCGCCCGTTCCAGCTGCGGGAGTTCATCCAGCAGTCGTGGTTCATCGCGAGCGTGACGATCCTGCCGACGGCCCTGGTGGCCATCCCGTTCGGTGCCGTCATCTCGCTGCAGTTCGGGTCGCTCGCCCGCCAGCTGGGCGCGCAGTCCTACACCGGCGCGGGCTCCGTGCTCGCCACCGTGCAGCAGGCCAGTCCGCTGGTCACCGCGCTGCTGGTGGCGGGTGCGGGCGGCTCCGCCGTCTGCGCCGACATCGGCGCCCGGACCATCCGCGAAGAGATCGCCGCGATGGAGGTGCTCGGCGTCTCCGCGGTGCAGCGGCTGATCGTGCCGCGCACCCTCGCGATGATGCTGGTCGCGCTCCTGCTCAACGGCATGGTCAGCGTCATCGGCGTGCTCGGCGGCTACTTCTTCAACGTCGTGCTGCAGGGCGGGACGCCGGGTGCGTACCTGGCGAGCTTCTCCGCCCTCGCGCAGCTGCCCGACCTCTGGGTCGGCGAGCTCAAGGCGCTGATCTTCGGGTTCATCGCCGCCGTCGTCGCGTCCTACCGGGGCCTGAACCCCTCCGGCGGCCCGAAGGGCGTCGGGGACGCGGTGAACCAGTCGGTGGTCATCACGTTCCTGCTGCTGTTCGTCGTGAACTTCGTGATCACCCTGATCTACCTGCAGATCGTGCCCGGAAAGCTGGACTAG	MSSPATQAKIPGIGMLRETGNLFALGLDIVRGLFQRPFQLREFIQQSWFIASVTILPTALVAIPFGAVISLQFGSLARQLGAQSYTGAGSVLATVQQASPLVTALLVAGAGGSAVCADIGARTIREEIAAMEVLGVSAVQRLIVPRTLAMMLVALLLNGMVSVIGVLGGYFFNVVLQGGTPGAYLASFSALAQLPDLWVGELKALIFGFIAAVVASYRGLNPSGGPKGVGDAVNQSVVITFLLLFVVNFVITLIYLQIVPGKLD	MLKLSKRMLTSVGEYVLLLGKVIKRPQKHNIFFKLLMREINDLGVNSFGLVLFTSIFVGAVVAIQMYNNFKASTIPIPLYFIGYATKVVLILEFSPTIISLILAGKVGSYIASSIGTMRVTEQIDALDIMGVNSPNFLILPKIVANVIFNPLLIAISIVFGIYGGYLAGVATGNWTEADYITGIQRYIPDYFIWYAFFKTVVFAFLIATIPAYFGYNVKGGSLEVGRASTQAVVWTMVAIIIAELISTQLFLS	104.35	gnl|BL_ORD_ID|2868|hsp_num:0	3824		
BGC0000136.1|Rifamycin_5 # 3527 # 4363 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.658	BGC0000136.1|Rifamycin_5 	3527	4363	+	Loose	450	77.411	RanB	31.16	3005090	protein homolog model	n/a	n/a		antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACGTTCCTCCAGGGCGCGAAACGCGTCGTCAACCGACCCCTCCAGACACTGGACACCTTGGGTGACCAGATGTCGTTCTACGGCCGCGCGCTGCTGTGGACGCCGCGGACGCTGCGCCGCTACACCAAAGAGGTGCTCCGGCTGCTGGCCGAGGTGAGCTTCGGGTCCGGCTCGCTGGCGGTCATCGGCGGCACGGTGGGCGTGATGGTCGGCCTGACGCTGTTCACCGGTGTCCTCGTCGGCCTCCAGGGCTATTCGGCGCTGAACTCGATCGGGACGTCGGCCTTCACCGGCTTCCTGACCGCGTTCTTCAACACGCGCGAGATCGCCCCGCTGGTCGCCGGGCTCGCCCTGAGCGCCACCGTCGGCGCCGGGTTCACCGCGCAGCTGGGCGCCATGCGGATCTCGGAGGAGATCGACGCACTGGAAGTCATGGGTGTGCCGAGCCTGCCGTACCTGGTGACGACGCGGATCATCGCCGGGTTCGTCGCGGTCATCCCGCTCTACATCATCGGCCTGCTGAGCTCGTACCTCGCGTCGAGACTGGTCGTGATCTACATCTACCACCAGTCGGCCGGTACCTACGACCACTACTTCGACCTGTTCCTGCCCCCGCAGGACGTGCTGTATTCGTTCATCAAGGTGCTGCTGTTCAGCGTCCTGATCATCCTGTCGCACTGCTACTTCGGGTACCGGGCGACCGGTGGCCCGGCCGGGGTCGGCGTCGCGGTCGGCAAGGCCGTGCGGCTGTCCATCGTCACGGTGTCGATCATGAACTTCTTCATCGGGTTCGCCATCTGGGGAACCGACGTCACGGTAAGGATCGCGGGATGA	MTFLQGAKRVVNRPLQTLDTLGDQMSFYGRALLWTPRTLRRYTKEVLRLLAEVSFGSGSLAVIGGTVGVMVGLTLFTGVLVGLQGYSALNSIGTSAFTGFLTAFFNTREIAPLVAGLALSATVGAGFTAQLGAMRISEEIDALEVMGVPSLPYLVTTRIIAGFVAVIPLYIIGLLSSYLASRLVVIYIYHQSAGTYDHYFDLFLPPQDVLYSFIKVLLFSVLIILSHCYFGYRATGGPAGVGVAVGKAVRLSIVTVSIMNFFIGFAIWGTDVTVRIAG	MLKLSKRMLTSVGEYVLLLGKVIKRPQKHNIFFKLLMREINDLGVNSFGLVLFTSIFVGAVVAIQMYNNFKASTIPIPLYFIGYATKVVLILEFSPTIISLILAGKVGSYIASSIGTMRVTEQIDALDIMGVNSPNFLILPKIVANVIFNPLLIAISIVFGIYGGYLAGVATGNWTEADYITGIQRYIPDYFIWYAFFKTVVFAFLIATIPAYFGYNVKGGSLEVGRASTQAVVWTMVAIIIAELISTQLFLS	109.88	gnl|BL_ORD_ID|2868|hsp_num:0	3824		
BGC0000136.1|Rifamycin_6 # 4360 # 5685 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.689	BGC0000136.1|Rifamycin_6 	4360	5685	+	Loose	550	25.409	vgbB	40.0	3001308	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGAGGACGCTCCGACGCAGGCTGCTCGGCCTGCTGCTCATCGCCGTGATGGTCGGCGGGGTGGCGCTGTCCATCGCGCTCTACGACAAGGCGTTCACCCCGGTCGTCACGGTCAGGCTGCAGGCCGACAAGATCGGCAACCAGCTGATCAAGCAGTCCGACGTCAAGGTGCGCGGCCTGATCGTCGGCTCGGTGCAGGACATCGTCGCCACCGACCACGGCGCCGAGCTGACCCTGGCGCTCCAGCCGGAGTCCGCGAAGCTCATCCCGGAGAACGTCTCGGCGCGGTTCCTGCCCAAGACGCTCTTCGGCGAGCGGTTCGTCTCGCTGGAGATCCCGAAGGACCCGTCGGCCAAGACGATCGCAGACGGCGACGTCATCCCGCAGGACCGCACGTCGAGCGCGATCGAGCTGGACCAGGCCTTCGAGCACCTGATGCCGGTGCTGCAGGCGGTGCAGCCGCAGAAGCTGTCGGCGACGCTCACCGCGATCTCGACCGCGCTGCAGGGCCGCGGCGACCAGCTCGGCGACACGCTCTCGCAGCTGGGCACCTACATCGGCGAGCTGAACCCGCACGAGCCGGAGCTGCAGCACAACCTCAAGGCGCTCGCGGAGTTCTCCGACCACCTCAAGGACGCGGCCCCGGACCTGGTGCAGAGCCTGGACAACCTGAGCACGACAACCCGCACCGTGGTCGACGAGCGGCAGAACCTGTCGAACCTCTACGGCAGCCTGACCCAGGCCTCGGTGGACCTGCAGACGTTCCTGCAGAACAACAAGGACAACATCATCTCCCTCGTCGACACCGCCCGGCCGACGGCCGAACTGCTGGCGAAGTACGCGCCGGAGTACCCCTGCGTGATCTCCCAGATGGCCAAGAACGTGCCGCTGATCGACCAGGCGCTCGGCAAGGGCACCAACCAGCCCGGCCTGCACGCGACCATCGAGATCATCGTCCCGCGCGCGCCGTACCAGGCGGGCAAGGAAGAGCCGCGGTTCGACGACAAGCGCGGCCCGCGCTGCTACGACATCAAGGACATCCCGAAGCCGTTCCCGTCCGAGCCGCCGGACGGCGCGTTCAAGGACGGCACGCTGCACCAGGCCGCGCCGAAGAGCGTCGGCGAGGGCCTCAACCCGGCCAAGTTCAAGGCGGACTCGGCCGGCAACGGCGGCAGCGGTGGTGATCTGGCGTACTCGACGGCGGAGCAGGGCTTCCTGGCCGACCTGCTCGGCCCGCAGCTGGGCATGAGCGCCGCGGACGTCCCGGGCTGGAGCTCGCTGCTCGTCGGCCCGCTGTACCGGGGTGCGGAGGTGACGGTCAAGTGA	MRTLRRRLLGLLLIAVMVGGVALSIALYDKAFTPVVTVRLQADKIGNQLIKQSDVKVRGLIVGSVQDIVATDHGAELTLALQPESAKLIPENVSARFLPKTLFGERFVSLEIPKDPSAKTIADGDVIPQDRTSSAIELDQAFEHLMPVLQAVQPQKLSATLTAISTALQGRGDQLGDTLSQLGTYIGELNPHEPELQHNLKALAEFSDHLKDAAPDLVQSLDNLSTTTRTVVDERQNLSNLYGSLTQASVDLQTFLQNNKDNIISLVDTARPTAELLAKYAPEYPCVISQMAKNVPLIDQALGKGTNQPGLHATIEIIVPRAPYQAGKEEPRFDDKRGPRCYDIKDIPKPFPSEPPDGAFKDGTLHQAAPKSVGEGLNPAKFKADSAGNGGSGGDLAYSTAEQGFLADLLGPQLGMSAADVPGWSSLLVGPLYRGAEVTVK	MNFYLEEFNLSIPDSGPYGITSSEDGKVWFTQHKANKISSLDQSGRIKEFEVPTPDAKVMCLIVSSLGDIWFTENGANKIGKLSKKGGFTEYPLPQPDSGPYGITEGLNGDIWFTQLNGDRIGKLTADGTIYEYDLPNKGSYPAFITLGSDNALWFTENQNNSIGRITNTGKLEEYPLPTNAAAPVGITSGNDGALWFVEIMGNKIGRITTTGEISEYDIPTPNARPHAITAGKNSEIWFTEWGANQIGRITNDKTIQEYQLQTENAEPHGITFGKDGSVWFALKCKIGKLNLNE	149.49	gnl|BL_ORD_ID|1080|hsp_num:0	1144		
BGC0000136.1|Rifamycin_7 # 5682 # 6710 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.671	BGC0000136.1|Rifamycin_7 	5682	6710	+	Loose	1300	25.7942	mecB	45.0	3003440	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGAGGGGCCTGCTCGCGCCGCTGATCAAGCTCGGCATCTTCGTGGTCGTCACCGTGCTGTTCACGACGATCCTCGGGATCAGCATCGCCAACATCAACACCACCAGCACCAACGCCTACAACGCGCGCTTCACCGACGCGACGCTGCTGCTGCCCAACGACGACGTCCGCATCGCCGGCGTCCGGGTCGGGCAGGTCAAGGACGTGCACATCGTCGACAAGCGCCAAGCCGAGGTCGAGTTCGAGGTCGACGCCGGCCGGACGCTGCCGGCCGGGGTGACCGCGCAGATCAAGTTCCGCAACCTGGTCGGGCAGCGGTACGTCTCGCTCGGCGAGGGCGACGACAGCGCCGGCAAGACGCTGCCGCCCGGCGGCACCATCCCGCTGGAGCGGACCACGCCGGCGCTGGACCTGACCGAGCTGTTCAACGGCTTCAAGCCGCTGTTCACCGCGCTCAACCCCGAGGACGTCAACAAGCTGTCCTACGAGGTCATCCAGGTCCTGCAGGGCGAGGGCGGCACCGTGGAAAGCCTGCTTTCGCACACGGCGTCGCTGGCCACCACGATCGCCGACAAGGACCAGGTGATCGGCGAGGTCATCGACAACCTCAACTCGGTGCTCGACACGGTCAACGCGCACACGCCGCAGCTCAACGACCTGATCGTGAAGCTGCAGCAGCTGGTGTCCGGGCTGGCCGCCGACCGCAAGCCGATCGGCGACGCGATCGAGAGCCTCGGCAACCTGGCGCAGACGACGTCCGGGCTGCTCGGCGAGGTCCGCGAGCCGCTGAAGAACGACATCGACGCGCTCGGGAACCTGACGAGCGCGCTCAACAAGAACGAGCCGGAGCTGGAGCACTTCATCCAGTTCCTGCCGACCAAGGTGAGCACGCTGACCCGCACCGCGGACTACGGCTCCTGGTTCAACTTCTACGCCTGTGAGTTCTCCGGGAGCGTGAGCTTGCCGCCACTGATCAACGACGTCGCCCTGCCCCTGATCCCGGCGAACCGGGCGAGGTGCCAGGGATGA	MRGLLAPLIKLGIFVVVTVLFTTILGISIANINTTSTNAYNARFTDATLLLPNDDVRIAGVRVGQVKDVHIVDKRQAEVEFEVDAGRTLPAGVTAQIKFRNLVGQRYVSLGEGDDSAGKTLPPGGTIPLERTTPALDLTELFNGFKPLFTALNPEDVNKLSYEVIQVLQGEGGTVESLLSHTASLATTIADKDQVIGEVIDNLNSVLDTVNAHTPQLNDLIVKLQQLVSGLAADRKPIGDAIESLGNLAQTTSGLLGEVREPLKNDIDALGNLTSALNKNEPELEHFIQFLPTKVSTLTRTADYGSWFNFYACEFSGSVSLPPLINDVALPLIPANRARCQG	MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRYKRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITKKWLLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKKNKKNISKLLSISESTLNKKLKQTWVKEGVFLPLKSYIELDDELKLGIQKYHLTVNQTKGRVYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVITSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLALVSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTIDASTSYNIVTKGWQRNSSWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFIKGMKALDIGRNIPSDYYFQKGQIANPESLKNNFKNEILLADSGYGQGEILISPVQILSIYSSLINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFAGKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENKGMSSYNARKFAEIMDELYENGTKKYEIDR	50.74	gnl|BL_ORD_ID|1499|hsp_num:0	1595		
BGC0000136.1|Rifamycin_8 # 6707 # 7693 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.666	BGC0000136.1|Rifamycin_8 	6707	7693	+	Loose	750	27.335	smeD	36.36	3003055	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGTCCTTCCAGAAGCGCAACCCCGTGCCGATCGCGCTGGTCGGGATCGTCGTGCTGGCGCTCGCCTTCACCGCCGCGCTCAACTCCGACGACCTGCCGGTGATCGGCGGGGGCACCACCTACAGCGCCGAGTTCAGCGAGGCTTCCGGGCTGCAGAAGGACAACGACGTCCGGATCGCCGGCGTCAAGGTCGGCAAGGTCAGCGACATCGCGCTCGACGGCGCGTCGGTGAAGGTGTCTTTCAAGGTCAAGGACGCCTGGCTGGGCGACCGGACCAGTGCCGCGATCAAGATCAAGACGTTGCTCGGGCAGAAGTACCTGTCGCTGGACCCGCAGGGTGAGACCGCGCTGAACCCGGGCACCGGCATCCCGCGCGACCGCACGATGGCACCCTACGACGTGCTCGACGCCTTCCGCGGGCTGTCCCAGACCGTCGACAACATCGACACCAAGCAGCTGGCGCAGAGCTTCGACACGATCTCGCAGACCTTCGCCAACACGCCGCAGGACGTGAAGGGCGCGCTGTCGGGGCTGTCGAAGCTGTCGGACACGATCGCCTCGCGCGACCAGCAGCTGTCGAACCTGCTGGCCAACACCCGCCAGGTGTCGCAGACGCTGGTCGACCGCGACGCCGAGGTGCAGAAGCTGCTCGACGACGGCAACGACCTGCTCGCCGAGCTGGCCAAGCGCGAGGACGCGATCACCGCGCTGCTGGACGGCTCCCGCGAGCTGGCCACCCAGCTGCAGGGCCTGATCGACGACAACGGAAAGCAGCTCGACCCGGTGCTGACCCAGCTCGACCAGCTGACGTCGATGCTGCAGCGCAACCAGGACTCCCTCGCCGAGGGGCTCAAGAAGTTCGCGCCGTTCATCCGCGTCTTCACCAACACCATCGGCAACGGCCGCTGGTTCGACAACTACATCTGCGGCCTGCTGCTGCCGTCGTTCGGCCCGATCAACGAAGAGGGGTGCTACACGAAATGA	MKSFQKRNPVPIALVGIVVLALAFTAALNSDDLPVIGGGTTYSAEFSEASGLQKDNDVRIAGVKVGKVSDIALDGASVKVSFKVKDAWLGDRTSAAIKIKTLLGQKYLSLDPQGETALNPGTGIPRDRTMAPYDVLDAFRGLSQTVDNIDTKQLAQSFDTISQTFANTPQDVKGALSGLSKLSDTIASRDQQLSNLLANTRQVSQTLVDRDAEVQKLLDDGNDLLAELAKREDAITALLDGSRELATQLQGLIDDNGKQLDPVLTQLDQLTSMLQRNQDSLAEGLKKFAPFIRVFTNTIGNGRWFDNYICGLLLPSFGPINEEGCYTK	MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFLVAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARLSAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRIGKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVSILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDAVLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQKIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK	83.25	gnl|BL_ORD_ID|263|hsp_num:0	284		
BGC0000136.1|Rifamycin_9 # 7690 # 8874 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAGGGG;rbs_spacer=11bp;gc_cont=0.695	BGC0000136.1|Rifamycin_9 	7690	8874	+	Loose	600	27.335	vanHO	31.58	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAGTGACACCCGCTTCGGACTGGCCCTGACCCGGGGCTTCACCATCGCGATCGTCCTCGCGCTCGTCGTCGCCGGCGGGATCTGGTGGACCCTCAAGGACGCCGGCCGCAACCACCTGACCGCGTACTTCGCCGGCGCCGTCGGCCTGTACGAGGGCAACAGCGTGCGGATGCTCGGCGTCGACATGGGCACGGTCACCAAGATCACCCCGATGGGCAACCAGGTGAAGGTCGACTTCGAGTACGACCGCTCGGTCGCCGTCCCGGCGGACGCGAAGGCGCTCATCGTGGCGCCGTCGCTGGTGTCCGACCGCTACGTCCAGCTGGCCCCGGCCTACACCGGCGGCCCGCGGATCTCCGACGGCGCGGTCATCGGCCTCGACCGCACCGAGGTGCCGCTGGAGGTCGACCAGCTGGCGGCCAGCCTGGCCCGGGTCAGCGAGACCCTCGGCCCGAACGGCGCCAACAAGTCCGGGTCGCTGTCGAACCTGCTGAACACCGCGGCGGCCAACGTCGACGGCAACGGCAAGGCCCTGCACGACACGATCACCAAGCTCGGCCAGGCGGCCGGCACGCTGTCGGGCAACAAGGACGACCTGTTCTCCACCGTCGAGAACCTCGGCAAGTTCTCGCAGACGCTGGCCGACTCCGACAAGCAGGTCCGCAGCTTCGAGAGCCAGCTCGCCGGCGTCAGCGGCTACCTGGCGTCCGAAAAGGACAACCTGGCCGCGACCGTGCAGCAGCTCGGCACGACGCTGACCGCGGTGCAGGCGTTCATCGACGCCAACCACGACCGGCTCAAGTCCAATGTGGACAAGCTGGCCGGCATCACCAAGGTGCTCGTCGACCAGCGCAGCTCGCTCGCCGAGATCCTCGACGTCGCCCCGGTCGGCCTGAGCAACCTGGTCAACACCTACAACGGCGCGGCGGGCACGCTCGACGCCCGGCCGAACCTCAACGAGCTGACCCAGCCGCCGCTGGTGATGATCTGCCGGCTGCTCAAGCAGGTCGGCAGCAAGGGCATTCCGGACGTGCTCGGCAACGCCTGCGAGAGCATCGCCGGCGTGGTCGACAAGGTGATCCCGCTGCCGTCCGTGGCGCAGACCGTGCAGGCCCTGCAGTCCGGTCAGCTGCCGCCGCTGCCGCTGCCCATCGCCGGGCAGCTCTACGGAGGTGGCCAGTGA	MSDTRFGLALTRGFTIAIVLALVVAGGIWWTLKDAGRNHLTAYFAGAVGLYEGNSVRMLGVDMGTVTKITPMGNQVKVDFEYDRSVAVPADAKALIVAPSLVSDRYVQLAPAYTGGPRISDGAVIGLDRTEVPLEVDQLAASLARVSETLGPNGANKSGSLSNLLNTAAANVDGNGKALHDTITKLGQAAGTLSGNKDDLFSTVENLGKFSQTLADSDKQVRSFESQLAGVSGYLASEKDNLAATVQQLGTTLTAVQAFIDANHDRLKSNVDKLAGITKVLVDQRSSLAEILDVAPVGLSNLVNTYNGAAGTLDARPNLNELTQPPLVMICRLLKQVGSKGIPDVLGNACESIAGVVDKVIPLPSVAQTVQALQSGQLPPLPLPIAGQLYGGGQ	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	112.57	gnl|BL_ORD_ID|741|hsp_num:0	786		
BGC0000136.1|Rifamycin_10 # 8871 # 10043 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.689	BGC0000136.1|Rifamycin_10 	8871	10043	+	Loose	500	28.4906	OXY-2-5	40.68	3002400	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	OXY beta-lactamase	GTGAAGAAACTCCTGACCGTCGGGGTGCTGGCCACCGTGTCCGCGCTGGCGCTCTCCGGCTGTGCCTTCAAGGGCATCTACGACCTGCCGCTGCCCGGTGGCGCCGACCTCGGCGACCACCCGTACACGGTGAACGTCGAGTTCCGGGACGTGCTCGACCTGACCCCGCAGGCGGGGGTGAAGGTCGACGAGGTGCCGGTCGGCCGGGTCGAGAACGTCGGGCTCACCAAGGACGGCTGGCACGCGCTGGTCACCTTGCGGGTCAACGGCGACGTCAAGCTGCCGGCCAACGCGATCGCCAACGTCAAGCAGTCCAGCCTGCTCGGGGAGAAGTACGTCGAGCTGGCCTCGCCCGGCGCCGACCAGGCCCACGGCAAGCTCGCCGACAACGCGACCATCCCGCTGGCCCGCACGAACCGCAGCGTCGAGGTCGAAGAGCTGCTCGGGGCGCTGTCCCTGCTGCTCAACGGCGGTGGCGTCGACCAGCTGAACACCATCACCAAGGAGCTCAACAACGCCACGTCCGGCCGCGAGCCGGACATCAAGGCGTTGCTGGACAACGCGAACCAGCTGGTGACGAACCTCGACCGGCAGTCGAAGAACATCACCCGGGCCATCGACGGGCTGAACCGGCTCTCCTCGACCCTCAACGACCAGAAGGACAAGCTGGTCGGCGCGGTCGACAACCTCGGGCCCGGGCTCGGCGTGCTGGAGCAGCAGCGCGGCCAGCTGGTCACCATGCTGCAGGCGCTGGACAACCTCTCCGGCGTCGCCACCGACACGGTGAACAAGTCGCAGAAGGACCTCGTCGCCGACCTGAAGGCGCTGACGCCGACGCTGCAGAAGCTCGGCGAGGCGGGCAACGACCTGCCGAAGGCGCTGGAGATCCTGCTGACTTTCCCGTTCAGCGACCAGGCCGTCAACGGCGTCAAGGGCGACTACTTCAACCTGTTCGCGAAGGTGGACCTGAACCTGAAGACCGTCGTGGAGAACCTGGGCAACAGCCGGCAGAACGCCCTGTCCGGGCAGCTGCCGCTGGCCGGCCTGACCGGCGGGGTGCAGGGCACGCCGGCCAACCAGCCGCCACCGCTGCCGATCCCCGGCACCGGGCAGCAGCAGTCGAAGCCGGGCCTGGGCAACCTCTTCGGGCTCCTGCCGGGAGGTGCGGGCTGA	MKKLLTVGVLATVSALALSGCAFKGIYDLPLPGGADLGDHPYTVNVEFRDVLDLTPQAGVKVDEVPVGRVENVGLTKDGWHALVTLRVNGDVKLPANAIANVKQSSLLGEKYVELASPGADQAHGKLADNATIPLARTNRSVEVEELLGALSLLLNGGGVDQLNTITKELNNATSGREPDIKALLDNANQLVTNLDRQSKNITRAIDGLNRLSSTLNDQKDKLVGAVDNLGPGLGVLEQQRGQLVTMLQALDNLSGVATDTVNKSQKDLVADLKALTPTLQKLGEAGNDLPKALEILLTFPFSDQAVNGVKGDYFNLFAKVDLNLKTVVENLGNSRQNALSGQLPLAGLTGGVQGTPANQPPPLPIPGTGQQQSKPGLGNLFGLLPGGAG	MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTESTLNTAIPGDERDTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGSGDYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL	134.48	gnl|BL_ORD_ID|599|hsp_num:0	643		
BGC0000136.1|Rifamycin_11 # 10043 # 11308 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=9bp;gc_cont=0.703	BGC0000136.1|Rifamycin_11 	10043	11308	+	Loose	2300	27.7202	evgS	23.89	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGATCCGCCGGACGAAGATCCAGCTGATCGCCTTCGTGGTGATCTCGGTCGTCGCGATCGTGTACGCGCTGATCCGGTTCGCCGGGCTCGGCAGCGTGTTCGGCAACGACGGCTACACGGTGAAGTTGCAGCTCAACGAATCGGGCGGCATCTTCACCAACGCCGAGGTGACCTACCGCGGCTACAACATCGGCCGTGTCGGCGAAATGCGGCTCACCGCGACCGGGCTCGAGGCCGACCTCAACATCGACCCCTCGGCGCCGAAGGTACCCGCGGACCTCGATGCCGTCGTCGCCAACCGGTCGGCGGTCGGCGAGCAGTACGTCGACCTCAAGCCGAAGGCCGACCAGGGCCCCTACCTGGCGGCCGGCTCGGTGATCCCGGCGACCAAGACGACCACGCCGGTCAGCACCGACCGGCTGATCGGCGACCTCGACTCGCTCGCCGCGTCGGTCCCGGTCGACTCGCTGCGCACGGTCGTCGACGAGTCCTACGACGCCTTCCGCGGCACCGGCGGCGACCTGCAGAAGCTGCTGGACACCGCGCGCAGCTTCACCACGACGGCGCAGCAGTACCTGCCGCAGACGATCCAGCTGCTGGACGCCGGCGGCCAGGTGCTGGACACGCAGAACGCCGAGGCGGCGAACTTCGCCTCGTTCAGCAAGAGCCTCAACGAGCTCACCGGCACGCTGAAGAACTCCGACGGCGACCTGCGCAAGCTCATCGGGATCACCCCGCAGGTGGCGTCGCAGATCAGCCAGGTGCTGGCCGAATCCGGCCCGGGCCTGGGTGCGCTGACGGCGAACCTGCTCACCACGGCCAACCTGACCGTGACCCGCCTCGACGGGATCGAGCAGGGCCTGGTCACCTACCCGGCGCTGGCCGGCGCGGCGAGCAGCGTGGCGCCCGGCGACGGCACCGCGCACCTCGGCCTGGTGCTCAACCTGTTCAACCCGCCGGCCTGCACGAAGGGGTACCTGCCGTACTCGAAGTACCGCACCGGCAACGACCTCTCGGCGAAGCCGGCGAAGGAAGACGCGTACTGTGCCGAACCGAAGGGCAGCCCGATCAACGTCCGCGGGGCGCAGAACGCGCCCTACGGCGGGGTGCCGGTCGCGCCGTCGGACAGCGACGTCTCGGCCAACGCGAACCGGCCGGCGCAGGAGCTGGCCGAGGAGCGGGACACCCGGGGGGTGCCGGGCATCGTCGGCAGCCCCGGCGTCAGCCTGACCAGCCTGGGCTCGCTGCTCGGCCTGACCTGA	MLIRRTKIQLIAFVVISVVAIVYALIRFAGLGSVFGNDGYTVKLQLNESGGIFTNAEVTYRGYNIGRVGEMRLTATGLEADLNIDPSAPKVPADLDAVVANRSAVGEQYVDLKPKADQGPYLAAGSVIPATKTTTPVSTDRLIGDLDSLAASVPVDSLRTVVDESYDAFRGTGGDLQKLLDTARSFTTTAQQYLPQTIQLLDAGGQVLDTQNAEAANFASFSKSLNELTGTLKNSDGDLRKLIGITPQVASQISQVLAESGPGLGALTANLLTTANLTVTRLDGIEQGLVTYPALAGAASSVAPGDGTAHLGLVLNLFNPPACTKGYLPYSKYRTGNDLSAKPAKEDAYCAEPKGSPINVRGAQNAPYGGVPVAPSDSDVSANANRPAQELAEERDTRGVPGIVGSPGVSLTSLGSLLGLT	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	35.17	gnl|BL_ORD_ID|1243|hsp_num:0	1318		
BGC0000136.1|Rifamycin_12 # 11346 # 11921 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.693	BGC0000136.1|Rifamycin_12 	11346	11921	+	Loose	1000	25.0238	MCR-3.1	29.23	3004139	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAGCACGGACGAGCCGGCCGCCACGTCGGTAGCGGAAGAGTCTTCCGCGGCGCCGCCGAAGGACGCCTCGCGGACCCTGGTGCTCGGCGCCGCGGCACTGGCACTGGCCGCCCTCATCGCGGCGGCGATCTTCGGCGTCCAGTGGTGGATGGCCGCGAACGACGACAACGCCGGCCTGGCGGCGTCGCGCGAGGCCGTGGTGAAGGCGGGCACCAACGCGCTGAAGGCCTACACCGAGGTCGACTACACCGATCTCGACGGCTTCTTCACCCGGCAGAAGGCCGTGTCGGACGAGAAGATGTCGCAGCAGATCGACCAGTCGGCGCCGACGTTCCGCAAGGCCCTCGCCGACGCCAAGACGAAGGTCACCACGGACGTCCAGGACGTCGCCGTCGAGGAGCTGGACGACCACGAAGGCAAGGCCAGCTTCCTCGCCGCCATCGCCACCACCGTCACCCAGGGGGACAAGAGCAGCGCGAAGCCGTTGCGCCTCGAAGTCTCGATGAGCAAGGTGGGCGAGGATTGGAAGCTGTCCGGCATCGACAGCGTCCCGCTCGTCGCGGCCGGCCAGTAG	MSTDEPAATSVAEESSAAPPKDASRTLVLGAAALALAALIAAAIFGVQWWMAANDDNAGLAASREAVVKAGTNALKAYTEVDYTDLDGFFTRQKAVSDEKMSQQIDQSAPTFRKALADAKTKVTTDVQDVAVEELDDHEGKASFLAAIATTVTQGDKSSAKPLRLEVSMSKVGEDWKLSGIDSVPLVAAGQ	MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNFVFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPIIVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGRNNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLDSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTIRYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQVWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNVQ	35.30	gnl|BL_ORD_ID|2474|hsp_num:0	2795		
BGC0000136.1|Rifamycin_15 # 14275 # 15309 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=GGCAG;rbs_spacer=15bp;gc_cont=0.743	BGC0000136.1|Rifamycin_15 	14275	15309	+	Loose	600	34.6538	vanHF	33.72	3002945	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	TTGGTAATGGCTCCCACCGGCGGCGTGGGCGAGTCTCGATACGTGAAGACGTTGCGGCAGCTCGAGGTGGCCCTGATCGGTGCGGGGCTCATCGCCCGGCTGCACCTGGAAGCGTGGCTCGGCGCCGGCGCCGCCGTGCGGGTGTACTCCGACGACGGCCGGAGCCGCGAGCTGGCGGCGGAGTTCGGCGCGAAGGCCGCCGGGTCCCTGGAAGAGGCGCTCGACGGCGCCGACGCCGTCGACATCTGCACGCCGACCGCGAGCCACCACGAGATCGCCCTGACCGCCATCGCCGCCGGTGTCGGCGTCGTGTGCGAGAAGCCGCTGGCGGCCAGCGCCGAAGAGGCCGAAGAGATCGTCACCGCCGCCGAACGGGCCGGGGTGCGGCTCTACGCCGCCCACGACGTGCGGTTCGCGGCGCCCTACGCGCGATTGCACGAGCTCGTTGCGAGCGGGCGGCTCGGGGAGGGTGCCCTCGGCCGGTTCTCCTTCTCCGCCTACCACCCGCGGCCCTGGACCGGGCACGCCTCCGCGCGGTCGGGCGGCATCCTCACCGACCAGCTGCTGCACGGCGCCGACCTCGCCCACTGGGTCTTCGGGGACGTCGTCCGCGTGCACGCCTGCTACCAGGGCGACATCGCCACCCCGGCGCCCGAAGGGGCCGTCGCGACCGGGACCGCCGTGCTCACCCACGCGAGCGGCGCCATCAGCCAGGTGGTGAGCCGGTGGACGGCCACGCCGCGGCCGCCGGTGCGGGTGGCCTTCCACGTCTCGGGTACCGGCGGGTCCGTCAGCTACGACTCCGAGTGGCCGCAGGAGGTCCGGGTCGTCGACGGCGGCGCCGGGAACTTCGCTTACGGCGGGCCGTCGGTGTTCGACACCGAAATGCGGGAGTTCGCCACGGCTTTCGCGGGTGGACCCGAGCCGAGGATCGGCGCGAAGGACGCGCTGGCCGCCGTGCGGATCATCCACGCCGCCGCCGAGTCCGCGTGGACCGGGCGGGCCGTCGAACTGCCGGTGAGGGGAGCAGCGTGA	MVMAPTGGVGESRYVKTLRQLEVALIGAGLIARLHLEAWLGAGAAVRVYSDDGRSRELAAEFGAKAAGSLEEALDGADAVDICTPTASHHEIALTAIAAGVGVVCEKPLAASAEEAEEIVTAAERAGVRLYAAHDVRFAAPYARLHELVASGRLGEGALGRFSFSAYHPRPWTGHASARSGGILTDQLLHGADLAHWVFGDVVRVHACYQGDIATPAPEGAVATGTAVLTHASGAISQVVSRWTATPRPPVRVAFHVSGTGGSVSYDSEWPQEVRVVDGGAGNFAYGGPSVFDTEMREFATAFAGGPEPRIGAKDALAAVRIIHAAAESAWTGRAVELPVRGAA	MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEISESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIRNAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKEAAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGALIKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRALYDTVEKTILNCLEFERRETLE	106.83	gnl|BL_ORD_ID|1691|hsp_num:0	1790		
BGC0000136.1|Rifamycin_16 # 15306 # 16073 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GAGGGG;rbs_spacer=6bp;gc_cont=0.720	BGC0000136.1|Rifamycin_16 	15306	16073	+	Loose	750	24.2534	adeA	37.5	3000774	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGTCGCCATCCTGTCGTCCACGCCCCAGGCCTACGCCGGGGCGCTGCGCGGCCTGCCGGACGTCGAAGTCGTGGCCGCGGCGAGCTGGGACGCGTTCGAGCCCGTCCGGCAAGCGGCCGAGGCCGGCGCGCGCGTGCTGTGCGAATACCCGCCCGCGGCCAAGGAAACCGACCTGAAAGCGATGATCGACGCCGCGGGCGACCGGCTCACGTTCGCGTCCCCGGCCTGCCACGGCGAGGCGTTCGCCGTGGTGCGCAAGGGAATCGCCGACGGTGGCATCGGTGAGCTCACGACCGTCCTCGGCTCGGTGGCCACGAGCGTGGACGGGGTGCTGGGTGCCGCCGCGCCGTACCTGCTCGACCTGGCGGACGCCGTTCTCGGTGGTGAGCCCGCGCAGCAGGTGTACGCCCAGACCAACATCGTCCTCAGTGGACGGATCGGGGAAAGCGCGGCGGTGCTGACCGTGCGGTACCGGAGCGGGCAGGTCGCGTCGTTCGACTGCCGCCGCCACGGTTCCGCGACGGGACTGCCGGCCGTCACCTTCATCGGGGACCAGGGGAGCGTCCAGTACGACGCCGGTCCGCAGCTGCTCGGCGGCGAGCGGCCCGAACTGGGTGGCGAAGACCTGGAGGCGTTGATGCTCAAGGACTTCCTGGGTGCCGGGGACGGGCCCGGACCGGACGGTCAGGCCGCTCTGCGGACGTTCCGGATCATCCAAGCGGCCTACGAATCGGCGCACACGGGGCAGCCCGTCGACCTGTAA	MKVAILSSTPQAYAGALRGLPDVEVVAAASWDAFEPVRQAAEAGARVLCEYPPAAKETDLKAMIDAAGDRLTFASPACHGEAFAVVRKGIADGGIGELTTVLGSVATSVDGVLGAAAPYLLDLADAVLGGEPAQQVYAQTNIVLSGRIGESAAVLTVRYRSGQVASFDCRRHGSATGLPAVTFIGDQGSVQYDAGPQLLGGERPELGGEDLEALMLKDFLGAGDGPGPDGQAALRTFRIIQAAYESAHTGQPVDL	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	64.39	gnl|BL_ORD_ID|1239|hsp_num:0	1313		
BGC0000136.1|Rifamycin_17 # 16262 # 16477 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.653	BGC0000136.1|Rifamycin_17 	16262	16477	+	Loose	650	21.9422	otrC	35.0	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAGTGTTACGCAGGTGAAAATCGCGTTGAGCGGTGGACCGGCCGAACTGGCGCCGGCGCACCGCAGCGTCGACTCCGGCGCGCTGGAGAACACGCTCAAGATCCGCCACGGGGCCGGTTACGAGCATTTCGTGCACGGCGGCGAATTCCAGGCCGTCGACGGCTGCGACATCGCGGTCTTCCGGTGGTCGCACCGCACGAAGATCGCCGAATAA	MSVTQVKIALSGGPAELAPAHRSVDSGALENTLKIRHGAGYEHFVHGGEFQAVDGCDIAVFRWSHRTKIAE	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	20.23	gnl|BL_ORD_ID|1880|hsp_num:0	1991		
BGC0000136.1|Rifamycin_18 # 16510 # 17700 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.693	BGC0000136.1|Rifamycin_18 	16510	17700	+	Loose	650	28.8758	MexA	33.33	3000377	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGACGCAATATCCTTCGAGGTGCCGTGGGACCGGACCGACAAGTTCGACCCGCCCGCGGTGTTCGACTCTCTGCGCGAAGAACGTCCGCTCGCGAAGATGGTTTACCCGGATGGGCACGTCGGCTGGATCGTTTCCAGCTACGAGCTGGTCCGCGAGGTCCTCAGCGACCTGCGGTTCAGCCACAGCTGCGAAGTCGGCCACTTCCCGGTGACCCACCAGGGCCAGGTCATCCCGACCCACCCGCTGATCCCCGGCATGTTCATCCACATGGACCCGCCCGAGCACACGCGCTACCGCAAGCTGCTGACCGGCGAGTTCACCGTCCGCCGCGCCAGCAGGCTGATCCCGCGGGCCGAGGCCGTGGCCGCCGAGCAGATCGAGGTCATGCGGGCCAAGGGCGCCCCCGCGGACGTGGTCATGGACTTCGCCAAGCCGCTGGTGCTGCGGATGCTGGGCGAGCTCGTCGGCCTGCCCTACGAGGAACGCGACCGGTACGTGCCCGCGGTGACCCTCCTGCACGACGCCGAAGCGGACCCGGCCGAGGCCGCGGCCGCCTACGAGGTGGCCGGGAAGTTCTTCGACGAGGTCATCGAGCGCCGCCGGCAGCGGCCCCAGGACGACCTCATCAGCTCGCTCGTCACCGAGGACCTGACCCAGGAGGAGCTGCGCAACATCGTCACCCTGCTGCTGTTCGCCGGGTACGAGACCACCGAGGGCGCGCTCGCCACCGGCGTCTTCGCGCTGCTGCACCACACCGATCAGCTGGCGGCACTGCGCGCGGAGCCGGAAAAGCTCGACGCCGCGATCGAAGAGCTGCTGCGCTACCTGACCGTCAACCAGTACCACACCTACCGCACCGCGCTGGAGGACGTGAAGCTGGAGGGCGAGCTGATCAAGAAGGGCGACACGGTGACGGTGTCGCTGCCCGCGGCCAACCGCGACCCGGCCAAGTTCGGCTGTCCCGCGGAGCTCGACATCGAGCGGGACACCTCCGGCCACGTCGCGTTCGGCTTCGGCATCCACCAGTGCCTGGGCCAGAACCTGGCGCGCATCGAGCTGCGGGCCGGCTTCACGGCGCTCCTGCGGGCGTTCCCCGAGCTCCGGCTGGCCGTCCCGGCCGACGAGGTTCCGCTGCGGCTGAAGGGTTCCGTCTTCTCGGTGAAGAAGCTGCCCGTCTCCTGGTGA	MTDAISFEVPWDRTDKFDPPAVFDSLREERPLAKMVYPDGHVGWIVSSYELVREVLSDLRFSHSCEVGHFPVTHQGQVIPTHPLIPGMFIHMDPPEHTRYRKLLTGEFTVRRASRLIPRAEAVAAEQIEVMRAKGAPADVVMDFAKPLVLRMLGELVGLPYEERDRYVPAVTLLHDAEADPAEAAAAYEVAGKFFDEVIERRRQRPQDDLISSLVTEDLTQEELRNIVTLLLFAGYETTEGALATGVFALLHHTDQLAALRAEPEKLDAAIEELLRYLTVNQYHTYRTALEDVKLEGELIKKGDTVTVSLPAANRDPAKFGCPAELDIERDTSGHVAFGFGIHQCLGQNLARIELRAGFTALLRAFPELRLAVPADEVPLRLKGSVFSVKKLPVSW	MQRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNAFRIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRYKLLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVTNGQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYPLEGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTRDLKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKTVPAKNVASAQKADAAPAKTDSKG	103.39	gnl|BL_ORD_ID|451|hsp_num:0	440		
BGC0000136.1|Rifamycin_19 # 17741 # 31948 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.737	BGC0000136.1|Rifamycin_19 	17741	31948	+	Loose	700	29.6462	ACC-3	24.37	3001817	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	GTGCGCACCGATCTCATCAAGCCACTTCACGTCGCACTCCTGGAGAACGCGACCCGCTTCGCCGGCAAGCCGGCCTTCGCCGACGACCACCGGACGGTCACCTACGGCGACCTCGAGGCGCGGACGCGCCGGCTGGCCGGGCACCTGGCCGGCCTCGGTGTCCGGCACGGCGACCGGGTGGCGATCTGCCTCGGCAACCGGGTGTCCACTGTGGAGAGTTACTTCGCGATCCTGCGCGCGGGTGCCGTCGGCGTGCCGCTCAACCCCGGTTCGGCGACGGCCGAGCTCGAGCACCCGCTGACCGACAGCGGCGCCACGGTGGTCGTCACCGACGCCGCCCAGGCGGCCCGGCTCCGGCTCGCGCCGCACGTCGAGCTGCTGGTGACCGGCGACGACGTCCCGGAGGGCGCCCACTCCTACGACGAACTCGCCCTCAGCGAACCGGCCGAGCCCGCCGCGGACGACCTCGAGCTCGACGAGCCGGCGTGGATGTTCTACACGTCGGGCACGACCGGGCGGCCCAAGGGCGTCGTGTCCACGCAGCGCAACTGCCTCTGGTCCGTCGCTTCCTGCTACGTGCCGTTCCCCGGGTTGTCGGACCAGGACCGGGTGCTCTGGCCGCTCCCGCTGTTCCACAGCCTTTCGCACATCGCCTGCGTCCTGTCCGCCACCGTGGTCGGGGCCAGCGTCCGGATCGCCGACGGCAGCTCCGCCGACGACGTGATGCGGCTGATCGAGGCGGAGAGCTCGACCTTCCTGGCCGGCGTGCCGACCACCTACCACCACCTGGTGCGGGCCGCCCGGCAGCGCGGTTTCTCCGCGCCGAGCCTGCGGATCGGCCTGGCCGGGGGCGCGGTCCTCGGCGCCGGGCTGCGAAGCGAGTTCGAAGAGACCTTCGGGGTCCCGCTGATCGACGCCTACGGCAGCACCGAGACCTGCGGGGCGATCACCATGAACCCGCCGGACGGCGCCCGCGTCGAGGGCTCGTGCGGCTTGGCCGTGCCGGGCGTCGACGTGCGGGTCGTCGACCCCGACACCGGGCTCGACGTCCCCGCCGGCGAGGAGGGCGAGGTCTGGGTCAGCGGGCCGAACGTCATGCTCGGCTACCACAACAGCCCGGAGGCGACCGCCGCGGCGATGCGGGACGGCTGGTTCCGGACCGGGGACCTGGCCCGCCGCGACGACGCCGGTTACTTCACCATCTGCGGCCGGATCAAGGAACTCATCATCCGCGGCGGCGCGAACATCCACCCCGGCGAGGTCGAGGCGGTCCTGCGCACGGTCGACGGCGTCGCGGACGCGGCGGTCGGCGGTGTGCCGCACGACACGCTCGGCGAGGTGCCGGTCGCCTACGTCATCCCCGGACCGACCGGTTTCGATCCTGCGGCGTTGATCGAGAAGTGCCGCGAACAGCTGTCCGCCTACAAGGTGCCGGACCGGATCCTCGAGGTCGCCCACATTCCCCGGACCGCGTCGGGCAAGATCCGGCGCGGGCTGCTGACCGACGAGCCCGCGCAGCTGCGGTACGCCGCGACCGAACACGAGGAACAGTCCCGGCACGCCGACGAGTCCGTCGCGGCGGCGCTGCGCGCGCGACTGTCCGGTTTGGACGAACGCGCCCAGTGCGAGCTCCTGGAAGACCTCGTCCGCACCCAGGCGGCCGACGTGCTGGGGCAGCCGGTCCCGGACGGGCGTGCGTTCCGCGACCTCGGCTTCACGTCGCTGGCCATCGTGGAGCTGCGCAACCGGCTGACCGAGCACACCGGGCTCTGGCTGCCCGCCAGCGCCGTCTTCGACCACCCCACGCCGGCGGCGCTGGCCGCCCGCGTCCGGGCTGAGCTCCTCGGGATCACGCAGGCCGTCGCGGAGCCGGTCGTCGCGGCCGACCCGGGCGAGCCGATCGCGATCGTGGGGATGGCCTGCCGCCTGCCGGGTGGCGTGGCGTCCCCGGAAGACCTGTGGCGGCTGGTGGCCGAGCGCGTCGACGCCGTTTCGGAGTTCCCCGGCGACCGCGGCTGGGACCTGGACAGCCTGATCGACCCGGACCGGGAGCGCGCCGGGACGTCGTACGTCGGCCAGGGCGGATTCCTGCACGACGCCGGCGAGTTCGACGCCGGGTTCTTCGGGATCTCGCCGCGTGAGGCCGTCGCGATGGACCCGCAGCAGCGGTTGCTGCTGGAGACGTCGTGGGAGGCCCTCGAAAACGCCGGAGTCGACCCGATCGCGTTGAAGGGCACCGACACCGGCGTGTTCTCCGGCCTCATGGGCCAGGGGTACGGGTCCGGCGCGGTGGCGCCGGAGCTCGAAGGTTTCGTCACCACCGGGGTCGCGTCGAGCGTGGCCTCGGGCCGGGTGTCGTACGTGCTGGGACTGGAAGGCCCGGCGGTCACCGTGGACACCGCGTGTTCGTCGTCGCTGGTCGCGATGCACCTGGCCGCGCAGGCCCTGCGGCAGGGCGAATGCTCGATGGCGCTCGCCGGCGGGGTCACGGTGATGGCCACGCCGGGCTCGTTCGTCGAGTTCTCCCGCCAGCGGGCCCTGGCGCCCGACGGGCGCTGCAAGGCCTTCGCGGCGGCGGCCGACGGGACCGGCTGGTCCGAGGGTGTCGGCGTGGTCGTCCTCGAGCGGCTGTCCGTGGCGCGCGAGCGGGGCCACCGGATCCTGGCCGTTTTGCGTGGCAGCGCGGTCAACCAGGACGGCGCGTCCAACGGGCTCACCGCGCCGAACGGCCTCTCGCAGCAGCGGGTCATCCGCCGCGCGCTGGCCGCGGCCGGGCTGGCACCGTCCGATGTGGACGTCGTCGAGGCGCACGGCACCGGGACCACGCTGGGTGACCCGATCGAGGCGCAGGCCCTGCTGGCGACCTACGGCCAGGAGCGGAAGCAGCCGTTGTGGCTCGGTTCGCTCAAGTCGAACATCGGCCACGCGCAGGCGGCCGCGGGCGTTGCGGGCGTCATCAAGATGGTGCAGGCGCTGCGGCACGAGACCTTGCCGCCGACGCTGCATGTCGACAAGCCGACTCTTGAGGTGGACTGGTCCGCCGGTGCCATTGAACTGCTGACGGAGGCCCGTGCGTGGCCGCGCAACGGCCGTCCGCGCCGGGCCGGGGTGTCGTCGTTCGGCGTCAGCGGGACCAACGCGCACCTGATCCTGGAGGAGGCGCCGGCCGAGGAGCCGGTCGCTGCCCCGGAACTGCCGGTGGTGCCCCTGGTGGTGTCGGCGCGGAGCACGGAGTCGCTGTCCGGGCAGGCCGAGCGGCTGGCGTCCCTCCTCGAAGGGGACGTCTCGCTGACCGAGGTGGCCGGGGCGCTGGTGTCCCGCCGGGCGGTGCTGGACGAGCGGGCCGTCGTCGTGGCCGGTTCGCGCGAGGAAGCCGTGACCGGGCTGCGGGCGCTGAACACGGCCGGTTCGGGGACGCCGGGCAAGGTCGTGTGGGTGTTCCCGGGGCAGGGGACGCAGTGGGCCGGGATGGGCCGTGAGCTGCTGGCCGAGTCCCCGGTGTTCGCCGAGCGGATCGCCGAGTGCGCGGCCGCGTTGGCGCCGTGGATCGACTGGTCGCTCGTCGACGTCCTGCGCGGCGAGGGCGACCTGGGTCGGGTCGATGTGCTGCAGCCGGCCTGTTTCGCGGTGATGGTCGGGCTGGCTGCCGTCTGGGAGTCCGTGGGGGTCCGGCCGGACGCCGTCGTCGGGCACTCGCAGGGTGAGATCGCGGCTGCCTGCGTTTCGGGGGCGTTGTCCCTCGAGGACGCGGCGAAGGTGGTGGCCCTGCGCAGCCAGGCCATCGCGGCGGAACTGTCCGGCCGCGGCGGGATGGCGTCGGTCGCCCTGGGCGAGGACGACGTCGTTTCGCGGCTGGTGGACGGGGTCGAGGTCGCCGCCGTCAACGGCCCGTCGTCGGTGGTGATCGCCGGGGATGCCCATGCCCTCGACGCGACCCTGGAAATCTTGTCCGGGGAAGGCATCCGGGTTCGGCGGGTGGCGGTGGACTACGCCTCGCACACCCGGCATGTCGAGGACATCCGCGACACTCTTGCCGAAACCTTGGCCGGGATCAGTGCGCAGGCGCCGGCTGTGCCGTTCTACTCCACCGTCACGAGCGAGTGGGTGCGCGACGCGGGGGTGCTGGACGGCGGCTACTGGTACCGGAACCTGCGCAACCAGGTCCGGTTCGGAGCGGCCGCGACGGCCCTGCTCGAGCAGGGCCACACGGTGTTCGTCGAGGTCAGTGCGCACCCGGTGACGGTCCAGCCCTTGAGCGAGCTCACCGGGGACGCGATCGGGACATTGCGGCGTGAAGACGGTGGCCTGCGGCGGTTGCTGGCTTCGATGGGTGAGCTGTTCGTCCGCGGCATCGACGTGGACTGGACGGCGATGGTGCCCGCGGCCGGCTGGGTCGACTTGCCGACCTACGCGTTCGAACACCGGCACTACTGGCTCGAGCCCGCCGAGCCCGCTTCGGCCGGAGACCCGCTGCTGGGCACAGTCGTCAGCACTCCCGGTTCGGACCGACTCACCGCCGTGGCGCAGTGGTCGCGCCGGGCGCAGCCCTGGGCGGTGGACGGCCTGGTGCCGAACGCGGCCCTGGTCGAGGCGGCCATCCGGCTCGGCGACCTGGCCGGCACCCCCGTCGTCGGCGAACTGGTCGTCGACGCGCCGGTGGTGCTGCCGCGGCGCGGCAGCCGCGAGGTCCAGCTGATCGTCGGCGAGCCCGGCGAGCAGCGGCGGCGTCCGATCGAGGTCTTTTCCCGGGAAGCCGACGAGCCGTGGACGCGGCACGCGCACGGCACACTCGCTCCCGCCGCCGCTGCGGTGCCAGAACCGGCGGCGGCGGGAGACGCCACCGACGTCACCGTGGCCGGCCTGCGCGACGCGGACCGGTACGGGATCCACCCCGCGCTGCTGGACGCCGCCGTCCGCACGGTCGTCGGCGACGACCTGCTCCCGTCGGTGTGGACCGGCGTGTCCCTGCTGGCCTCCGGGGCCACGGCCGTGACCGTGACGCCGACGGCGACCGGCCTGCGGCTGACCGACCCGGCCGGGCAGCCCGTCCTGACCGTCGAATCCGTGCGCGGCACGCCGTTCGTCGCCGAGCAGGGGACCACCGACGCGCTCTTCCGCGTCGACTGGCCGGAAATCCCGCTGCCCACCGCCGAAACCGCGGACTTCCTGCCGTACGAAGCCACGTCGGCCGAGGCGACCCTCTCCGCGCTCCAGGCCTGGCTGGCAGACCCCGCGGAAACCCGGCTGGCCGTGGTCACCGGGGACTGCACCGAACCCGGCGCGGCCGCGATCTGGGGCCTGGTGCGCTCGGCGCAGTCCGAACACCCCGGCCGGATCGTGCTGGCCGACCTCGACGACCCCGCCGTGCTGCCCGCCGTGGTGGCGAGCGGCGAACCGCAGGTGCGGGTGCGCAACGGCGTCGCCTCGGTGCCGCGCTTGACCCGGGTTACTCCCCGGCAGGACGCGCGGCCGCTCGACCCCGAGGGCACCGTCCTGATCACCGGCGGCACCGGCACGCTCGGTGCGCTGACCGCCCGGCACCTCGTCACCGCGCACGGCGTCCGGCACCTGGTGCTGGTCAGCCGCCGCGGTGAGGCTCCCGAGCTGCAGGAAGAACTGACCGCACTGGGGGCATCCGTCGCCATCGCCGCCTGCGACGTGGCAGACCGGGCGCAGCTCGAAGCCGTCTTGCGCGCGATCCCGGCCGAGCACCCGCTCACCGCCGTGATCCACACCGCGGGGGTCCTCGACGACGGCGTCGTCACCGAGCTGACCCCGGACCGGCTCGCCACCGTGCGGCGGCCGAAGGTCGACGCCGCCCGGCTCCTGGACGAGCTCACCCGGGAGGCCGATCTCGCCGCGTTCGTGCTGTTCTCCTCGGCGGCGGGTGTGCTGGGCAACCCCGGCCAGGCCGGGTACGCCGCCGCCAACGCCGAGCTGGATGCGTTGGCGCGCCAGCGGAACAGCCTCGACCTGCCCGCGGTGTCCATCGCATGGGGCTACTGGGCGACGGTCAGCGGGATGACCGAGCACCTGGGCGACGCCGACCTGCGGCGCAACCAGCGGATCGGCATGTCCGGGCTTCCCGCCGACGAGGGCATGGCGCTGCTGGACGCCGCCATCGCCACCGGTGGCACGCTGGTCGCGGCCAAGTTCGACGTCGCCGCGCTGCGGGCGACGGCGAAGGCCGGCGGCCCGGTGCCGCCGCTGCTGCGTGGCCTGGCCCCGCTGCCGCGCCGGGCGGCGGCCAAGACCGCGTCGCTGACCGAACGCCTCGCCGGGCTGGCCGAGACCGAGCAGGCCGCGGCCCTGCTCGACCTGGTCCGGCGGCACGCCGCCGAGGTGCTCGGGCACAGCGGCGCCGAATCCGTCCATTCAGGACGGACGTTCAAGGACGCCGGCTTCGACTCGCTGACCGCGGTGGAACTGCGGAACCGCCTCGCGGCCGCGACCGGGCTCACCCTGTCCCCGGCGATGATCTTCGACTACCCGAAGCCCCCGGCGCTCGCGGACCACCTGCGCGCCAAGCTCTTCGGATCGGCGGCGAACCGGCCGGCCGAGATCGGCACCGCCGCGGCCGAGGAGCCGATCGCGATCGTCGCGATGGCGTGCCGCTTCCCCGGTGGCGTGCACAGCCCCGAGGACCTGTGGCGGCTGGTCGCCGACGGCGCCGACGCCGTCACCGAGTTCCCCGCCGACCGCGGCTGGGACACCGACCGGCTCTACCACGAAGACCCCGACCACGAAGGCACGACGTACGTCCGGCACGGCGCCTTCCTCGACGACGCCGCCGGGTTCGACGCCGCCTTCTTCGGCATCTCGCCGAACGAGGCGCTCGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGACGTCCTGGGAGCTGTTCGAGCGGGCCGCGATCGACCCGACCACGCTGGCCGGCCAGGACATCGGCGTCTTCGCCGGCGTCAACAGCCACGACTACAGCATGCGGATGCACCGGGCCGCCGGTGTCGAGGGCTTCCGGCTCACCGGCGGTTCGGCCAGCGTGCTCTCCGGCCGCGTCGCCTACCACTTCGGCGTCGAAGGCCCGGCCGTCACGGTCGACACGGCCTGCTCGTCTTCGCTGGTCGCGCTGCACATGGCGGTGCAGGCCCTGCAGCGCGGCGAGTGCTCCATGGCGCTCGCGGGCGGCGTGATGGTGATGGGCACGGTCGAGACGTTCGTCGAGTTCTCGCGGCAGCGCGGGCTGGCCCCCGACGGCCGCTGCAAGGCGTTCGCCGACGGCGCGGACGGCACCGGCTGGTCCGAGGGCGTCGGGCTGCTCCTGGTGGAGCGGCTGTCCGAGGCTCAGCGTCGCGGGCACCAGGTCCTCGCCGTGGTCCGCGGGTCGGCGGTCAACTCCGACGGCGCGTCGAACGGCTTGACGGCCCCGAACGGCCCGTCCCAGCAGCGCGTGATCCGCAAGGCACTGGCCGCCGCCGGACTGTCCACATCGGACGTCGACGCGGTGGAGGCGCACGGCACCGGGACGACCCTGGGCGACCCGATCGAGGCCGAGGCGCTGCTGGCCACCTACGGCCAGAACCGGGAAACGCCGCTGTGGCTCGGGTCGGTGAAGTCGAACCTCGGGCACACGCAGGCGGCTGCGGGTGTCGCAGGCGTGATCAAGATGGTCATGGCCATGCGCCACGGCGTCCTGCCCCGGACGCTGCACGTCGACCGGCCGTCGTCCTATGTGGACTGGTCGGCCGGTGCGGTCGAGCTGCTGACCGAGGCACGGGACTGGGTGAGCAACGGCCACCCGCGCCGCGCGGGCGTGTCGTCGTTCGGCATCGGCGGCACCAACGCGCACGTCGTCCTCGAAGAGGTTGCCGCACCGATCACCACGCCGCAGCCTGAGCCGGCCGAGTTCCTGGTGCCGGTGCTCGTCTCCGCGCGGACGGCGGCGGGTCTGCGCGGCCAGGCCGGACGGCTCGCCGCGTTCCTCGGCGACCGGACCGACGTCCGCGTCCCCGATGCCGCCTACGCACTGGCCACCACGCGCGCCCAGCTCGACCACCGGGCCGTCGTCCTGGCCTCCGACCGGGCACAGCTCTGCGCGGACCTTGCCGCGTTCGGCTCCGGCGTCGTGACCGGAACGCCGGTTGACGGCAAGCTGGCCGTGCTCTTCACCGGCCAGGGCAGCCAGTGGGCCGGGATGGGCCGTGAACTCGCCGAGACGTTCCCGGTCTTCCGCGACGCCTTCGAGGCCGCGTGCGAGGCCGTGGACACGCACCTGCGTGAGCGTCCGCTGCGCGAGGTCGTGTTCGACGACAGCGCGCTGCTCGACCAGACGATGTACACCCAGGGCGCCCTGTTCGCCGTGGAGACCGCGTTGTTCCGGCTCTTCGAGTCCTGGGGTGTGCGGCCGGGTCTCCTCGCCGGTCACTCGATCGGCGAGCTCGCCGCCGCGCACGTGTCCGGCGTGCTGGACCTGGCCGACGCGGGCGAGCTGGTCGCCGCGCGCGGCCGGCTGATGCAGGCCCTGCCCGCGGGCGGCGCGATGGTCGCCGTCCAGGCGACCGAGGACGAAGTCGCGCCCCTGCTCGACGGCACGGTCTGCGTCGCCGCGGTCAACGGTCCGGACTCGGTGGTGCTCTCCGGCACCGAAGCCGCCGTGCTCGCCGTCGCGGATGAACTGGCTGGTCGCGGCCGTAAGACCCGACGGCTGGCCGTGAGCCACGCCTTCCACTCGCCGCTCATGGAACCGATGCTCGACGACTTCCGCGCGGTCGCCGAACGCCTGACGTACCGGGCCGGTTCGCTGCCCGTCGTCTCGACGCTGACCGGGGAACTCGCGGCGCTCGACAGCCCGGACTACTGGGTCGGCCAGGTGCGCAACGCCGTGCGGTTCAGCGACGCCGTCACCGCGCTGGGCGCCCAAGGCGCGTCGACGTTCCTCGAGCTCGGCCCGGGCGGTGCGCTCGCCGCGATGGCGCTCGGCACGCTCGGCGGACCCGAGCAGAGCTGCGTCGCGACCCTGCGCAAGAACGGCGCCGAGGTGCCCGACGTCCTCACCGCGCTCGCCGAACTGCACGTCCGGGGCGTGGGCGTCGACTGGACGACCGTGCTCGACGAACCGGCCACGGCGGTCGGGACCGTCCTGCCCACCTACGCGTTCCAGCACCAGCGCTTCTGGGTCGACGTCGACGAAACAGCGGCCGTCAGCGTCACCCCGCCGCCGGCGGAGCCGATCGTGGACCGGCCGGTGCAGGACGTGCTGGAGCTGGTCCGGGAGAGCGCCGCGGTGGTGCTCGGGCACCGGGACGCCGGCAGTTTCGACCTCGACCGGTCCTTCAAGGACCACGGCTTCGACTCGCTCAGCGCGGTCAAGCTGCGCAACCGTCTGCGCGACTTCACCGGCGTGGAGCTGCCCAGCACCCTGATCTTCGACTACCCGAACCCGGCCGTCCTCGCGGACCACCTGCGGGCCGAACTGCTCGGCGAGCGCCCGGCCGCGCCGGCCCCGGTGACGAGGGACGTCTCCGACGAGCCGATCGCGATCGTCGGCATGAGCACCCGGCTGCCGGGTGGCGCCGACAGCCCCGAAGAGCTGTGGAAGCTCGTCGCGGAGGGACGGGACGCCGTGTCCGGCTTCCCCGTCGACCGCGGCTGGGACCTCGACGGCCTCTACCACCCGGACCCCGCCCACGCCGGGACGAGCTACACGCGTTCGGGCGGCTTCCTGCACGACGCGGCCCAGTTCGACGCCGGGCTCTTCGGGATCTCACCGCGTGAGGCCCTGGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGACGTCGTGGGAAGCCTTGGAGCGCGCGGGGGTCGACCCGCTGTCCGCCCGCGGCAGCGACGTCGGCGTCTTCACCGGGATCGTCCACCACGACTACGTGACGCGGCTGCGCGAAGTGCCCGAAGACGTCCAGGGCTACACGATGACCGGCACGGCTTCGAGCGTGGCGTCGGGCCGGGTGGCGTACGTCTTCGGCTTCGAGGGCCCGGCGGTCACCGTGGACACCGCGTGTTCGTCGTCGCTGGTCGCGATGCACCTGGCGGCGCAGGCGCTGCGGCAGGGGGAGTGCTCGATGGCCCTGGCCGGCGGCGCGACCGTGATGGCCAGCCCGGACGCCTTCCTCGAGTTCTCCCGCCAGCGCGGCCTGTCCGCGGACGGCCGGTGCAAGGCGTACGCGGAAGGCGCGGACGGCACGGGCTGGGCCGAGGGCGTCGGTGTCGTCGTCCTCGAACGGCTTTCGGTGGCACGCGAACGTGGCCACCGGGTGCTGGCGGTCCTGCGCGGCAGCGCGGTGAACCAGGACGGTGCTTCCAACGGCCTGACCGCCCCGAACGGGCCGTCGCAGCAGCGGGTGATCCGCGGCGCGCTGGCGAGCGCCGGGCTGGCACCGTCCGATGTGGACGTCGTGGAGGGCCACGGGACCGGGACCGCGCTGGGTGACCCGATCGAGGTCCAGGCGCTGCTGGCCACCTACGGGCAGGAGCGGGAACAGCCGTTGTGGCTCGGCTCGCTGAAGTCGAACCTCGGGCACACGCAGGCCGCGGCCGGGGTCGTGGGCGTGATCAAGATGATCATGGCCATGCGCCACGGCGTCATGCCGGCCACGCTGCACGTCGACGAGCGCACGAGCCAGGTCGACTGGTCGGCGGGCGCGATCGAGGTGTTGACCGAGGCCCGGGAGTGGCCGCGCACCGGACGTCCGCGCCGGGCCGGGGTGTCCTCCTTCGGCGCCAGCGGCACCAACGCGCACCTGATCATCGAGGAAGGTCCCGCCGAAGAGGCCGTGGACGAAGAGGTGGCCTCCGTGGTGCCGCTGGTCGTCTCCGCCCGCAGCGCCGGTTCGCTGGCCGGGCAGGCCGGGCGCCTGGCCGCGGTCCTCGAGAACGAATCGTTGGCCGGGGTGGCCGGTGCCCTGGTTTCCGGCCGCGCGACGCTGAACGAGCGCGCGGTCGTCATCGCGGGCTCCCGCGACGAGGCCCAGGACGGCCTGCAGGCACTGGCCCGCGGCGAGAACGCGCCCGGCGTCGTGACCGGGACGGCGGGCAAGCCGGGCAAGGTCGTCTGGGTCTTCCCCGGCCAGGGCTCGCAGTGGATGGGCATGGGCCGGGACCTCCTGGACTCCTCGCCGGTGTTCGCCGCGCGGATCAAGGAATGCGCTGCGGCACTGGAACAGTGGACCGACTGGTCGCTGCTGGACGTGCTGCGCGGCGACGCCGACCTGCTGGACCGGGTCGACGTGGTGCAGCCGGCCAGCTTCGCGATGATGGTCGGGCTCGCCGCGGTGTGGACCTCGCTGGGGGTGACCCCGGATGCGGTGCTCGGCCACTCCCAGGGCGAGATCGCCGCGGCGTGCGTGTCCGGCGCGCTGTCGCTGGACGACGCGGCGAAGGTGGTCGCGTTGCGCAGCCAGGCGATCGCGGGGGAGCTGGCGGGCCGCGGCGGGATGGCGTCGGTCGCACTGAGCGAAGAGGACGCAGTCGCGCGGCTGACGCCGTGGGCGAACCGGGTCGAGGTGGCCGCGGTCAACAGCCCGTCCTCGGTCGTCATCGCGGGAGACGCGCAGGCCCTCGACGAAGCCCTCGAAGCCCTGGCCGGCGACGGTGTCCGGGTCCGGCGGGTCGCGGTGGACTACGCCTCCCACACCCGGCACGTCGAGGCGATCGCCGAAACCCTGGCCAAGACCTTGGCCGGGATCGACGCGCGGGTTCCGGCGATTCCGTTCTATTCCACCGTCCTGGGCACGTGGATCGAGCAGGCCGTCGTCGACGCGGGCTACTGGTACCGGAACCTGCGGCAGCAGGTGCGGTTCGGCCCCTCGGTGGCGGACCTGGCCGGGCTGGGGCACACGGTGTTCGTGGAGATCAGCGCCCACCCGGTGCTGGTCCAGCCGCTGAGCGAGATCAGCGACGACGCGGTGGTGACCGGGTCGCTGCGGCGGGACGACGGGGGACTGCGGCGCCTGCTGGCGTCGGCGGCCGAACTGTACGTCCGGGGCGTGGCCGTGGACTGGACGGCGGCCGTGCCCGCGGCCGGCTGGGTGGACCTGCCGACGTACGCCTTCGACCGCCGCCACTTCTGGCTGCACGAAGCCGAGACCGCCGAAGCCGCCGAGGGCATGGACGGCGAGTTCTGGACGGCGATCGAACAGTCCGATGTGGACAGCTTGGCCGAGCTGCTCGAGCTGGTGCCGGAGCAGCGCGGGGCGCTCAGCACCGTCGTGCCCGTGCTGGCGCAGTGGCGGGACCGGCGCCGCGAGCGCTCGACCGCGGAGAAGCTGCGCTACCAGGTCACCTGGCAGCCCCTGGAGCGCGAAGCCGCCGGCGTGCCGGGCGGGCGCTGGCTGGCCGTCGTCCCGGCCGGCACCACCGACGCGCTCCTGAAGGAGCTGACCGGCCAGGGACTCGACATCGTCCGGCTGGAGATCGAGGAAGCTTCGCGGGCACAGCTCGCCGAGCAGCTGCGGAACGTCCTGGCGGAGCACGACCTCACCGGCGTGCTGTCGCTGCTCGCTCTCGACGGCGGCCCCGCGGACGCGGCCGAGATCACCGCGTCGACGCTCGCGCTGGTCCAGGCCCTGGGCGACACCACCACGTCCGCGCCGCTGTGGTGCCTCACTTCCGGCGCGGTGAACATCGGCATCCAGGACGCCGTGACCGCACCGGCCCAGGCGGCCGTGTGGGGGCTCGGCCGGGCCGTCGCGCTGGAGCGCCTCGACCGGTGGGGCGGCCTGGTCGACTTGCCCGCCGCGATCGACGCCCGCACGGCTCAGGCCCTGCTCGGCGTCCTGAACGGCGCCGCCGGGGAAGACCAGCTCGCGGTCCGGCGCTCGGGCGTCTACCGCAGGCGGCTGGTCCGCAAGCCCGTGCCGGAGTCCGCGACGAGCCGGTGGGAACCCCGCGGCACGGTCCTGGTGACCGGTGGGGCCGAAGGACTCGGCCGGCACGCCTCGGTCTGGCTCGCGCAGTCCGGCGCCGAACGGCTCATCGTCACCGGCACCGACGGCGTCGACGAACTGACGGCCGAGCTGGCCGAGTTCGGCACCACGGTCGAGTTCTGCGCCGACACCGACCGGGACGCGATCGCGCAGCTGGTGGCGGACTCGGAGGTCACCGCCGTGGTGCACGCCGCGGACATCGCGCAGACCAGCTCCGTCGACGACACCGGCGTGGCCGACCTCGACGAGGTGTTCGCCGCGAAGGTGACCACCGCGGTGTGGCTGGACCAGCTGTTCGAGGACACCCCGCTCGACGCGTTCGTCGTGTTCTCCTCGATCGCCGGCATCTGGGGCGGTGGCGGGCAGGGCCCGGCGGGTGCGGCGAACGCCGTCCTCGACGCCCTGGTCGAATGGCGCCGGGCCCGCGGCCTCAAGGCGACGTCGATCGCCTGGGGCGCGCTCGACCAGATCGGCATCGGCATGGACGAGGCCGCCCTCGCCCAGCTGCGCCGCCGCGGTGTCATCCCGATGGCGCCGCCGCTGGCGGTCACCGCGATGGTGCAGGCGGTCGCCGGCAACGAGAAGGCCGTGGCGGTGGCCGACATGGACTGGGCCGCCTTCATCCCGGCGTTCACCTCGGTCCGGCCCAGCCCGCTGTTCGCCGATCTGCCCGAGGCGAAGGCCATCCTCCGGGCGGCGCAGGACGACGGCGAAGACGGCGACACCGCGTCGTCGCTCGCGGACTCCCTGCGCGCGGTCCCCGACGCCGAGCAGAACCGCATCCTGCTGAAGCTGGTCCGCGGCCACGCTTCGACGGTGCTCGGCCACAGCGGCGCCGAAGGCATCGGCCCGCGCCAGGCGTTCCAGGAGGTCGGCTTCGACTCGCTGGCCGCGGTCAACCTCCGCAACAGCCTGCACGCGGCCACCGGGCTGCGGCTGCCCGCGACGCTGATCTTCGACTACCCCACCCCGGAGGCGCTGGTCGGCTACCTGCGCGTCGAACTCCTGCGGGAGGCCGACGACGGCCTGGACGGGCGGGAAGACGACCTCCGGCGAGTCCTCGCGGCCGTGCCGTTCGCCCGGTTCAAGGAGGCGGGCGTGCTGGACACGCTGCTCGGCCTCGCCGACACCGGCACCGAACCGGGCACGGACGCCGAGACCACCGAAGCGGCCCCGGCCGCCGACGACGCAGAACTGATCGACGCACTGGACATCTCCGGTCTCGTGCAACGAGCCCTCGGGCAGACGAGCTGA	MRTDLIKPLHVALLENATRFAGKPAFADDHRTVTYGDLEARTRRLAGHLAGLGVRHGDRVAICLGNRVSTVESYFAILRAGAVGVPLNPGSATAELEHPLTDSGATVVVTDAAQAARLRLAPHVELLVTGDDVPEGAHSYDELALSEPAEPAADDLELDEPAWMFYTSGTTGRPKGVVSTQRNCLWSVASCYVPFPGLSDQDRVLWPLPLFHSLSHIACVLSATVVGASVRIADGSSADDVMRLIEAESSTFLAGVPTTYHHLVRAARQRGFSAPSLRIGLAGGAVLGAGLRSEFEETFGVPLIDAYGSTETCGAITMNPPDGARVEGSCGLAVPGVDVRVVDPDTGLDVPAGEEGEVWVSGPNVMLGYHNSPEATAAAMRDGWFRTGDLARRDDAGYFTICGRIKELIIRGGANIHPGEVEAVLRTVDGVADAAVGGVPHDTLGEVPVAYVIPGPTGFDPAALIEKCREQLSAYKVPDRILEVAHIPRTASGKIRRGLLTDEPAQLRYAATEHEEQSRHADESVAAALRARLSGLDERAQCELLEDLVRTQAADVLGQPVPDGRAFRDLGFTSLAIVELRNRLTEHTGLWLPASAVFDHPTPAALAARVRAELLGITQAVAEPVVAADPGEPIAIVGMACRLPGGVASPEDLWRLVAERVDAVSEFPGDRGWDLDSLIDPDRERAGTSYVGQGGFLHDAGEFDAGFFGISPREAVAMDPQQRLLLETSWEALENAGVDPIALKGTDTGVFSGLMGQGYGSGAVAPELEGFVTTGVASSVASGRVSYVLGLEGPAVTVDTACSSSLVAMHLAAQALRQGECSMALAGGVTVMATPGSFVEFSRQRALAPDGRCKAFAAAADGTGWSEGVGVVVLERLSVARERGHRILAVLRGSAVNQDGASNGLTAPNGLSQQRVIRRALAAAGLAPSDVDVVEAHGTGTTLGDPIEAQALLATYGQERKQPLWLGSLKSNIGHAQAAAGVAGVIKMVQALRHETLPPTLHVDKPTLEVDWSAGAIELLTEARAWPRNGRPRRAGVSSFGVSGTNAHLILEEAPAEEPVAAPELPVVPLVVSARSTESLSGQAERLASLLEGDVSLTEVAGALVSRRAVLDERAVVVAGSREEAVTGLRALNTAGSGTPGKVVWVFPGQGTQWAGMGRELLAESPVFAERIAECAAALAPWIDWSLVDVLRGEGDLGRVDVLQPACFAVMVGLAAVWESVGVRPDAVVGHSQGEIAAACVSGALSLEDAAKVVALRSQAIAAELSGRGGMASVALGEDDVVSRLVDGVEVAAVNGPSSVVIAGDAHALDATLEILSGEGIRVRRVAVDYASHTRHVEDIRDTLAETLAGISAQAPAVPFYSTVTSEWVRDAGVLDGGYWYRNLRNQVRFGAAATALLEQGHTVFVEVSAHPVTVQPLSELTGDAIGTLRREDGGLRRLLASMGELFVRGIDVDWTAMVPAAGWVDLPTYAFEHRHYWLEPAEPASAGDPLLGTVVSTPGSDRLTAVAQWSRRAQPWAVDGLVPNAALVEAAIRLGDLAGTPVVGELVVDAPVVLPRRGSREVQLIVGEPGEQRRRPIEVFSREADEPWTRHAHGTLAPAAAAVPEPAAAGDATDVTVAGLRDADRYGIHPALLDAAVRTVVGDDLLPSVWTGVSLLASGATAVTVTPTATGLRLTDPAGQPVLTVESVRGTPFVAEQGTTDALFRVDWPEIPLPTAETADFLPYEATSAEATLSALQAWLADPAETRLAVVTGDCTEPGAAAIWGLVRSAQSEHPGRIVLADLDDPAVLPAVVASGEPQVRVRNGVASVPRLTRVTPRQDARPLDPEGTVLITGGTGTLGALTARHLVTAHGVRHLVLVSRRGEAPELQEELTALGASVAIAACDVADRAQLEAVLRAIPAEHPLTAVIHTAGVLDDGVVTELTPDRLATVRRPKVDAARLLDELTREADLAAFVLFSSAAGVLGNPGQAGYAAANAELDALARQRNSLDLPAVSIAWGYWATVSGMTEHLGDADLRRNQRIGMSGLPADEGMALLDAAIATGGTLVAAKFDVAALRATAKAGGPVPPLLRGLAPLPRRAAAKTASLTERLAGLAETEQAAALLDLVRRHAAEVLGHSGAESVHSGRTFKDAGFDSLTAVELRNRLAAATGLTLSPAMIFDYPKPPALADHLRAKLFGSAANRPAEIGTAAAEEPIAIVAMACRFPGGVHSPEDLWRLVADGADAVTEFPADRGWDTDRLYHEDPDHEGTTYVRHGAFLDDAAGFDAAFFGISPNEALAMDPQQRLLLETSWELFERAAIDPTTLAGQDIGVFAGVNSHDYSMRMHRAAGVEGFRLTGGSASVLSGRVAYHFGVEGPAVTVDTACSSSLVALHMAVQALQRGECSMALAGGVMVMGTVETFVEFSRQRGLAPDGRCKAFADGADGTGWSEGVGLLLVERLSEAQRRGHQVLAVVRGSAVNSDGASNGLTAPNGPSQQRVIRKALAAAGLSTSDVDAVEAHGTGTTLGDPIEAEALLATYGQNRETPLWLGSVKSNLGHTQAAAGVAGVIKMVMAMRHGVLPRTLHVDRPSSYVDWSAGAVELLTEARDWVSNGHPRRAGVSSFGIGGTNAHVVLEEVAAPITTPQPEPAEFLVPVLVSARTAAGLRGQAGRLAAFLGDRTDVRVPDAAYALATTRAQLDHRAVVLASDRAQLCADLAAFGSGVVTGTPVDGKLAVLFTGQGSQWAGMGRELAETFPVFRDAFEAACEAVDTHLRERPLREVVFDDSALLDQTMYTQGALFAVETALFRLFESWGVRPGLLAGHSIGELAAAHVSGVLDLADAGELVAARGRLMQALPAGGAMVAVQATEDEVAPLLDGTVCVAAVNGPDSVVLSGTEAAVLAVADELAGRGRKTRRLAVSHAFHSPLMEPMLDDFRAVAERLTYRAGSLPVVSTLTGELAALDSPDYWVGQVRNAVRFSDAVTALGAQGASTFLELGPGGALAAMALGTLGGPEQSCVATLRKNGAEVPDVLTALAELHVRGVGVDWTTVLDEPATAVGTVLPTYAFQHQRFWVDVDETAAVSVTPPPAEPIVDRPVQDVLELVRESAAVVLGHRDAGSFDLDRSFKDHGFDSLSAVKLRNRLRDFTGVELPSTLIFDYPNPAVLADHLRAELLGERPAAPAPVTRDVSDEPIAIVGMSTRLPGGADSPEELWKLVAEGRDAVSGFPVDRGWDLDGLYHPDPAHAGTSYTRSGGFLHDAAQFDAGLFGISPREALAMDPQQRLLLETSWEALERAGVDPLSARGSDVGVFTGIVHHDYVTRLREVPEDVQGYTMTGTASSVASGRVAYVFGFEGPAVTVDTACSSSLVAMHLAAQALRQGECSMALAGGATVMASPDAFLEFSRQRGLSADGRCKAYAEGADGTGWAEGVGVVVLERLSVARERGHRVLAVLRGSAVNQDGASNGLTAPNGPSQQRVIRGALASAGLAPSDVDVVEGHGTGTALGDPIEVQALLATYGQEREQPLWLGSLKSNLGHTQAAAGVVGVIKMIMAMRHGVMPATLHVDERTSQVDWSAGAIEVLTEAREWPRTGRPRRAGVSSFGASGTNAHLIIEEGPAEEAVDEEVASVVPLVVSARSAGSLAGQAGRLAAVLENESLAGVAGALVSGRATLNERAVVIAGSRDEAQDGLQALARGENAPGVVTGTAGKPGKVVWVFPGQGSQWMGMGRDLLDSSPVFAARIKECAAALEQWTDWSLLDVLRGDADLLDRVDVVQPASFAMMVGLAAVWTSLGVTPDAVLGHSQGEIAAACVSGALSLDDAAKVVALRSQAIAGELAGRGGMASVALSEEDAVARLTPWANRVEVAAVNSPSSVVIAGDAQALDEALEALAGDGVRVRRVAVDYASHTRHVEAIAETLAKTLAGIDARVPAIPFYSTVLGTWIEQAVVDAGYWYRNLRQQVRFGPSVADLAGLGHTVFVEISAHPVLVQPLSEISDDAVVTGSLRRDDGGLRRLLASAAELYVRGVAVDWTAAVPAAGWVDLPTYAFDRRHFWLHEAETAEAAEGMDGEFWTAIEQSDVDSLAELLELVPEQRGALSTVVPVLAQWRDRRRERSTAEKLRYQVTWQPLEREAAGVPGGRWLAVVPAGTTDALLKELTGQGLDIVRLEIEEASRAQLAEQLRNVLAEHDLTGVLSLLALDGGPADAAEITASTLALVQALGDTTTSAPLWCLTSGAVNIGIQDAVTAPAQAAVWGLGRAVALERLDRWGGLVDLPAAIDARTAQALLGVLNGAAGEDQLAVRRSGVYRRRLVRKPVPESATSRWEPRGTVLVTGGAEGLGRHASVWLAQSGAERLIVTGTDGVDELTAELAEFGTTVEFCADTDRDAIAQLVADSEVTAVVHAADIAQTSSVDDTGVADLDEVFAAKVTTAVWLDQLFEDTPLDAFVVFSSIAGIWGGGGQGPAGAANAVLDALVEWRRARGLKATSIAWGALDQIGIGMDEAALAQLRRRGVIPMAPPLAVTAMVQAVAGNEKAVAVADMDWAAFIPAFTSVRPSPLFADLPEAKAILRAAQDDGEDGDTASSLADSLRAVPDAEQNRILLKLVRGHASTVLGHSGAEGIGPRQAFQEVGFDSLAAVNLRNSLHAATGLRLPATLIFDYPTPEALVGYLRVELLREADDGLDGREDDLRRVLAAVPFARFKEAGVLDTLLGLADTGTEPGTDAETTEAAPAADDAELIDALDISGLVQRALGQTS	MRKKMQNTLKMLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVTLNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYVPELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIGTGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNMEVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWEQLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVT	1255.97	gnl|BL_ORD_ID|1337|hsp_num:0	1422		
BGC0000136.1|Rifamycin_20 # 31955 # 47164 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGCAG;rbs_spacer=15bp;gc_cont=0.739	BGC0000136.1|Rifamycin_20 	31955	47164	+	Loose	700	28.8758	mgtA	34.15	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	ATGGCGAACCAATCGTGGAGGAAGAACATGTCCGCGCCGAACGAGCAGATCGTTGACGCACTGCGCGCGTCGCTGAAGGAGAACGTCCGGCTTCAGCAGGAGAACAGCGCGCTCGCCGCGGCCGCCGCGGAGCCCGTCGCGATCGTCTCCATGGCCTGCCGCTACGCGGGCGGGATCCGCGGCCCGGAGGACTTCTGGCGGGTGGTGTCGGAAGGCGCCGACGTCTACACCGGCTTCCCCGAGGACCGCGGCTGGGACGTCGAAGGCCTCTACCACCCGGACCCCGACAACCCCGGCACGACGTACGTGCGGGAGGGCGCCTTCCTGCAGGACGCGGCCCAGTTCGACGCCGGGTTCTTCGGCATCTCGCCGCGCGAGGCGCTGGCCATGGACCCCCAGCAGCGGCAGCTCCTGGAGGTGTCCTGGGAGACCTTGGAACGGGCCGGCATCGACCCGCATTCGGTGCGGGGCAGCGACATCGGCGTCTACGCCGGGGTCGTGCACCAGGACTACGCCCCCGACCTCAGCGGGTTCGAAGGCTTCATGAGCCTGGAGCGCGCCCTGGGCACCGCGGGCGGTGTCGCCTCCGGCCGGGTCGCCTACACGCTCGGGCTCGAAGGCCCCGCCGTCACCGTCGACACGATGTGCTCGTCGTCGCTGGTGGCGATTCACCTTGCCGCGCAAGCTCTTCGCCGTGGTGAGTGCTCGATGGCCCTCGCGGGCGGCTCGACCGTGATGGCGACCCCGGGCGGGTTCGTCGGCTTCGCGCGTCAGCGGGCGTTGGCCTTCGACGGGCGCTGCAAGTCCTACGCCGCGGCCGCCGACGGTTCCGGCTGGGCCGAGGGCGTCGGCGTGCTGCTGCTGGAGCGGCTGTCGGTGGCGCGCGAGCGCGGGCACCAGGTGCTGGCCGTCATCCGCGGCAGCGCGGTCAACCAGGACGGCGCTTCCAACGGCCTGACCGCGCCCAACGGCCCGGCGCAGCAGCGGGTCATCCGCAAGGCACTGGCGAGCGCCGGGCTGACACCGTCCGATGTGGACACCGTGGAGGGCCACGGCACCGGCACCGTCCTCGGCGACCCGATCGAGGTCCAGGCGCTGCTGGCCACCTACGGCCAGGGCCGCGACCCGCAGCAACCGCTGTGGCTGGGCTCGGTCAAGTCCGTCGTCGGGCACACGCAGGCGGCATCCGGTGTGGCCGGCGTGATCAAGATGGTCCAGTCGCTGCGGCACGGGCAGCTCCCGGCGACCCAGCACGTCGACGCGCCCACGCCGCAAGTGGACTGGTCGGCCGGAGCGATCGAGCTGCTGGCCGAGGGCCGGGAGTGGCCGCGCAACGGCCACCCGCGCCGGGGCGGCATCTCGTCGTTCGGGGCCAGCGGCACGAACGCGCACATGATCCTCGAAGAAGCGCCCGAGGACGAGCCGGTGACCGAAGCGCCGGCGCCCACGGGTGTCGTACCGCTGGTGGTGTCGGCGGCGACCGCTGCTTCCCTGGCCGCCCAGGCCGGTCGGCTGGCGGAGGTCGGCGACGTCTCCCTGGCGGATGTCGCCGGGACGCTGGTGTCCGGCCGCGCGATGCTCAGCGAGCGCGCGGTCGTCGTGGCCGGCTCCCACGAAGAAGCCGTGACCGGGCTGCGGGCGCTGGCCCGCGGCGAGAGCGCGCCCGGCCTGCTTTCCGGCCGCGGCTCGGGGGTCCCGGGCAAGGTCGTCTGGGTGTTCCCCGGCCAGGGCACGCAGTGGGCCGGCATGGGCCGCGAGCTGCTGGACTCCTCGGAGGTGTTCGCCGCGCGGATCGCCGAGTGCGAGACCGCGCTCGGGCGGTGGGTCGACTGGTCGCTGACCGACGTGCTGCGCGGCGAGGCCGACCTGCTGGACCGGGTCGACGTGGTGCAACCGGCGAGCTTCGCCGTGATGGTCGGGCTTGCCGCCGTCTGGGCCTCCCTCGGCGTCGAGCCCGAGGCCGTGGTGGGCCACTCGCAGGGCGAGATCGCGGCCGCATGCGTGTCCGGGGCACTGTCCCTGGAGGACGCGGCGAAGGTGGTGGCGTTGCGCAGCCAGGCGATCGCCGCCTCGCTGGCCGGCCGGGGCGGCATGGCGTCGGTCGCGTTGAGCGAAGAAGACGCGACCGCGCGGCTCGAGCCGTGGGCGGGCCGCGTGGAGGTCGCCGCCGTCAACGGGCCGACGTCCGTGGTGATCGCCGGGGACGCCGAGGCGCTGGACGAAGCCCTCGACGCGCTCGACGACCAAGGCGTCCGGATCCGGCGGGTGGCGGTGGACTACGCCTCCCACACCCGGCACGTCGAAGCCGCGCGCGACGCACTGGCCGAGATGCTGGGCGGGATCCGCGCGCAGGCGCCGGAAGTGCCGTTCTACTCGACCGTGACCGGCGGCTGGGTCGAAGACGCCGGCGTGCTCGACGGCGGCTACTGGTACCGGAACCTCCGCCGTCAGGTGCGGTTCGGCCCGGCGGTGGCCGAGCTGATCGAGCAGGGCCACCGGGTGTTCGTCGAGGTCAGCGCGCATCCCGTGCTGGTTCAGCCGATCAACGAACTCGTCGACGACACCGAAGCCGTGGTCACCGGGACGCTGCGGCGCGAGGACGGCGGCCTCCGGCGCCTGCTGGCCTCGGCGGCCGAGCTCTTCGTCCGCGGCGTGACCGTGGACTGGTCCGGTGTGCTGCCACCGTCCCGCCGGGTCGAGCTGCCGACGTACGCCTTCGACCACCAGCACTACTGGCTGCAGATGGGCGGGTCGGCCACCGACGCCGTGTCGCTGGGCCTGGCCGGCGCCGACCACCCGCTGCTGGGCGCGGTCGTCCCGCTGCCGCAGTCCGACGGGCTCGTCTTCACCTCGCGGCTGTCGCTGAAGTCGCACCCGTGGCTGGCCGGGCACGCGATCGGCGGGGTCGTGCTCATTCCGGGCACGGTGTACGTCGACCTCGCGCTGCGCGCCGGCGACGAGCTCGGCTTCGGCGTCCTGGAAGAGCTCGTGATCGAGGCACCGCTGGTGCTGGGCGAGCGCGGCGGCGTTCGCGTGCAGGTCGCCGTGAGCGGGCCGAACGAGACCGGCTCGCGTGCGGTGGACGTCTTCTCCATGCGGGAAGACGGCGACGAATGGACCCGGCACGCGACCGGTCTCCTCGGGGCGTCGACGTCCCGGGAACCGAGCCGCTTCGACTTCGCCGCCTGGCCGCCGGCCGGGGCGGAGCCGATCGACGTCGAAAACTTCTACACCGACCTCACCGAGCGCGGGTACGCCTACAGCGGCGCCTTCCAGGGCATGCGGGCGGTCTGGCGGCGCGGTGACGAGGTCTTCGCCGAGGTCGCGCTGCCTGACGACCACCGCGAGGACGCCGGCAAGTTCGGCCTCCACCCCGCCCTCCTCGACGCCGCTCTGCACACGAACGCCTTCGCGAACCCGGACGACGACCGCAGTGTGCTGCCGTTCGCGTGGAACGGCCTGGTCCTGCACGCCGTGGGCGCGTCGGCGCTGCGGGTGCGGGTGGCGCCGGGCGGTCCGGACGCGCTGACGTTCCAGGCCGCCGACGAGACCGGTGGCCTGGTCGTCACCATGGATTCGCTGGTGTCCCGCGAGGTGTCGGCCGCGCAGCTGGAGACGGCGGCGGGCGAAGAGCGCGACTCGCTGTTCCAGGTGGACTGGATCGAGGTCCCCGCGACCGAGACCGCGGCCACCGAGCACGCCGAGGTGCTCGAAGCCTTCGGCGAGGCAGCGCCCCTCGAGCTGACCAGCCGGGTGCTGGAGGCCGTGCAGTCCTGGCTCGCCGACGCGGCCGACGAAGCACGGTTGGTCGTGGTGACCCGTGGCGCCGTGCGCGAGGTGACGGACCCGGCCGGTGCCGCCGTGTGGGGTTTGGTGCGAGCCGCCCAGGCGGAGAACCCGGGCCGGATCATCCTCGTCGACACCGACGGCGACGTCCCGCTGGGTGCGGTGCTGGCCAGTGGTGAGCCGCAGCTCGCCGTGCGCGGCAACGCTTTCTCCGTCCCGCGCCTCGCCCGGGCCACCGGCGAGGTGCCGGAGGCCCCCGCGGTGTTCAGTCCGGAAGGGACGGTCCTGCTCACCGGCGGCACCGGCTCGCTGGGCGGTCTGGTGGCCAAGCACCTGGTTGCCCGGCACGGCGTCCGGCGGCTGGTGCTCGCCAGCCGCCGAGGCGTGGCCGCGGAAGACCTCGTCACCGAGCTGACCGAGCAGGGCGCGACGGTGTCCGTGGTGGCTTGCGACGTCTCCGACCGCGACCAGGTGGCCGCGTTGCTGGCCGAACACCGCCCGACCGGCATCGTGCACCTGGCCGGCCTGCTGGACGACGGCGTCATCGGAGCCCTGAACCGGGAGCGGCTGGCCGGGGTGTTCGCGCCCAAGGTCGATGCCGTCCAGCACCTCGACGAACTGACCCGCGACCTCGGCCTCGACGCGTTCGTCGTGTTCTCGTCCGCAGCCGCGCTCATGGGCTCCGCCGGCCAGGGCAACTACGCGGCCGCCAACGCCTTCCTCGACGGCTTGATGGCCGGGCGCCGCGCGGCGGGCCTGCCAGGCGTGTCCCTGGCGTGGGGCCTGTGGGAGCAGGCGGACGGCCTGACCGCGAACCTCAGCGCCACCGACCAGGCCCGGATGAGCCGCGGCGGCGTGCTGCCGATGACACCGGCCGAGGCCCTGGACATCTTCGACATCGGCCTGGCCGCCGAGCAGGCCCTGCTGGTCCCGATCAAGCTCGACCTGCGGACGCTGCGCGGCCAGGCCACCGCCGGCGGCGAGGTGCCGCACCTGCTGCGCGGCCTGGTCCGCGCGAGCCGCCGCGTGACCCGCACGGCTGCCGCGAGTGGCGGCGGTGGCCTGGTCCACAAGCTCGCCGGGCGGCCAGCCGAAGAGCAGGAAGCCGTGCTGCTGGGCATCGTCCAGGCGGAGGCGGCCGCGGTGCTCGGCTTCAACGCCCCCGAGCTGGCCCAGGGCACCCGCGGGTTCAGCGACCTCGGCTTCGACTCGCTGACCGCGGTCGAGCTGCGGAACCGGCTGAGCGCGGCGACCGGCGTCAAATTGCCCGCCACGCTCGTCTTCGACTACCCGACGCCGGTCGCGCTCGCCCGCCACCTGCGCGAAGAGCTGGGCGAGACGGTGGCGGGTGCGCCGGCCACGCCGGTGACGACCGTCGCCGACGCGGGCGAGCCGATCGCCATCGTCGGCATGGCGTGCCGCCTGCCGGGCGGCGTGATGAGCCCCGACGACCTCTGGCGGATGGTCGCCGAGGGCCGCGATGGGATGTCGCCGTTCCCCGGAGACCGCGGCTGGGACCTGGACGGCCTGTTCGACTCGGACCCCGAGCGCCCGGGCACCGCCTACATCCGCCAAGGCGGCTTCCTGCACGAGGCCGCGCTGTTCGACCCGGGCTTCTTCGGGATCTCGCCGCGCGAAGCCCTGGCCATGGACCCGCAGCAGCGGCTGCTGCTCGAAGCCTCCTGGGAAGCCCTGGAGCGCGCGGGCATCGACCCGACCAAGGCCCGCGGTGACGCCGTCGGCGTCTTCTCCGGCGTCTCCATCCACGACTACCTCGAGTCCCTGAGCAACATGCCCGCCGAGCTCGAAGGCTTCGTCACCACGGCCACGGCGGGCAGCGTCGCCTCGGGCCGGGTGTCCTACACCTTCGGGTTCGAGGGCCCGGCGGTCACGGTGGACACGGCGTGCTCGTCGTCGCTGGTCGCGATCCACCTGGCCGCACAGGCACTGCGGCAGGGCGAGTGCACGATGGCCCTGGCCGGCGGTGTCGCCGTGATGGGCTCGCCGATCGGTGTCATCGGCATGTCGCGGCAGCGCGGCATGGCCGAGGACGGCCGGGTCAAGGCGTTCGCCGACGGCGCGGACGGCACCGTCCTGTCCGAAGGCGTCGGCATCGTCGTCCTCGAACGGCTTTCGGTGGCCCGCGAACGCGGGCACCGGGTGCTCGCCGTGCTCCGCGGCAGCGCGGTCAACCAGGACGGCGCTTCGAACGGCCTGACCGCGCCCAACGGGCCGTCGCAGCAGCGGGTGATCCGCAGCGCGCTGGCCGGGGCCGGACTGCAACCGTCCGAAGTGGACGTCGTCGAGGCGCACGGCACCGGGACCGCGCTGGGCGACCCGATCGAGGCCCAGGCCCTGCTGGCCACCTACGGCAAGAGCCGCGAGACGCCGTTGTGGCTCGGGTCGCTGAAGTCGAACATCGGCCACACCCAGGCGGCCGCGGGCGTGGCGGCCGTGATCAAGATGGTCCAGGCGCTGCGGCACGACACCCTGCCGCCGACCCTCCACGTGCAGGAACCCACCAAGCAGGTGGACTGGTCCGCGGGTGCGGTCGAGCTGCTGACCGAAGGCCGGGAGTGGGCCCGCAACGGCCACCCGCGCCGGGCCGGTGTCTCGTCGTTCGGCATCAGCGGCACCAACGCGCACCTCATCCTGGAAGAGGCGCCCGCCGACGACACCGCCGAGGCGGACGTGCCCGACGCCGTGGTGCCCGTGGTGATCTCCGCGCGCAGCACCGGATCCCTGGCGGGCCAGGCCGGACGCCTGGCGGCGTTCCTCGACGGAGACGTCCCGCTGACCCGCGTGGCGGGTGCCCTGCTGTCGACCCGGGCGACGCTGACCGACCGGGCCGTCGTCGTGGCGGGCTCGGCCGAGGAGGCCCGGGCGGGGCTGACCGCGCTGGCCCGCGGCGAGAGCGCGAGCGGGCTTGTGACCGGTACCGCAGGGATGCCGGGCAAGACGGTCTGGGTGTTCCCCGGCCAGGGGACGCAGTGGGCGGGCATGGGCCGGGAGCTCCTCGAAGCGTCCCCGGTGTTCGCCGAGCGCATTGAGGAATGCGCGGCCGCGCTGCAGCCGTGGATCGACTGGTCGCTGCTGGACGTCCTCCGTGGCGAAGGTGAGCTGGATCGGGTCGACGTGCTGCAGCCGGCGTGTTTCGCGGTGATGGTGGGGCTGGCCGCCGTCTGGGCCTCGGTCGGCGTCGTGCCGGACGCGGTCCTGGGCCACTCCCAGGGCGAGATTGCCGCCGCCTGCGTGTCGGGTGCACTGTCCCTCGAGGACGCAGCCAAGGTCGTCGCGCTGCGCAGCCAGGCGATCGCGGCGGAGCTGTCGGGCCGCGGGGGCATGGCGTCGATCCAGCTGAGCCACGACGAGGTGGCTGCCCGGCTCGCGCCGTGGGCGGGCCGCGTCGAGATCGCCGCCGTCAACGGTCCGGCCTCGGTCGTGATCGCCGGTGACGCCGAAGCGCTCACCGAGGCCGTCGAAGTCCTCGGCGGTCGGCGGGTGGCGGTGGACTACGCGTCCCACACGCGGCACGTCGAGGACATCCAGGACACCCTCGCCGAGACTCTGGCCGGGATCGACGCGCAGGCCCCCGTGGTGCCCTTCTACTCCACGGTCGCCGGCGAGTGGATCACCGATGCCGGGGTCGTCGACGGCGGGTACTGGTACCGGAACCTGCGCAACCAGGTCGGCTTCGGCCCGGCCGTGGCCGAGCTGATCGAGCAGGGGCACGGGGTGTTCGTCGAGGTCAGTGCGCATCCGGTGCTGGTGCAGCCGATCAGCGAGCTCACCGATGCGGTCGTCACCGGGACGTTGCGGCGCGACGACGGTGGGGTGCGGCGGCTGCTGACCTCGATGGCCGAACTGTTCGTCCGCGGTGTCCCGGTCGACTGGGCCACGATGGCGCCGCCCGCGCGCGTCGAGCTGCCGACCTACGCCTTCGACCACCAGCACTTCTGGCTCAGCCCGCCCGCCGTGGCGGACGCGCCCGCGCTCGGCCTGGCCGGCGCCGACCACCCGCTGCTGGGGGCGGTTCTCCCGCTGCCGCAGTCCGACGGCCTGGTGTTCACCTCGCGCCTGTCGGTGCGGACGCATCCGTGGCTGGCCGACGGCGTCCCCGCCGCCGCCTTGGTGGAGCTGGCCGTGCGGGCCGGTGACGAAGCCGGTTGCCCGGTCCTCGCCGACCTGACCGTCGAAAAGCTGCTGGTGCTGCCGGAGAGCGGTGGCCTGCGCGTCCAGGTGATCGTGAGCGGCGAGCGCACGGTCGAGGTGTATTCGCAGCTCGAAGGCGCCGAAGACTGGATCCGGAACGCCACCGGGCACCTGTCCGCCACGGCTCCGGCGCACGAGGCCTTCGACTTCACCGCCTGGCCGCCCGCCGGAGCCCAGCAGGTCGACGGCCTCTGGCGGCGCGGCGACGAGATCTTCGCCGAGGTCGCCCTGCCGGAGGAGCTGGACGCCGGCGCGTTCGGCATCCACCCCTTCCTGCTGGACGCGGCCGTGCAGCCGGTCCTCGCGGACGACGAGCAGCCGGCGGAGTGGCGCAGCCTGGTCCTGCACGCCGCGGGTGCCTCGGCGCTGCGCGTGCGGCTGGTGCCCGGCGGTGCCCTCCAAGCGGCGGACGAAACCGGCGGGCTGGTCCTCACGGCGGATTCGGTGGCAGGCCGGGAACTCTCGGCCGGGAAGACCCGCGCCGGATCGCTGTACCGGGTCGACTGGACCGAAGTGTCCATTGCAGACAGTGCGGTGCCGGCCAACATCGAGGTCGTCGAAGCCTTCGGTGAAGAGCCCCTGGAACTGACCGGCCGGGTCCTGGAGGCTGTGCAGACCTGGCTCGTCACCGCGGCCGACGATGCGCGGCTGGTCGTGGTGACCCGCGGCGCCGTGCGCGAGGTGACCGACCCCGCCGGTGCGGCCGTGTGGGGCCTGGTCCGAGCCGCGCAGGCGGAGAACCCCGGTCGCATCTTCCTGATCGACACCGACGGCGAGATCCCGGCCCTGACCGGTGACGAGCCCGAGATCGCGGTGCGCGGCGGGAAGTTCTTCGTGCCCCGCATCACTCGCGCGGAGCCGAGCGGGGCCGCCGTGTTCCGCCCGGACGGGACAGTGCTGATCTCGGGCGCGGGTGCGCTCGGTGGCCTGGTGGCCCGGCGTCTCGTCGAACGCCACGGCGTGCGGAAGCTCGTGCTGGCGTCCCGGCGCGGCCGAGACGCCGACGGCGTGGCGGACCTGGTCGCCGACCTGGCCGCGGACGTGTCCGTGGTGGCTTGCGACGTCTCCGATCGCGCCCAGGTGGCGGCCCTGCTCGACGAGCACCGGCCGACCGCCGTCGTGCACACCGCCGGCGTCATCGACGCGGGCGTGATCGAGACGCTGGACCGGGACCGGCTGGCCACGGTGTTCGCGCCGAAGGTCGACGCCGTGCGGCACCTCGACGAGCTGACCCGCGACCGCGACCTCGACGCCTTCGTCGTCTACTCCTCGGTCTCGGCCGTGTTCATGGGCGCGGGCAGCGGCAGTTACGCCGCGGCGAACGCCTTCCTGGACGGCCTGATGGCGAACCGCCGGGCGGCGGGCCTGCCGGGCCTGTCGCTGGCGTGGGGCCTGTGGGACCAGAGCACCGGTATGGCCGCCGGCACCGACGAGGCCACCCGGGCGCGGATGAGCCGCCGCGGTGGCCTGCAGATCATGACGCAGGCCGAGGGCATGGACCTGTTCGACGCCGCGCTGTCGTCGGCCGAGTCGCTGCTGGTGCCCGCCAAGCTCGACCTGCGTGGGGTGCGCGCCGACGCCGCCGCGGGCGGGGTCGTGCCGCACATGCTGCGTGGCCTGGTCCGCGCGGGCCGGGCGCAGGCCCGCGCGGCGTCCACTGTGGACAACGGGCTGGCCGGACGGCTGGCCGGGCTCGCCCCGGCGGACCAGCTCACGCTGCTCCTGGACCTGGTCCGGGCGCAGGTCGCGGCCGTGCTCGGGCACGCCGACGCGAGCGCCGTCCGCGTCGACACGGCCTTCAAGGACGCCGGCTTCGACTCGCTGACCGCGGTCGAGCTGCGCAACCGCATGCGGACCGCCACCGGCCTGAAGCTGCCCGCGACGCTCGTCTTCGACTACCCGAACCCCCAGGCGCTCGCCCGGCACCTGCGCGACGAACTCGGTGGTGCGGCCCAGACGCCGGTGACCACAGCGGCCGCGAAGGCCGACCTCGACGAGCCGATCGCCATCGTCGGGATGGCGTGCCGCTTGCCGGGCGGGGTCGCCGGGCCCGAGGACCTCTGGCGGCTGGTCGCCGAGGGCCGGGACGCGGTGTCGAGCTTCCCGACCGACCGCGGCTGGGACACCGACAGCCTGTACGACCCCGATCCGGCCCGCCCGGGCAAGACCTACACCCGGCACGGCGGCTTCCTGCACGAAGCCGGGCTCTTCGACGCGGGCTTCTTCGGGATCTCGCCACGCGAGGCCGTCGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGGCCTCCTGGGAGGCCATGGAAGACGCCGGGGTCGACCCACTTTCGCTGAAGGGCAACGACGTCGGCGTGTTCACCGGCATGTTCGGCCAGGGTTACGTCGCTCCCGGGGACAGCGTCGTCACGCCGGAGCTGGAGGGTTTCGCGGGCACGGGCGGGTCGTCGAGTGTCGCGTCCGGCCGCGTGTCGTACGTGTTCGGGTTCGAAGGCCCGGCCGTGACGATCGACTCGGCGTGCTCGTCCTCGCTGGTCGCGATGCACCTCGCCGCGCAGTCGCTGCGGCAGGGCGAGTGCTCGATGGCCTTGGCCGGCGGCGCGACGGTGATGGCGAACCCCGGCGCATTCGTGGAGTTCTCGCGGCAGCGGGGCCTCGCCGTCGACGGTCGCTGCAAGGCGTTCGCCGCCGCGGCCGACGGCACCGGCTGGGCCGAGGGCGTCGGTGTGGTCATCCTCGAGCGGCTGTCGGTGGCGCGGGAACGCGGCCACCGGATCCTGGCCGTGCTGCGCGGCAGCGCGGTCAACCAGGACGGCGCCTCGAACGGCCTGACCGCGCCGAACGGGCCGTCGCAGCAGCGGGTGATCCGCCGGGCGCTGGTGAGCGCCGGGCTGGCACCGTCCGATGTGGACGTCGTCGAGGCGCACGGCACCGGGACCACGCTGGGTGACCCGATCGAGGCGCAAGCTCTGCTGGCTACCTACGGCAAGGACCGCGAGTCGCCGCTGTGGCTCGGCTCGCTGAAGTCGAACATCGGCCACGCGCAGGCCGCCGCGGGGGTCGCCGGCGTCATCAAGATGGTCCAGGCGCTCCGGCACGAAGTCCTGCCGCCGACGCTGCACGTCGACCGGCCTACCCCCGAGGTCGACTGGTCGGCCGGTGCCGTCGAACTGCTGACGGAAGCCCGCGAGTGGCCGCGCAACGGGCGCCCGCGCCGGGCCGGGGTCTCCGCGTTCGGCGTCAGCGGCACGAACGCGCACCTGATCCTGGAGGAGGCGCCCGCCGAAGAGCCGGTGCCCACACCCGAGGTTCCCCTGGTGCCGGTCGTGGTCTCCGCGCGGAGCAGGGCGTCCCTGGCCGGTCAGGCCGGTCGCCTCGCCGGATTCGTGGCGGGTGACGCGTCCTTGGCCGGTGTGGCCCGGGCGCTGGTGACGAACCGGGCCGCGCTGACCGAGCGCGCGGTCATGGTCGTGGGCTCTCGCGAAGAAGCCGTGACGAACCTGGAAGCGCTGGCCCGCGGCGAAGACCCGGCCGCGGTGGTCACCGGCCGGGCGGGTTCGCCGGGCAAGCTCGTCTGGGTCTTCCCCGGCCAGGGCTCGCAGTGGATCGGGATGGGCCGGGAACTCCTGGACTCTTCGCCGGTCTTCGCCGAGCGGGTCGCCGAATGCGCGGCCGCCCTGGAACCGTGGATCGATTGGTCACTGCTCGACGTGCTGCGCGGGGAGTCCGACCTGCTGGACCGGGTCGACGTCGTGCAGCCCGCCAGCTTCGCGATGATGGTCGGCCTGGCCGCGGTGTGGCAGTCGGTGGGTGTCCGCCCGGATGCCGTCGTCGGCCACTCGCAGGGCGAGATCGCCGCCGCCTGCGTCTCGGGCGCGCTGTCGCTGCAGGACGCCGCGAAGGTGGTTGCCTTGCGCAGCCAGGCGATCGCCACCCGGCTGGCCGGGCGCGGCGGCATGGCTTCCGTGGCGTTGAGCGAAGAAGACGCGACCGCGTGGCTGGCGCCGTGGGCCGACCGGGTCCAGGTGGCCGCGGTCAACAGCCCTGCCTCCGTGGTGATCGCCGGGGAAGCCCAGGCCCTCGACGAGGTCGTCGACGCGTTGTCCGGTCAGGAAGTCCGCGTCCGGCGGGTGGCCGTGGACTACGGGTCCCACACCAACCAGGTCGAAGCCATCGAGGATCTGCTGGCCGAGACCTTGGCCGGCATCGAGGCGCAGGCCCCGAAGGTGCCCTTCTACTCGACCCTGATCGGTGACTGGATCCGTGACGCCGGGATCGTCGACGGCGGCTACTGGTACCGGAACCTGCGCAACCAGGTCGGGTTCGGTCCGGCCGTCGCGGAGCTCGTTCGCCAGGGCCACGGGGTGTTCGTCGAGGTCAGCGCGCACCCGGTGCTGGTCCAGCCGCTCAGTGAACTCAGCGACGACGCGGTGGTGACCGGGTCGCTGCGGCGCGAAGACGGTGGCCTGCGCCGCCTGCTGACGTCGATGGCCGAGCTGTACGTGCAGGGTGTCCCGCTCGACTGGACCGCGGTCCTGCCGCGGACCGGCCGGGTCGACCTGCCGAAGTACGCCTTCGACCACCGGCACTACTGGCTGCGGCCCGCCGAGTCCGCGACCGACGCGGCTTCGCTGGGCCAGGGGGCGGCCGACCACCCGTTGCTGGGCGCGGTCGTCGAGCTGCCGCAGTCCGACGGCCTGGTGTTCACCTCGCGGCTGTCCGTGCGGACGCACCCGTGGCTGGCCGACCACGCGGTCGGTGGCGTGGTCATCCTCCCCGGCTCCGGGCTGGCCGAACTGGCCGTCCGGGCCGGCGACGAAGCCGGGTGCACCGCCCTCGACGAGCTGATTATCGAAGCTCCGCTGGTCGTGCCCGCCCAAGGCGCGGTCCGCGTCCAGGTCGCGTTGAGCGGCCCGGACGAGACCGGCTCGCGCACGGTGGACCTCTACTCCCAGCGCGACGGCGGCGCGGGGACGTGGACGCGGCACGCCACCGGCGTGCCGTCGACGGCCCCCGCTCAGGAACCCGAGTTCGACTTCCACGCCTGGCCGCCCGCGGATGCCGAGCGGATCGACGTCGAGACCTTCTACACCGACCTGGCCGAGCGTGGTTACGGCTACGGGCCGGCGTTCCAGGGGCTGCAAGCGGTGTGGCGGCGCGACGGCGATGTCTTCGCCGAGGTCGCCCTGCCCGAGGACCTGCGCAAGGACGCGGGCCGGTTCGGCGTCCACCCGGCGCTGCTCGACGCGGCGCTGCAGGCCGCCACGGCCGTGGGCGGCGACGAGCCCGGTCAGCCGGTGCTGGCGTTCGCGTGGAACGGCCTGGTCCTGCACGCCGCGGGCGCGTCGGCCCTGCGGGTCCGGCTCGCGCCGAGCGGCCCGGACACGCTGTCCGTGGCAGCCGCCGACGAAACCGGCGGCTTGGTCCTGACCATGGAATCGCTGGTCTCCCGGCCGGTTTCGGCCGAGCAGCTCGGCGCCGCGGCCGACGCGGGCCACGACGCGATGTTCCGCGTCGACTGGACCGAGCTGCCTGCCGTGCCCCGCGCGGAACTGCCGCCGTGGGTGCGGATCGACACCGCCGACGACGTCGCGGCCTTGGCGGAGAAGGCGGACGCACCACCGGTGGTGGTCTGGGAAGCCGCCGGGGGAGACCCGGCCCTGGCCGTGAGTTCCCGGGTGCTCGAGATCATGCAGGCCTGGCTGGCCGCGCCCGCGTTCGAGGAGGCCCGGCTGGTCGTGACGACCCGCGGCGCGGTACCCGCCGGCGGTGACCACACACTGACCGACCCGGCCGCGGCCGCGGTGTGGGGCCTGGTCCGGTCCGCGCAGGCGGAACACCCGGACCGGGTCGTCCTGCTGGACACCGACGGCGAAGTTCCGCTGGGCGCGGTGCTGGCCTCCGGTGAGCCGCAGCTCGCGGTGCGCGGAACGACGTTCTTCGTGCCCCGGCTGGCCCGCGCCACCCGGCTCTCGGACGCGCCTCCTGCGTTCGACCCGGACGGGACCGTGCTGGTCTCGGGCGCCGGATCGCTGGGCACCTTGGTGGCCCGGCACCTGGTCACCCGGCACGGCGTGCGCCGGGTGGTGCTGGCCAGCCGGCAGGGCCGGGACGCCGAGGGCGCCCAGGACCTGATCACCGAGCTCACCGGCGAAGGCGCGGACGTGTCCTTCGTGGCCTGTGACGTCTCCGATCGCGACCAGGTGGCCGCGCTGCTCGCGGGCCTCCCGGACCTGACCGGGGTGGTGCACACCGCCGGCGTCTTCGAGGACGGCGTGATCGAGGCGCTGACGCCCGACCAGCTCGCGAACGTGTACGCGGCCAAGGTCACGGCCGCGATGCACCTCGACGAGCTCACCCGCGACCGGGATCTCGGCGCGTTCGTCGTGTTCTCCTCCGTCGCGGGGGTGATGGGTGGTGGCGGTCAAGGCCCGTACGCGGCGGCGAACGCCTTCCTGGACGCGGCGATGGCGAGTCGTCAGGCCGCGGGCCTGCCGGGCCTGTCCCTGGCGTGGGGCCTCTGGGAACGCAGCAGCGGCATGGCCGCCCACCTCAGCGAGGTCGACCACGCGCGGGCGAGCCGCAACGGTGTCCTGGAACTGACCCGGGCCGAGGGCCTGGCGCTGTTCGACCTCGGGCTGCGGATGGCCGAGTCGCTGCTCGTGCCGATCAAGCTCGACCTCGCCGCGATGCGGGCGAGCACGGTCCCGGTCCTGTTCCGCGGCCTGGTCCGGCCGAGCCGGACCCAGGCGCGCACGGCGTCCACTGTGGACCGGGGGCTGGCCGGGCGGCTCGCCGGGCTGCCGGTGGCCGAGCGGGCGGCGGTGCTGGTCGACCTGGTGCGCGGGCAGGTCGCGGTCGTGCTCGGCTACGACGGGCCGGAGGCCGTCCGCCCGGACACGGCGTTCAAGGACACCGGGTTCGACTCGCTGACGTCGGTGGAACTGCGCAACCGGCTGCGCGAGGCGACCGGGCTCAAGCTCCCCGCCACGCTCGTCTTCGACTACCCGAACCCCTTGGCGGTGGCGCGCTACCTGGGCGCGCGGCTGGTCCCGGACGGGACCGCGAACGGCAACGGGAACGGGAATGGGCACAGCGAAGACGACCGGCTGCGGCACGCGCTGGCGGCCATCGCGGCCGAGGACGCGGGCGAGGAGCGGTCGATCGCCGACCTGGGCGTCGACGACCTCGTGCAACTGGCTTTCGGCGACGAGTGA	MANQSWRKNMSAPNEQIVDALRASLKENVRLQQENSALAAAAAEPVAIVSMACRYAGGIRGPEDFWRVVSEGADVYTGFPEDRGWDVEGLYHPDPDNPGTTYVREGAFLQDAAQFDAGFFGISPREALAMDPQQRQLLEVSWETLERAGIDPHSVRGSDIGVYAGVVHQDYAPDLSGFEGFMSLERALGTAGGVASGRVAYTLGLEGPAVTVDTMCSSSLVAIHLAAQALRRGECSMALAGGSTVMATPGGFVGFARQRALAFDGRCKSYAAAADGSGWAEGVGVLLLERLSVARERGHQVLAVIRGSAVNQDGASNGLTAPNGPAQQRVIRKALASAGLTPSDVDTVEGHGTGTVLGDPIEVQALLATYGQGRDPQQPLWLGSVKSVVGHTQAASGVAGVIKMVQSLRHGQLPATQHVDAPTPQVDWSAGAIELLAEGREWPRNGHPRRGGISSFGASGTNAHMILEEAPEDEPVTEAPAPTGVVPLVVSAATAASLAAQAGRLAEVGDVSLADVAGTLVSGRAMLSERAVVVAGSHEEAVTGLRALARGESAPGLLSGRGSGVPGKVVWVFPGQGTQWAGMGRELLDSSEVFAARIAECETALGRWVDWSLTDVLRGEADLLDRVDVVQPASFAVMVGLAAVWASLGVEPEAVVGHSQGEIAAACVSGALSLEDAAKVVALRSQAIAASLAGRGGMASVALSEEDATARLEPWAGRVEVAAVNGPTSVVIAGDAEALDEALDALDDQGVRIRRVAVDYASHTRHVEAARDALAEMLGGIRAQAPEVPFYSTVTGGWVEDAGVLDGGYWYRNLRRQVRFGPAVAELIEQGHRVFVEVSAHPVLVQPINELVDDTEAVVTGTLRREDGGLRRLLASAAELFVRGVTVDWSGVLPPSRRVELPTYAFDHQHYWLQMGGSATDAVSLGLAGADHPLLGAVVPLPQSDGLVFTSRLSLKSHPWLAGHAIGGVVLIPGTVYVDLALRAGDELGFGVLEELVIEAPLVLGERGGVRVQVAVSGPNETGSRAVDVFSMREDGDEWTRHATGLLGASTSREPSRFDFAAWPPAGAEPIDVENFYTDLTERGYAYSGAFQGMRAVWRRGDEVFAEVALPDDHREDAGKFGLHPALLDAALHTNAFANPDDDRSVLPFAWNGLVLHAVGASALRVRVAPGGPDALTFQAADETGGLVVTMDSLVSREVSAAQLETAAGEERDSLFQVDWIEVPATETAATEHAEVLEAFGEAAPLELTSRVLEAVQSWLADAADEARLVVVTRGAVREVTDPAGAAVWGLVRAAQAENPGRIILVDTDGDVPLGAVLASGEPQLAVRGNAFSVPRLARATGEVPEAPAVFSPEGTVLLTGGTGSLGGLVAKHLVARHGVRRLVLASRRGVAAEDLVTELTEQGATVSVVACDVSDRDQVAALLAEHRPTGIVHLAGLLDDGVIGALNRERLAGVFAPKVDAVQHLDELTRDLGLDAFVVFSSAAALMGSAGQGNYAAANAFLDGLMAGRRAAGLPGVSLAWGLWEQADGLTANLSATDQARMSRGGVLPMTPAEALDIFDIGLAAEQALLVPIKLDLRTLRGQATAGGEVPHLLRGLVRASRRVTRTAAASGGGGLVHKLAGRPAEEQEAVLLGIVQAEAAAVLGFNAPELAQGTRGFSDLGFDSLTAVELRNRLSAATGVKLPATLVFDYPTPVALARHLREELGETVAGAPATPVTTVADAGEPIAIVGMACRLPGGVMSPDDLWRMVAEGRDGMSPFPGDRGWDLDGLFDSDPERPGTAYIRQGGFLHEAALFDPGFFGISPREALAMDPQQRLLLEASWEALERAGIDPTKARGDAVGVFSGVSIHDYLESLSNMPAELEGFVTTATAGSVASGRVSYTFGFEGPAVTVDTACSSSLVAIHLAAQALRQGECTMALAGGVAVMGSPIGVIGMSRQRGMAEDGRVKAFADGADGTVLSEGVGIVVLERLSVARERGHRVLAVLRGSAVNQDGASNGLTAPNGPSQQRVIRSALAGAGLQPSEVDVVEAHGTGTALGDPIEAQALLATYGKSRETPLWLGSLKSNIGHTQAAAGVAAVIKMVQALRHDTLPPTLHVQEPTKQVDWSAGAVELLTEGREWARNGHPRRAGVSSFGISGTNAHLILEEAPADDTAEADVPDAVVPVVISARSTGSLAGQAGRLAAFLDGDVPLTRVAGALLSTRATLTDRAVVVAGSAEEARAGLTALARGESASGLVTGTAGMPGKTVWVFPGQGTQWAGMGRELLEASPVFAERIEECAAALQPWIDWSLLDVLRGEGELDRVDVLQPACFAVMVGLAAVWASVGVVPDAVLGHSQGEIAAACVSGALSLEDAAKVVALRSQAIAAELSGRGGMASIQLSHDEVAARLAPWAGRVEIAAVNGPASVVIAGDAEALTEAVEVLGGRRVAVDYASHTRHVEDIQDTLAETLAGIDAQAPVVPFYSTVAGEWITDAGVVDGGYWYRNLRNQVGFGPAVAELIEQGHGVFVEVSAHPVLVQPISELTDAVVTGTLRRDDGGVRRLLTSMAELFVRGVPVDWATMAPPARVELPTYAFDHQHFWLSPPAVADAPALGLAGADHPLLGAVLPLPQSDGLVFTSRLSVRTHPWLADGVPAAALVELAVRAGDEAGCPVLADLTVEKLLVLPESGGLRVQVIVSGERTVEVYSQLEGAEDWIRNATGHLSATAPAHEAFDFTAWPPAGAQQVDGLWRRGDEIFAEVALPEELDAGAFGIHPFLLDAAVQPVLADDEQPAEWRSLVLHAAGASALRVRLVPGGALQAADETGGLVLTADSVAGRELSAGKTRAGSLYRVDWTEVSIADSAVPANIEVVEAFGEEPLELTGRVLEAVQTWLVTAADDARLVVVTRGAVREVTDPAGAAVWGLVRAAQAENPGRIFLIDTDGEIPALTGDEPEIAVRGGKFFVPRITRAEPSGAAVFRPDGTVLISGAGALGGLVARRLVERHGVRKLVLASRRGRDADGVADLVADLAADVSVVACDVSDRAQVAALLDEHRPTAVVHTAGVIDAGVIETLDRDRLATVFAPKVDAVRHLDELTRDRDLDAFVVYSSVSAVFMGAGSGSYAAANAFLDGLMANRRAAGLPGLSLAWGLWDQSTGMAAGTDEATRARMSRRGGLQIMTQAEGMDLFDAALSSAESLLVPAKLDLRGVRADAAAGGVVPHMLRGLVRAGRAQARAASTVDNGLAGRLAGLAPADQLTLLLDLVRAQVAAVLGHADASAVRVDTAFKDAGFDSLTAVELRNRMRTATGLKLPATLVFDYPNPQALARHLRDELGGAAQTPVTTAAAKADLDEPIAIVGMACRLPGGVAGPEDLWRLVAEGRDAVSSFPTDRGWDTDSLYDPDPARPGKTYTRHGGFLHEAGLFDAGFFGISPREAVAMDPQQRLLLEASWEAMEDAGVDPLSLKGNDVGVFTGMFGQGYVAPGDSVVTPELEGFAGTGGSSSVASGRVSYVFGFEGPAVTIDSACSSSLVAMHLAAQSLRQGECSMALAGGATVMANPGAFVEFSRQRGLAVDGRCKAFAAAADGTGWAEGVGVVILERLSVARERGHRILAVLRGSAVNQDGASNGLTAPNGPSQQRVIRRALVSAGLAPSDVDVVEAHGTGTTLGDPIEAQALLATYGKDRESPLWLGSLKSNIGHAQAAAGVAGVIKMVQALRHEVLPPTLHVDRPTPEVDWSAGAVELLTEAREWPRNGRPRRAGVSAFGVSGTNAHLILEEAPAEEPVPTPEVPLVPVVVSARSRASLAGQAGRLAGFVAGDASLAGVARALVTNRAALTERAVMVVGSREEAVTNLEALARGEDPAAVVTGRAGSPGKLVWVFPGQGSQWIGMGRELLDSSPVFAERVAECAAALEPWIDWSLLDVLRGESDLLDRVDVVQPASFAMMVGLAAVWQSVGVRPDAVVGHSQGEIAAACVSGALSLQDAAKVVALRSQAIATRLAGRGGMASVALSEEDATAWLAPWADRVQVAAVNSPASVVIAGEAQALDEVVDALSGQEVRVRRVAVDYGSHTNQVEAIEDLLAETLAGIEAQAPKVPFYSTLIGDWIRDAGIVDGGYWYRNLRNQVGFGPAVAELVRQGHGVFVEVSAHPVLVQPLSELSDDAVVTGSLRREDGGLRRLLTSMAELYVQGVPLDWTAVLPRTGRVDLPKYAFDHRHYWLRPAESATDAASLGQGAADHPLLGAVVELPQSDGLVFTSRLSVRTHPWLADHAVGGVVILPGSGLAELAVRAGDEAGCTALDELIIEAPLVVPAQGAVRVQVALSGPDETGSRTVDLYSQRDGGAGTWTRHATGVPSTAPAQEPEFDFHAWPPADAERIDVETFYTDLAERGYGYGPAFQGLQAVWRRDGDVFAEVALPEDLRKDAGRFGVHPALLDAALQAATAVGGDEPGQPVLAFAWNGLVLHAAGASALRVRLAPSGPDTLSVAAADETGGLVLTMESLVSRPVSAEQLGAAADAGHDAMFRVDWTELPAVPRAELPPWVRIDTADDVAALAEKADAPPVVVWEAAGGDPALAVSSRVLEIMQAWLAAPAFEEARLVVTTRGAVPAGGDHTLTDPAAAAVWGLVRSAQAEHPDRVVLLDTDGEVPLGAVLASGEPQLAVRGTTFFVPRLARATRLSDAPPAFDPDGTVLVSGAGSLGTLVARHLVTRHGVRRVVLASRQGRDAEGAQDLITELTGEGADVSFVACDVSDRDQVAALLAGLPDLTGVVHTAGVFEDGVIEALTPDQLANVYAAKVTAAMHLDELTRDRDLGAFVVFSSVAGVMGGGGQGPYAAANAFLDAAMASRQAAGLPGLSLAWGLWERSSGMAAHLSEVDHARASRNGVLELTRAEGLALFDLGLRMAESLLVPIKLDLAAMRASTVPVLFRGLVRPSRTQARTASTVDRGLAGRLAGLPVAERAAVLVDLVRGQVAVVLGYDGPEAVRPDTAFKDTGFDSLTSVELRNRLREATGLKLPATLVFDYPNPLAVARYLGARLVPDGTANGNGNGNGHSEDDRLRHALAAIAAEDAGEERSIADLGVDDLVQLAFGDE	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	1212.68	gnl|BL_ORD_ID|2357|hsp_num:0	515		
BGC0000136.1|Rifamycin_22 # 52544 # 57730 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=GGGAG;rbs_spacer=9bp;gc_cont=0.739	BGC0000136.1|Rifamycin_22 	52544	57730	+	Loose	1000	29.6462	MCR-1.10	29.85	3004506	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGGCTGACGAGGGACAACTCCGCGACTACCTCAAGCGGGCCATCGCCGACGCCCGCGACGCCCGCACGCGGCTGCGCGAGGTCGAGGAGCAGGCGCGGGAGCCGATCGCCATCGTCGCCATGGCGTGCCGGTACCCGGGCGGGGTGTCCTCGCCCGAGGACCTGTGGCGGCTGGTGGCCGAGGGGACCGACGCCGTCTCCGCGTTCCCCGGCGACCGCGGCTGGGACGTCGACGGGCTCGTCGACCCGGACCCCGACCGCCCGGGCACGACGTACACGGACCAGGGTGGCTTCCTCCACGAGGCCGGCCTCTTCGACGCGGGGTTCTTCGGGATCTCGCCGCGGGAGGCCGTCGCGATGGACCCGCAGCAGCGGCTGCTGCTGGAGACGTCCTGGGAGGCCATCGAACGCACCGGCACCGACCCGCTTTCGCTGAAGGGCAGCGACATCGGCGTCTTCACCGGCGTCGCGAGCATGGGTTACGGCGCCGGTGGCGGCGTGGTCGCGCCGGAGCTGGAGGGTTTCGTCGGCACCGGTGCGGCGCCGTGCATCGCGTCCGGCCGGGTGTCGTACGTCCTCGGCTTCGAAGGCCCGGCGGTCACCGTCGACACCGGGTGTTCGTCGTCGCTGGTGGCGATGCACCTCGCCGCGCAGGCGCTGCGGCGGGGTGAGTGCTCGATGGCTCTGGCCGGCGGCGCGATGGTGATGGCCCAGCCGGGTTCGTTCGTGTCCTTCTCGCGGCAACGCGGGCTCGCCCTGGACGGGCGCTGCAAGGCGTTTTCGGACAGCGCCGACGGGATGGGACTGGCCGAGGGCGTCGGCGTCATCGCGCTGGAACGGCTGTCGGTCGCCCGTGAGCGTGGGCACCGGGTGCTGGCCGTGCTGCGCGGTATCGCGGTGAACCAGGATGGCGCGTCGAACGGCTTGACCGCCCCGAACGGCCCGTCCCAGCAGCGGGTGATCCGCGCCGCGCTGGCCGAAGCCGGGCTGTCGCCGTCCGATGTGGACGCCGTCGAAGGGCACGGGACGGGCACGACGCTGGGCGATCCGATCGAAGCGCAGGCGTTGCTGGCCACCTACGGCAAGGGCCGGGACCCGGAGAAGCCGCTCTGGCTGGGCTCGGTGAAGTCGAACCTCGGGCACACGCAAGCGGCCGCGGGCGTGGCCAGCGTGATCAAGATGGTGCAGGCGCTGCGCCACGGCGTGCTGCCCCCGACGCTGCACGTCGACCGGCCGTCCACCGAAGTCGACTGGTCGGCCGGTGCGGTCTCGCTGTTGACGGAGGCTCGGGAGTGGCCGCGCGAAGGGCGGCCGCGCCGGGCCGGGGTGTCCTCGTTCGGGATCAGCGGGACCAACGCGCACCTCATCCTGGAGGAAGCGCCCGAGGAGGAGCCGCCCGTCGCCGAAGCGCCTTCCGCCGGAGTGGTGCCCGTGGTGGTGTCGGCTCGTGGGGCCCTGGCGGGTCAGGCCGGCCGGCTGGCCGCGTTCCTCGAGGCGTCCGACGAGCCGTTGGTGACCGTCGCCGGGGCGCTGATCTGCGGCCGGTCCCGGTTCGGCGACCGGGCCGTCGTGGTGGCGGGCACGCGCGCAGAGGCGACGGCCGGGCTGGCCGCGCTGGCCCGCGGCGAAAGCGCCGCCGACGTCGTGACCGGCACGGTCGCGGCCTCGGGCGTGCCGGGCAAGCTCGTGTGGGTGTTCCCGGGCCAGGGTTCGCAGTGGGTGGGCATGGGCCGGGAGCTCCTCGAAGCCTCGCCGGTGTTCGCCGCGCGGATCGCGGAGTGCGCGGCTGCCCTCGAACCGTGGATCGACTGGTCGCTGCTGGACGTCCTCCGTGGCGAGGGCGACCTCGACCGCGTCGACGTGGTGCAGCCCGCGAGTTTCGCGGTGATGGTCGGCCTGGCCGCGGTGTGGTCGTCCGTCGGGGTGGTGCCCGACGCGGTGCTCGGGCACTCGCAGGGGGAGATCGCGGCGGCGTGCGTGTCGGGGGCGTTGTCGCTGCAGGACGCGGCGAAGGTGGTCGCGTTGCGCAGCCAGGCGATCGCGGCGAAGCTGGCCGGCCGCGGCGGCATGGCCTCGGTCGCGCTGAGCGAGGAAGACGCGGTCGCGCGGTTGCGGCACTGGGCGGACCGGGTCGAGGTGGCCGCGGTCAACAGCCCGTCGTCGGTGGTGATCGCCGGCGACGCCGAAGCCCTCGACCAGGCCCTCGAAGCACTGACCGGCCAGGACATCCGGGTCCGGCGGGTGGCGGTGGACTACGCCTCGCACACCCGGCACGTCGAAGACATCCAGGAGCCCCTCGCCGAGGCACTGGCCGGGATCGAGGCGCACGCGCCGACCCTGCCGTTCTTCTCGACCCTCACCGGTGACTGGATTCGCGAAGCGGGCGTCGTGGACGGCGGCTACTGGTACCGGAACCTGCGCAACCAGGTCGGTTTCGGCCCGGCGGTGGCCGAGCTGCTCGGCCTCGGCCACCGGGTGTTCGTCGAGGTCAGCGCGCACCCCGTGCTCGTCCAGGCGATCAGCGCGATTGCCGACGACACCGACGCGGTCGTCACCGGCTCGCTGCGGCGCGAGGAGGGCGGCCTGCGGCGGCTGCTGACGTCGATGGCCGAGCTGTTCGTCCGCGGAGTCGACGTGGACTGGGCCACGATGGTGCCGCCAGCGCGGGTCGATTTGCCGACCTACGCCTTCGACCACCAGCACTACTGGCTGCGGTACGTCGAGACCGCGACCGACGCGGCCGGTCCGGTGGTCCGGCTGCCGCAGACGGGCGGCCTGGTCTTCACCACCGAGTGGTCGCTGAAGTCACAGCCGTGGCTGGCCGAGCACACCCTGGAAGACCTGGTCGTCGTCCCCGGCGCGGCACTGGTCGAGCTGGCCGTCCGGGCCGGTGACGAGGCCGGGACCCCGGTGCTGGACGAACTCGTCATCGAGACGCCCCTGGTCGTGCCGGAACGCGGCGCGATCCGGGTGCAGGTCACGGTGAGCGGACCGGACGACGGCACACGGACCCTGGAAGTGCATTCCCAGCCCGAAGACGCCACCGACGAATGGACCCGGCACGCCACCGGCACGCTGTCGGCGACCCCGGACGAAAGCAGCGGGTTCGACTTCACGGCCTGGCCGCCCCCGGGCGCCCGGCAGCTCGACGGCGTTCCGGCGATCTGGCGGGCCGGCGACGAGATCTTCGCCGAAGTCTCCCTGCCCGACGATGCGGACGCCGAGGCATTCGGCATCCACCCCGCGCTCCTGGACGCGGCCCTGCACCCCGCCCTGCCCGGCGATGACGGTCTGACGCAGCCCATGGAATGGCGTGGCCTGACGCTGCACGCCGCGGGGGCGTCGACGCTGCGGGTCCGGTTGGTGCCCGGCGGGTTCCTGGAAGCGGCCGACGGCGCCGGCAGCCTGGTCGTCACGGCGAAGGAGGTTGCCCTCCGCCCGGTGACGATCGCGCGGTCGCGCACCACCACCCGAGACTCGCTGTTCCAGCTGAACTGGATCGAGCTGCCCGAGAGTGGCGTGGTGGCCGCGGCAGACGACACCGAGGTGCTGGAGGTGCCCGCGGGCGATTCCCCGCTGGCGGCGACCTCCCGAGTCTTGGAGCGGCTCCAGACCTGGCTGACCGAGCCCGAGGCGGAACAGCTGGTCGTCGTGACGCGCGGCGCGGTGCCCGCCGGGGACACCCCGGTGACCGACCCGGCCGCGGCGGCGGTCTGGGGCCTGGTCCGGTCCGCGCAGGCGGAGAACCCGGACCGGATCGTCCTGCTCGACACCGACGGCGAAGTCCCGCTGGGTGCGGTGCTGGCCGGCGGCGAGCCGCAGGTCGCGGTGCGCGGCACGGCGCTGTACGTCCCGCGCCTGGCCCGCGCCGACGCGGCCCCGGTATCCGGTCTACATGGGACGGTCCTCGTCTCCGGTGCCGGTGTGCTCGGCGAGATCGTGGCGCGGCACCTGGTCACCCGCCACGGCGTGCGCAAGCTGGTGCTCGCCAGCCGCCGCGGCCTGGACGCCGACGGCGCGAAGGACCTCGTCACCGACCTCACCGGCGAGGGCGCGGACGTGTCCGTCGTCGCCTGCGACCTGGCCGATCGGAACCAGGTGGCCGCGCTGCTGGCCGACCACCGCCCGGCGAGCGTCATCCACACGGCGGGCGTCCTCGACGACGGCGTCATCGGGACGCTGACCCCGGAGCGGCTGGCCAAGGTGTTCGCGCCCAAGGTCGACGCGGTCCGCCATCTCGACGAGCTGACTCGCGACCTCGACCTCGACGCGTTCGTCGTGTTCTCCTCCGGCTCCGGCGTGTTCGGTTCGCCGGGGCAGGGCAACTACGCGGCGGCGAACGCGTTCCTGGACGCGGCGATGGCGAGCCGCCGCGCGGCGGGTCTTCCTGGTCTCTCGCTGGCGTGGGGCCTGTGGGAACAGGCCACCGGCATGACCGCGCACCTCGGCGGCACCGACCAGGCCCGGATGAGCCGGGGCGGGGTGCGGCCGATCACGGCCGAGGAAGGCATGGCCCTGTTCGACACGGCACTGGGTGCGCAGCCCGCGCTGCTCGTGCCGGTCAAGCTCGACCTGCGGGAGGTGCGGGCCGGCGGGGCCGTGCCGCACCTGCTGCGCGGGCTGGTCCGGGCCGGGCGGCGGCAGGCCCAAGCCGCGTCCACAGTGGACAACCAGCTGCTGGGCCGGCTGGCCGGGCTGGGCGCGCCCGAGCAGGAGGCGCTGCTCGTCGACCTCGTGCGCGGCCAGGTCGCGGCGGTGCTCGGGCACGCCGGGCCGGACGCGGTCCGCGCCGACACGGCGTTCAAGGACGCCGGGTTCGACTCGCTCACCTCGGTCGACCTGCGCAACCGGCTGCGGGAGAGCACCGGGCTGAAGCTGCCCGCCACGCTCGCCTTCGACTACCCGACCCCGCTGGTCCTCGCCCGGCACCTGCGTGACGAGCTCGGGGCCGGCGACGACGCGCTTTCGGTGGTGCACGCGCGGCTCGAAGACGTCGAGGCGCTGCTCGGCGGGCTGCGCCTCGACGAATCCACGAAGACCGGTCTCACCCTCCGGCTGCAGGGCCTGGTCGCCCGGTGCAACGGCGTGAACGACCAGACCGGCGGCGAAACGCTGGCGGACCGGCTCGAGGCCGCGTCCGCCGACGAAGTCCTCGACTTCATCGACGAGGAGCTGGGTCTCACCTGA	MADEGQLRDYLKRAIADARDARTRLREVEEQAREPIAIVAMACRYPGGVSSPEDLWRLVAEGTDAVSAFPGDRGWDVDGLVDPDPDRPGTTYTDQGGFLHEAGLFDAGFFGISPREAVAMDPQQRLLLETSWEAIERTGTDPLSLKGSDIGVFTGVASMGYGAGGGVVAPELEGFVGTGAAPCIASGRVSYVLGFEGPAVTVDTGCSSSLVAMHLAAQALRRGECSMALAGGAMVMAQPGSFVSFSRQRGLALDGRCKAFSDSADGMGLAEGVGVIALERLSVARERGHRVLAVLRGIAVNQDGASNGLTAPNGPSQQRVIRAALAEAGLSPSDVDAVEGHGTGTTLGDPIEAQALLATYGKGRDPEKPLWLGSVKSNLGHTQAAAGVASVIKMVQALRHGVLPPTLHVDRPSTEVDWSAGAVSLLTEAREWPREGRPRRAGVSSFGISGTNAHLILEEAPEEEPPVAEAPSAGVVPVVVSARGALAGQAGRLAAFLEASDEPLVTVAGALICGRSRFGDRAVVVAGTRAEATAGLAALARGESAADVVTGTVAASGVPGKLVWVFPGQGSQWVGMGRELLEASPVFAARIAECAAALEPWIDWSLLDVLRGEGDLDRVDVVQPASFAVMVGLAAVWSSVGVVPDAVLGHSQGEIAAACVSGALSLQDAAKVVALRSQAIAAKLAGRGGMASVALSEEDAVARLRHWADRVEVAAVNSPSSVVIAGDAEALDQALEALTGQDIRVRRVAVDYASHTRHVEDIQEPLAEALAGIEAHAPTLPFFSTLTGDWIREAGVVDGGYWYRNLRNQVGFGPAVAELLGLGHRVFVEVSAHPVLVQAISAIADDTDAVVTGSLRREEGGLRRLLTSMAELFVRGVDVDWATMVPPARVDLPTYAFDHQHYWLRYVETATDAAGPVVRLPQTGGLVFTTEWSLKSQPWLAEHTLEDLVVVPGAALVELAVRAGDEAGTPVLDELVIETPLVVPERGAIRVQVTVSGPDDGTRTLEVHSQPEDATDEWTRHATGTLSATPDESSGFDFTAWPPPGARQLDGVPAIWRAGDEIFAEVSLPDDADAEAFGIHPALLDAALHPALPGDDGLTQPMEWRGLTLHAAGASTLRVRLVPGGFLEAADGAGSLVVTAKEVALRPVTIARSRTTTRDSLFQLNWIELPESGVVAAADDTEVLEVPAGDSPLAATSRVLERLQTWLTEPEAEQLVVVTRGAVPAGDTPVTDPAAAAVWGLVRSAQAENPDRIVLLDTDGEVPLGAVLAGGEPQVAVRGTALYVPRLARADAAPVSGLHGTVLVSGAGVLGEIVARHLVTRHGVRKLVLASRRGLDADGAKDLVTDLTGEGADVSVVACDLADRNQVAALLADHRPASVIHTAGVLDDGVIGTLTPERLAKVFAPKVDAVRHLDELTRDLDLDAFVVFSSGSGVFGSPGQGNYAAANAFLDAAMASRRAAGLPGLSLAWGLWEQATGMTAHLGGTDQARMSRGGVRPITAEEGMALFDTALGAQPALLVPVKLDLREVRAGGAVPHLLRGLVRAGRRQAQAASTVDNQLLGRLAGLGAPEQEALLVDLVRGQVAAVLGHAGPDAVRADTAFKDAGFDSLTSVDLRNRLRESTGLKLPATLAFDYPTPLVLARHLRDELGAGDDALSVVHARLEDVEALLGGLRLDESTKTGLTLRLQGLVARCNGVNDQTGGETLADRLEAASADEVLDFIDEELGLT	MVQHTSVWYRCSVSPFVLVASVSVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLVRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDTRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNTICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFITQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	319.41	gnl|BL_ORD_ID|2731|hsp_num:0	3134		
BGC0000136.1|Rifamycin_24 # 68022 # 68798 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=AGAAG;rbs_spacer=8bp;gc_cont=0.680	BGC0000136.1|Rifamycin_24 	68022	68798	+	Loose	550	24.6386	OXA-416	23.88	3001607	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTTCGACGTGGAGACCTACCTCCAGCGGATCGGCTGCGGCGGGGAAACCGGCGTGGACCTCGAAACGCTGGCGAAGCTGCAGAAGAGCCACCTGATGGCGATCCCGTACAGCAGCCTCGCCTACGAACTCCGGGACGCGGTGAACGTCGTCGACCTCGACGAGGACGACGTCTTCGTCACCAGCATCGCCGAAGGGCAGGGCGGCGCCTGCTACCACCTGAACCGGCTGTTCCACCGGCTCCTGACCGAACTCGGCTACGACGTCACGCCGCTGGCCGGCAGCACCGCCGAAGGCCGGGAGACCTTCGGCACCGACGTCGAGCACATGTTCAACCTGGTCACCCTGGACGGCGCCGACTGGCTCGTGGACGTCGGCTACCCCGGCCCCACCTACGTCGAGCCACTGGCGGTCTCGCCCGCGGTGCAGACCCAGTACGGGAGCCAGTTCCGGTTGGTGGAACAGGAAACCGGTTATGCGCTGCAACGCCGGGGTGCGGTCACCCGCTGGAGCGTCGTCTACACGTTCACGACGCAACCGCGTCAGTGGAGTGACTGGAAGGAACTGGAGGACAACTTCCGGGCCCTCGTGGGGGACACCACCCGCACCGACACGCAGGAAACCCTGTGCGGCCGCGCGTTCGCGAACGGCCAGGTCTTCCTGCGGCAGCGCCGCTACCTGACGGTCGAGAACGGCCGCGAGCAGGTGCGCACGATCACCGACGACGACGAGTTCCGGGCGCTGGTGTCCCGCGTGCTGTCCGGCGACCACGGCTGA	MFDVETYLQRIGCGGETGVDLETLAKLQKSHLMAIPYSSLAYELRDAVNVVDLDEDDVFVTSIAEGQGGACYHLNRLFHRLLTELGYDVTPLAGSTAEGRETFGTDVEHMFNLVTLDGADWLVDVGYPGPTYVEPLAVSPAVQTQYGSQFRLVEQETGYALQRRGAVTRWSVVYTFTTQPRQWSDWKELEDNFRALVGDTTRTDTQETLCGRAFANGQVFLRQRRYLTVENGREQVRTITDDDEFRALVSRVLSGDHG	MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNLDTFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANADYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP	97.36	gnl|BL_ORD_ID|2631|hsp_num:0	3499		
BGC0000136.1|Rifamycin_25 # 68818 # 69006 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.656	BGC0000136.1|Rifamycin_25 	68818	69006	+	Loose	650	22.7126	MexH	64.29	3000807	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGGAAAAAGCGGGCCTGCTGGCGAAGTTCGCCGGCCTCTGCAAAACCGCCTACGAGCACCACTACATCCCGTACCTGCACTTCTTCTACGGCGGCGAGTACCTCCACCACGGCAGCGAGCCGGTGTCCCGGATCGCGGACCTGCCGTACGTGACCGTGCCGGAGCCGCGGAAGAAGGCGCCGTGA	MTEKAGLLAKFAGLCKTAYEHHYIPYLHFFYGGEYLHHGSEPVSRIADLPYVTVPEPRKKAP	MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR	16.76	gnl|BL_ORD_ID|1265|hsp_num:0	1344		
BGC0000136.1|Rifamycin_26 # 69003 # 70058 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=AGAAGG;rbs_spacer=4bp;gc_cont=0.752	BGC0000136.1|Rifamycin_26 	69003	70058	+	Loose	400	28.4906	AAC(3)-IV	30.17	3002539	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGAGGACGACGATCCCGGTCCGCCTGGCGGAACGGTCCTACGACGTGCTCGTCGGCCCCGGGGTGCGGGCGGCGCTGCCCGAGGTCGTCCGGCGGCTCGGCGCGAGACGGGCCGTGGTCGTGTCGGCCCGGCCGGCGGACTGGGTGCCCGGCACCGGCGTCGAGACCCTGCTGCTCCAGGCGCGCGACGGCGAGCCGACCAAGCGGCTGTCCACAGTGGAGGAACTGTGCGGTGAGTTCGCGCGGTTCGGGCTCACCCGGTCCGACGTCGTGGTCTCCTGCGGCGGCGGCACGACCACGGACGTCGTCGGGCTCGCGGCCGCGCTGTACCACCGGGGGGTCGCCGTGGTCCACCTGCCCACGTCCCTGCTCGCCCAGGTCGACGCCAGCGTCGGCGGGAAGACCGCGGTGAACCTGCCGGCGGGCGAGAACCTCGTCGGGGCGTACTGGCAGCCCAGCGCGGTGCTGTGCGACACGGACTACCTGACGACGCTGCCGCGGCGGGAGGTGCTGAACGGCCTCGGCGAGATCGCCCGCTGCCACTTCATCGGCGCGCCGGACCTGCGGGGGCGCTCGCGCCCGGAGCAGATCGCCGCCAGCGTCACCCTCAAGGCGGGCATCGTCGCGCAGGACGAGCGGGACACCGGCCCGCGGCACCTGCTCAACTACGGCCACACGCTGGGGCACGCGCTGGAGATCGCGACCGGCTTCGCCCTGCGCCACGGCGAGGCGGTGGCGATCGGCACGGTCTTCGCGGGCCGGCTGGCCGGCGCGCTCGGCCGCCTCGACCAGTCCGGTGTGGACGAACACCTCGCCGTCGTCCGCCACTACGGCCTGCCCGCCGCGCTGCCCGCGGACGTCGACCCGGCGGTGCTCGTCCGGCAGATGTACCGGGACAAGAAGGCGATCACCGGGCTCGCCTTCGTCCTGGCCGGGCCGCGGGGCGCGGAGCTGGTGAGCGACGTGCCGGCGCCGGTCGTCACCGACGTCCTGGACCGGATGCCCCGCGACAGCCTGGAAAACCTGGTGGGGACGACGGAAGCGGCGGCGCCGTGA	MRTTIPVRLAERSYDVLVGPGVRAALPEVVRRLGARRAVVVSARPADWVPGTGVETLLLQARDGEPTKRLSTVEELCGEFARFGLTRSDVVVSCGGGTTTDVVGLAAALYHRGVAVVHLPTSLLAQVDASVGGKTAVNLPAGENLVGAYWQPSAVLCDTDYLTTLPRREVLNGLGEIARCHFIGAPDLRGRSRPEQIAASVTLKAGIVAQDERDTGPRHLLNYGHTLGHALEIATGFALRHGEAVAIGTVFAGRLAGALGRLDQSGVDEHLAVVRHYGLPAALPADVDPAVLVRQMYRDKKAITGLAFVLAGPRGAELVSDVPAPVVTDVLDRMPRDSLENLVGTTEAAAP	MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVMPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLPLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEAGCEECDAARQSIG	136.05	gnl|BL_ORD_ID|2208|hsp_num:0	639		
BGC0000136.1|Rifamycin_27 # 70055 # 71380 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GACGG;rbs_spacer=13bp;gc_cont=0.748	BGC0000136.1|Rifamycin_27 	70055	71380	+	Loose	710	26.5646	tet(35)	23.57	3000481	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAAGCGGCAGCCGGACTTCGCGGCCCACGGCCGGGCGGTCGACCGGGTGCTGGCCGGCCGGCTGAGCGCGGCGCTGGCCCGGCCGGCCGCGCAGCAGCCGGGCTGGCCGGACGCCGAGCGGGCGGCCGAGGTGATCGAGCTGCTGCACGACGCCGAGCCGATCGTGGCGCCGGAGGAGACCGCACGGTTGCGCGCCCGGCTCGCGTCGGTCGCCCGCGGCGAGGCGTTCCTGCTGCAGGGCGGGGACTGCGCGGAGACGTTCGCCGGCAACACCGAGCCGCACCTGCGGGCCAACCTCGGGGTGCTGGCGCGGATGGGCGAAGTGCTGGCCGAGGCGGCCGGCCTGCCGGTGGTCAAGATCGCCCGGATGGCCGGGCAGTTCGCCAAGCCGCGGTCCCGGACCGTCGACGCGCTGGGCCTGCCGGTGTACCGGGGCGACATCGTGAACTCCCCGGAGTGCACGGTCGCCGCCCGGACCCCCGACCCGCACCGGATGCTGCTGGCATACGCCCACGCCGCCGGCGCGATGGACCTCGTCCGCAAGCTCTGCGCCGAGGGCCTCGAAGAACCCCTGGCGGCGCAGGTGGTGCTCGCGGGCGCCCGCCGCGCGTCGTCGCCCGGCGGGCGGCCGTTCCCGGACTTCGGCCGGCCACCGCGCCCGGCCGAGATCTACGTCAGCCACGAAATGCTCCTGCTCGACTACGAGCGGGCCGTCCTGCGGACGGATTCCAGCGGGCCGGAACCGCGGCTGTCCAGCGGGCTGGCGCACTTCCTGTGGATCGGCGAGCGCCCCGCCAGCTCGACGGCGCCCACATCGACGTTCGCGGAGCTGCTGTCCAACCCGATCGGGCTGAAGCTGGGGCCGAGCTGCACCCCGGAGGAGGTCGTCGAGTACGTGCGGCGGCTCGACCCGCACCGCACGCCGGGCCGGCTGACGCTGGTCAGCCGGATGGGGCACGCCCAGGTCCGGGAGCTCCTCCCGCCGATCGTGGAGAAGGTCGCCGCCTCCGGGCACGAGGTGATCTGGCAGTGCGACCCGATGCACGGCAACACCCGGACCTCGGGCAACGGCTACAAGACCCGGCACTTCGGCCACGTCGTCGCCGAGCTGGCCGGCTTCTTCGCCGTGCACCGGCAGCTCGGCACCCATCCCGGCGGCATCCACGTCGAGGTGACCGGCGACGACGTGACGGAATGCCTCGGCGGGGCCGCGGGCATCGCGGAGGCCGACCTGCCCGACCGCTACCTGACCGCCTGCGATCCGCGGCTCAACGCCGACCAGTCGGTCGAACTCGCGTTCGCGATCGCGAAGATGCTGCGCTAG	MKRQPDFAAHGRAVDRVLAGRLSAALARPAAQQPGWPDAERAAEVIELLHDAEPIVAPEETARLRARLASVARGEAFLLQGGDCAETFAGNTEPHLRANLGVLARMGEVLAEAAGLPVVKIARMAGQFAKPRSRTVDALGLPVYRGDIVNSPECTVAARTPDPHRMLLAYAHAAGAMDLVRKLCAEGLEEPLAAQVVLAGARRASSPGGRPFPDFGRPPRPAEIYVSHEMLLLDYERAVLRTDSSGPEPRLSSGLAHFLWIGERPASSTAPTSTFAELLSNPIGLKLGPSCTPEEVVEYVRRLDPHRTPGRLTLVSRMGHAQVRELLPPIVEKVAASGHEVIWQCDPMHGNTRTSGNGYKTRHFGHVVAELAGFFAVHRQLGTHPGGIHVEVTGDDVTECLGGAAGIAEADLPDRYLTACDPRLNADQSVELAFAIAKMLR	MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFGLDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVATIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEIARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGLMAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSSTGARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSKSKMASCQNA	119.51	gnl|BL_ORD_ID|1976|hsp_num:0	1969		
BGC0000136.1|Rifamycin_28 # 71400 # 72191 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=5bp;gc_cont=0.747	BGC0000136.1|Rifamycin_28 	71400	72191	+	Loose	500	25.7942	OXA-361	36.84	3001548	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCGATCAGCGGCACCACCCGCCTGTACGTCGTGCTGGGCGACCCGGTCGCCCAGGTCCGGTCGCCCGGGCTGCTGAACCCGCTCTTCGCGGACCTGGACGTCGACGCGGTGCTCGTCCCGGTGCACGCGCCGCCGCCGCACCTCGAGCGGATCGTCGCCGGGCTGCAGGCCGTCGCCAACCTCGACGGCATCTTCGTCACCGTGCCGCACAAGGTGGCCGTGGCCGGGCTCGCCGACCGGCGCAGCCCGATGGTGGAGATCACCGGCAGCGCCAACGCCTTGCGGCGCGAAGCCGACGGCCGGTGGTACGCCGAGAACTTCGACGGCACCGGCTTCGTCGCCGGGCTGGTCGAGGCCGGGCACGACCCGAAGGCCCGGCGGGTGTCCCTCGTCGGCGCCGGTGGGGCGGGCAGCGCCATCGCGGCCGCCGTGCTGGCGGCCGGCGCCGACCGGCTGGCGCTGTGCGACCCGGACACCGCGAAGCTGGCCGCCCTCAAGGGCCGCCTGGACGTGCACTGGCCGGGCCGGACGTCGGTGTCGGCCGAGCCGGACACCGCGGGCGCCGACCTCGTCGTGAACGCGACCCCGCTCGGGCTGCGGCCCGGCGACCCGCTGCCGTTCCGGCCGGACCGGCTGGCGCCGGGCCGCGTGGTCGCCGACATCATCATGAAACCCCGCGAAACCCGCCTTCTCCGCGAAGCGGCGGCCCTCGGCCACGACGTCCATTACGGCAGCCACATGCTCGCCGGGCAATTGGACTCCTATCGCGATTTCTTCGGCCTGGGTTGA	MPISGTTRLYVVLGDPVAQVRSPGLLNPLFADLDVDAVLVPVHAPPPHLERIVAGLQAVANLDGIFVTVPHKVAVAGLADRRSPMVEITGSANALRREADGRWYAENFDGTGFVAGLVEAGHDPKARRVSLVGAGGAGSAIAAAVLAAGADRLALCDPDTAKLAALKGRLDVHWPGRTSVSAEPDTAGADLVVNATPLGLRPGDPLPFRPDRLAPGRVVADIIMKPRETRLLREAAALGHDVHYGSHMLAGQLDSYRDFFGLG	MKILILLPLFSCLGLTACSLPVSSSPSQITSIQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQCIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKVMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVKTPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG	95.29	gnl|BL_ORD_ID|569|hsp_num:0	608		
BGC0000136.1|Rifamycin_29 # 72331 # 73497 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGAGA;rbs_spacer=11bp;gc_cont=0.722	BGC0000136.1|Rifamycin_29 	72331	73497	+	Loose	700	25.0238	OmpA	50.0	3005044	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	ATGAACGCGCGAAAGGCACCGGAATTCCCTGCGTGGCCGCAGTACGACGACGCCGAGCGGAACGGCTTGGTCCGCGCGCTCGAACAGGGTCAGTGGTGGCGCATGGGCGGGGACGAGGTGAACTCCTTCGAGCGCGAGTTCGCCGCCCACCACGGCGCCGCGCACGCGCTGGCGGTCACCAACGGCACGCACGCGCTGGAACTCGCCCTGCAGGTCATGGGCGTCGGCCCGGGCACCGAGGTCATCGTGCCGGCCTTCACCTTCATCTCCTCGTCCCAGGCGGCCCAGCGGCTCGGCGCGGTCACCGTCCCGGTCGACGTCGACGCGGCCACCTACAACCTCGACCCGGAGGCCGTCGCGGCCGCCGTCACCCCGCGCACCAAGGTGATCATGCCGGTGCACATGGCCGGGCTGATGGCCGACATGGACGCGCTGGCGAAGATCTCCGCCGACACGGGCGTCCCGCTGCTGCAGGACGCCGCGCACGCGCACGGCGCCCGCTGGCAGGGCAAGCGCGTCGGCGAGCTGGACAGCATCGCCACGTTCAGCTTCCAGAACGGCAAGCTGATGACGGCGGGCGAGGGCGGCGCGGTCGTCTTCCCCGACGGCGAGACCGAAAAGTACGAGACCGCCTTCCTCCGGCACAGCTGCGGCCGTCCCCGCGACGACCGCCGCTACTTCCACAAGATCGCCGGCTCGAACATGCGGCTCAACGAGTTCTCCGCGTCCGTGCTGCGCGCGCAGCTGGCCCGCCTCGACGAGCAGATCGCCGTGCGCGACGAGCCGTGGACCCTGCTGTCCCGGCTGCTCGGCGCGATCGACGGCGTCGTGCCCCAGGGCGGCGACGTGCGCGCCGACCGCAACTCCCACTACATGGCCATGTTCCGCATCCCCGGGCTCACCGAGGAACGGCGCAACGCCCTGGTCGACCGGCTCGTCGAGGCCGGCCTGCCCGCCTTCGCCGCGTTCCGCGCGATCTACCGCACCGACGCCTTCTGGGAGCTCGGCGCCCCCGACGAGAGCGTGGACGCGATCGCCCGGCGCTGCCCGAACACGGACGCGATCAGCAGCGACTGCGTCTGGCTGCACCACCGGGTCCTGCTGGCCGGCGAGCCGGAGCTGCACGCGACCGCCGAAATCATCGCCGACGCCGTGGGCCGGGCATGA	MNARKAPEFPAWPQYDDAERNGLVRALEQGQWWRMGGDEVNSFEREFAAHHGAAHALAVTNGTHALELALQVMGVGPGTEVIVPAFTFISSSQAAQRLGAVTVPVDVDAATYNLDPEAVAAAVTPRTKVIMPVHMAGLMADMDALAKISADTGVPLLQDAAHAHGARWQGKRVGELDSIATFSFQNGKLMTAGEGGAVVFPDGETEKYETAFLRHSCGRPRDDRRYFHKIAGSNMRLNEFSASVLRAQLARLDEQIAVRDEPWTLLSRLLGAIDGVVPQGGDVRADRNSHYMAMFRIPGLTEERRNALVDRLVEAGLPAFAAFRAIYRTDAFWELGAPDESVDAIARRCPNTDAISSDCVWLHHRVLLAGEPELHATAEIIADAVGRA	MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	103.74	gnl|BL_ORD_ID|2833|hsp_num:0	3787		
BGC0000136.1|Rifamycin_30 # 73571 # 74647 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GAGGGG;rbs_spacer=5bp;gc_cont=0.746	BGC0000136.1|Rifamycin_30 	73571	74647	+	Loose	700	24.6386	mef(D)	27.78	3005089	protein homolog model	n/a	n/a		antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCGTCCGGGCCGCGGTGGTCGGGCTCGGCTGGGCCGGCCGGGAACTGTGGCTGCCCCTGCTGCGCGAGCACGCTGACTTCGAGGTGGTCGCCGCGGTGGACGCCGATCCGGCGTCGCGGCAGGCGTTCACGAAGGCGACCGGCATCCCCACGCACGCCGCGGTGTCCGCGCTGACCGCGCGCGAGGTCGACCTCGCCGTCGTCGCGGTGCCCAACTACCTGCATACCGAGGTGGCGGGCGCGCTGCTCGCCACCGGGATCTCCGTCTTCCTCGAGAAGCCGGTGTGCCTGAACTCCGCCGAGATCGACGTCCTCGCGGCGGCCGAACGCAGCGGCGGGATGCTGCTGGCCGGCAGTGCCGCCCGCTACCGCGGTGACGTCGGTGCGCTGCGGCGGCTCCTGCCGGAGCTGGGCGAGATCCGGCACGTCGCCTTGGGCTGGATCCGGGCGCGGGGTGTCCCGCGCGCGGGCGGCTGGTTCACCCAGCGCGAGAAGGCCGGCGGGGGAGCGCTGTACGACCTCGGCTGGCACTTGCTCGACACGCTCGCGTTCCTGCTCGGCCCGGCCGCCTTCACCCAGGTCATCGGCGTGACGTCGGACGACTTCGTCAACGCCGGCGCCTGGCGTGCGGCGTGGCGGCAGGACCAGCTCGGCGCGGACGCCGCCGACGTCGAGGACACCGCGCGCGGCTTCCTGGTCCGCGACGACGGCGTCTCGGTCTCCCTGCGGGCGAGCTGGGCCTCGCACCAGGCGCGGGACGTCTCGGTGATCCACGTCGAGGGCAGCGCCGGCACCGCGGACCTGCGGTGCACCTTCGGCTTCAGCCCCAACCGCGAGCCCGAGCCCGTGCTGTCGGTGACCCGCGAGGGCACCACCACCCGGCTGCCCGTGCCGCTCGAGCGCATCGGCGTCGAATACACGCGCCAGGTGAGCGACCTCGCCGCGATGCTGGCCGATCCCGGCCACCGCGGCCGGGCCGTCGCCGAAGCGCGGCCGATCGTCTCGATGATCGAGAACTTCTACGCCTCCGCGGGCTCGGCGCGCGGCCGGGGTGCGGTTCCGGCGTACCAGTGA	MSVRAAVVGLGWAGRELWLPLLREHADFEVVAAVDADPASRQAFTKATGIPTHAAVSALTAREVDLAVVAVPNYLHTEVAGALLATGISVFLEKPVCLNSAEIDVLAAAERSGGMLLAGSAARYRGDVGALRRLLPELGEIRHVALGWIRARGVPRAGGWFTQREKAGGGALYDLGWHLLDTLAFLLGPAAFTQVIGVTSDDFVNAGAWRAAWRQDQLGADAADVEDTARGFLVRDDGVSVSLRASWASHQARDVSVIHVEGSAGTADLRCTFGFSPNREPEPVLSVTREGTTTRLPVPLERIGVEYTRQVSDLAAMLADPGHRGRAVAEARPIVSMIENFYASAGSARGRGAVPAYQ	MKNNKWKKKFIAIYIGQFFSLLSSAAVQFSIIWWLTDKTGGSPLVLTLAGLAGFLPQALAGPFAGTITDRYSRKLMMILADMTVALGSLILFISLYFYEINISFVILILAIRSLATAFHMPALQASIPLLVPEDDLTKAAGWGQTVSSISNITGPAVGMSILAASSIEWVLLLDVLGAVIASGILLFIYIPKIQNQNQQSIDSKGFFIEMKDGYNALVNHPILLKLTFVMTSVAVLYIPLGTYFPLITRNHFNKGVVEAGIVEIIFAVGLIIGGSFLGILGDKFNKINTMTTGILLMGIALFLTGILSPSLFYFFVVLAGLVGFSGPLFSAPFYALIQSEIEPHLLGRVFSFVTSISLLATPLGYVIAGLLIEITNVSTLFSIIGVLIIFNGIIINRLK	89.72	gnl|BL_ORD_ID|2867|hsp_num:0	3823		
BGC0000136.1|Rifamycin_31 # 74662 # 75360 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGTGA;rbs_spacer=14bp;gc_cont=0.721	BGC0000136.1|Rifamycin_31 	74662	75360	+	Loose	850	27.7202	abeM	43.75	3000753	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; acridine dye; triclosan	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGACATTCCCGATCGTCGACCGGCCGGACACCGGGGCCGATCCCTCGGCACCGGTCCGGCACGCGGTCATCTTCGACCTCGACGGGGTCGTCGTCGACAGCTTCGCGGTGATGAGCGAGGCCTTCGCCATCGCCTACGCCGAGGTGGTCGGCGACGGGCCCGCGCCCTTCGAGGAGTATCGGCGCCACCTCGGTCGATACTTTCCGGATATCATGCGGATCATGGACCTTCCACTGGAGATGGAGGAACCCTTCGTCCGCGAGAGCTACCGCCTCGCCGGCGAAGTCCAGGTCTTCGACGGGGTCACCGAGCTGCTCCTGACGCTGCGGACGCGTGGCCTGCGGCTGGCCATCGCCACCGGCAAGAGCGGGCCGCGGGCCCGGTCCCTGCTCGACAACCTCGGCCTGCTCCCGTTCTTCGAGCACGTCATCGGCTCCGACGAGGTCGCCCGGCCCAAGCCGGCGCCCGACATCGTGCGCCACGCGCTGGACCTGCTGGACGTCCCGCCGGAGGCGGCCATCATGATCGGCGACGCCCCCACCGACCTGGCCAGCGCCCGAGGCGCCGGCGTCGCGTCGGCCGCCGCGCTGTGGGCGCCCCCGGACGACATCGGCGAGCTGCTCGCCGCCGGTCCCGACGTGGTGCTGCGACAGCCGGCCGACCTGCTCGCGCTCTGTCCGTCGGTGCCCGGCCGCTGA	MTFPIVDRPDTGADPSAPVRHAVIFDLDGVVVDSFAVMSEAFAIAYAEVVGDGPAPFEEYRRHLGRYFPDIMRIMDLPLEMEEPFVRESYRLAGEVQVFDGVTELLLTLRTRGLRLAIATGKSGPRARSLLDNLGLLPFFEHVIGSDEVARPKPAPDIVRHALDLLDVPPEAAIMIGDAPTDLASARGAGVASAAALWAPPDDIGELLAAGPDVVLRQPADLLALCPSVPGR	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	51.79	gnl|BL_ORD_ID|1285|hsp_num:0	1368		
BGC0000136.1|Rifamycin_32 # 75365 # 76276 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000136.1|Rifamycin_32 	75365	76276	+	Loose	400	27.335	vanRC	28.07	3002922	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGGGCACCCCGTACCACCTCGGCATCGACGTGGGAGGCACGAAAGTCGCCTTCCGCGTCGAGTCCGGCTCCGCCTGTATCGAGGAAACCTCGTTCAGCTGGGGAGCCCGGCACAGTGCCGAGGACGACCTCGCCCAGCTGGCCGGCCACGTGGCCCGGCTGCGGGAGCGCATCGGCACGCCGCTGGAGGCGGTCGGGGTCGCCATGCCCGGCACCGTCGGCGCGGACGGCCGGGTCGCGACCTGGCCCAGCCGCCCGGAGTGGACCGGGGTGGACCTGAAAACGGCGTTGCACTCGCTGTTCCCCGAAGCGGCGGTCGCCTGGGCGGACGACGGCGATCTCGGCGCGCTCGCCGAGTCCCGGGCGTCGGGCTGCGAGAACCTGCTGTACATCGGGATCGGCACCGGCATCGGCGGCGGCCTGGTCCTGGGTGGCGTGCCGTGCCCCGGCCTCGGCCGCGGTTCGTTCGAGATCGGCCACGTGATCGTGGAGATGGGCGGCGTCCGCTGTGTGTGCGGCCGCCGCGGCTGCCTGCAGGCACTCGCCTCCGGCCCGGCGACCCTCCGCCGCGCGAGCCTGTTGCGCGGAGCGGACGTCACCTACTACCGGCTGCAGCGGGCGCTGCGCAACGGAGAGCCGTGGGCGGCCGACGCGCTGGAAGGAAGCACCCGGGCGCTGGCGGCCGCGGTGACCGGCGTCCAGGAGCTGGTCCACCCGGACCGCGTGCTGATCGGCGGCGGGTTCGCGGCGGGGATCCCGGAGATCGTGCCGTCGGTGTCGGGGTTCCTGGCGGATCTGGTGCGACAGGGTCAGGCGCCGCTGCCGGTGGAACCGGCCGCGTTGGGCGGGCTGTCGTCGTTGCGGGGAGCGGTGGCCCTCGCCGGGCTGGTGGCGGCGGGGGAAGTGCCGTGA	MGTPYHLGIDVGGTKVAFRVESGSACIEETSFSWGARHSAEDDLAQLAGHVARLRERIGTPLEAVGVAMPGTVGADGRVATWPSRPEWTGVDLKTALHSLFPEAAVAWADDGDLGALAESRASGCENLLYIGIGTGIGGGLVLGGVPCPGLGRGSFEIGHVIVEMGGVRCVCGRRGCLQALASGPATLRRASLLRGADVTYYRLQRALRNGEPWAADALEGSTRALAAAVTGVQELVHPDRVLIGGGFAAGIPEIVPSVSGFLADLVRQGQAPLPVEPAALGGLSSLRGAVALAGLVAAGEVP	MSEKIVVVDDEKEIADLVTTFLQNEGFSVQPFYDGTSAIAYIEKEAIDLAVLDVMLPDIDGFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNHSTASPTVEEYEKDGLILKINSHQCILYGKEVFLTPIEFKILLYLFEHQGSVVSSETLFEAVWKEKYLDNNNTVMAHIARLREKLHEEPRKPKLIKTVWGVGYIIEK	131.17	gnl|BL_ORD_ID|1455|hsp_num:0	1547		
BGC0000136.1|Rifamycin_33 # 76343 # 77110 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.710	BGC0000136.1|Rifamycin_33 	76343	77110	+	Loose	500	26.1794	APH(6)-Id	32.5	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGGGCACTCTCGTTTCCTTCCACGCACACCCCAACGACGACACCACCACCTGCGGAGGCGTCCTGCGCAAGGCCCACGAGGACGGCCACCGCGTCGTCCTCGTGCTCGCCACCCGCGGCGAACTCGGCTACAACCCGGACGGTCTCCTCGCCGAGGGCGAGACCTTGGGCGACCGACGGGCCGTCGAAGCCCGGGCGGCCGCCGACGTGCTCGGGGTGGACCGGCTCGAGTTCCTCGGCTACACCGATTCCGGGATGACGGCCGCGGCCGACGGCGCCGGCACGTTCCAGACCGCCGACGTCGAGGAAGCGGCGCGGAAGCTCGCCGCGATCCTGCGCGAGGAGCGGGCGGACGTGCTGACGGTGTACGACGAGAAGGGCACCTACGGCGACCCCGACCACATCCAGGTGCACCGCGTCGGCACGCGGGCCGCGGAACTGGCGGGCACGGCGAAGGTCTTCCAGTCCACGATCAACCGCGAGCACATCAAGGCGAACCAGCGCGTGCTCGCCGAGCAGGCCGGCGTCGACCTGCCCGCGGGCCCGGACTTCGGCACCCCGGAGGCCGAGCTCACCTGCCGCGTCGACGTCTCCGCGTACACCGAGTACAAGCGCAAGGCGCTGCTCGCCCACGCCAGCCAGATCACCCCGCAGTCCACGCTGTTCACGGACCTGCCGGAGGACACGTTCCGCACCATGTTCGGCACCGAGTGGTTCATCCGCGCCGGTCAGGGGCCGGGCATCACCGAAACCGACCTGATGGCGTAA	MGTLVSFHAHPNDDTTTCGGVLRKAHEDGHRVVLVLATRGELGYNPDGLLAEGETLGDRRAVEARAAADVLGVDRLEFLGYTDSGMTAAADGAGTFQTADVEEAARKLAAILREERADVLTVYDEKGTYGDPDHIQVHRVGTRAAELAGTAKVFQSTINREHIKANQRVLAEQAGVDLPAGPDFGTPEAELTCRVDVSAYTEYKRKALLAHASQITPQSTLFTDLPEDTFRTMFGTEWFIRAGQGPGITETDLMA	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	91.73	gnl|BL_ORD_ID|973|hsp_num:0	1031		
BGC0000136.1|Rifamycin_34 # 77187 # 78119 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.732	BGC0000136.1|Rifamycin_34 	77187	78119	+	Loose	400	24.6386	QnrS4	58.82	3002793	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGGTCTATGCGTTCGACCCCGAGCTCGCCACCGCAGTGCCGGCCCTGCCGGTCACCGACCTCGGCGACCTCGCCCTGGCCCGGGCGGGCGTCCGCGAGCTCAGAGAGCGCTTGCCGAGGCCGGACACGGCGGGCCTGCGGATCGACGACGTCCGGGTCCCCGGCGACGGGCACGAGGTGGCGCTGCGCGTCTACCGCCCGGTCCGGCCACGGACGCCGGCGGCCCTGTACTTCGTCCACGGCGGCGGGTTCGTGGTCGGCGACCTCGACGTCGCCCTGGTGCCCTGCGTCGAGCTGGTCCGGGCGCTGGGGATCGCGGTGGTGTCGGTGGACTACCGGCTGGCACCGGAGACGCGCTACCCCGGCCCGCTCGAGGACGTCTACACCGGCTTGTGCTGGCTCGTCGGGCACGCGGAGGAGCTGGGCGTGGACCCGAGGCGGATCGTCACGTACGGCATCAGCTCGGGAGGCTGCCTCAGCGGCGGCTTGGCCTTGCTGGCCCGCGACCGCGGCGGGCCGCCCATCGCCTACCAGTTCCTGAACGCCCCGGTCCTGGACGACCGGCTCGAGACGCCGAGCATGCGCGAGTTCGTCGACACGCCGTTGTGGAACCGGCCGCAGGCCGAGATCAGCTGGGACGCCTACCTCGGACCGGGTGTCCGGGCTACGGACGCGGTGCCGTACTACGCAGCCCCGGCCCGCGCGACCGACTTGAGCGGGCTGCCGCCGGCATACGTCGCGGTGAAGCAGTTCGACCCGCTGCGGGACGAAGGGATCGCGTACGCGGTGGCGATGCAGGCGGCGGGGGTGAACGTCGAGCTGCATCTGTTCCCGGGCACGTTTCATGGCTCGGCCCGGTGCACGGACGCGGCGATCAGCCGGCGTGAGCAGGAGGAGCAGTTCGCGGTCCTGCGGCACGTGACCGGCCGCTGA	MVYAFDPELATAVPALPVTDLGDLALARAGVRELRERLPRPDTAGLRIDDVRVPGDGHEVALRVYRPVRPRTPAALYFVHGGGFVVGDLDVALVPCVELVRALGIAVVSVDYRLAPETRYPGPLEDVYTGLCWLVGHAEELGVDPRRIVTYGISSGGCLSGGLALLARDRGGPPIAYQFLNAPVLDDRLETPSMREFVDTPLWNRPQAEISWDAYLGPGVRATDAVPYYAAPARATDLSGLPPAYVAVKQFDPLRDEGIAYAVAMQAAGVNVELHLFPGTFHGSARCTDAAISRREQEEQFAVLRHVTGR	METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD	142.20	gnl|BL_ORD_ID|641|hsp_num:0	682		
BGC0000136.1|Rifamycin_35 # 78416 # 79984 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGGGAG;rbs_spacer=14bp;gc_cont=0.709	BGC0000136.1|Rifamycin_35 	78416	79984	+	Loose	600	233.417	Acinetobacter baumannii AmvA	34.54	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCACGCCACGGCGGCGGTGACCGAAACCCGGAATCCACGGCGCTGGCTGATTCTGGCCGTCATCTCGCTGGCCCAGCTGGTCGTCCTGGTCGACAACACGGTTTTGAACCTGGCCATCCCCAAGCTCACCGAAGATCTCGGCGCCACCACCGCCGATATCCAATGGATGATCAACGCCTACGCCCTCGTCCAATCCGGGCTGCTTTTGACGGCCGGCAGTTTCAGTGACCGGTACGGCCGGAAACGGTCGTTGCTCGCCGGGCTCCTGCTGTTCGGCGTGGGTTCGCTGGCCGCGGCGTTCAGCCTGTCGTCCGGGCAGCTGATCGCCGCGCGGGCCGGGATGGGCATCGGCGGTGCGCTGCTGACCACCACCACGCTGGCCGTCGTCATGCAGGTCTTCGACGAAAAAGAACTGCCGAAGGCGATCGGGCTGTGGAGCGCGGTCAGCTCCTTCGGCTACGCCAGCGGCCCGCTGATCGGCGGCGCGCTGCTCGCGCACTTCTGGTGGGGCTCGATCTTCCTCATCAACATCCCGGTGGCGCTGCTCGGCTGCGTCGCCGTGGCGAAACTCGTGCCGGAATCCAAGGACCCGCAAGGCGCCCGGCCCGATCTGGTCGGTGCCGCGCTCTCCACGATCGGCATGGCCGGGATCGTCTACGCGATCATCTCCGGCCCGGAGCACGGCTGGGCCTCGGCCACCGTCCTGGTGGCGGCCGGCATCGGCGTGGCCGCGCTGGCCGCGTTCGTCCGGTGGGAGCTGCACGTGCCGCACCCCATGCTCGACATGGGTTTATTCCGCAACCGCCGGTTCAACGGCGCGATCTCCGGCGGCCTGCTGGTCGCCTTCGGGATGGGCGGCTCGGTCTTCCTGCTGACGCAGCAACTGCAGCTCGTGCTCGGCTACGACCCCCTGGAGGCCGGGCTCCGGACGGCTCCGCTCGCGCTGGTGGTCGTCGCGCTGAACGTCGCCGGGCTCGGCGCGAAGCTGCTCGAGAAGCTGGGCATCGCCATGACGATCGCCGTCGGGATGACGCTGAACGCCGTCGGGCTCGCCATGGTGGCCGTGCTGGGCACGCCCGATCGCGGGTTCGGCGGAATGCTGGCCTGCCTGCTCGTCATGGGTGGCGGTATCGCGCCGGCCATGCCCGCCATGGCCAACGCCATCATGACCTCGATCCCGGCCGAGAAGGCGGGGGCGGGAGCCGCGGTGCAGGGCACCGTGAACCAGTTCGGCAGCGGGCTCGGCGTCGCCATCCTCGGCGCCGTGCTCAACTCGCGGTTCGCCGCGCTGCTGCCGATCGGCCTCGGTGCCGGCGCCGCCGGTTCGCTGCACGAAGCGCTGCTCCAGGCGCGGACCCCCGCACTGCAGGCGCAGGTGCGCGACGCCTTCGCCGGCGGCGTGCGCGCCAGCGAGCTGATCGGGGCGCTGGCCGTGGTCCTCGGCGGCATGCTCGCCGGCATGCTGCTGCGCCGGGCGGCCCGGTCGGAGGCGCACCAGGCGGCCTGGGCCCGCCCCACGATCAGGCTGGAAGCGGCCCCTGCCCCCTTTACCGTTGACCTCCGGTGA	MHATAAVTETRNPRRWLILAVISLAQLVVLVDNTVLNLAIPKLTEDLGATTADIQWMINAYALVQSGLLLTAGSFSDRYGRKRSLLAGLLLFGVGSLAAAFSLSSGQLIAARAGMGIGGALLTTTTLAVVMQVFDEKELPKAIGLWSAVSSFGYASGPLIGGALLAHFWWGSIFLINIPVALLGCVAVAKLVPESKDPQGARPDLVGAALSTIGMAGIVYAIISGPEHGWASATVLVAAGIGVAALAAFVRWELHVPHPMLDMGLFRNRRFNGAISGGLLVAFGMGGSVFLLTQQLQLVLGYDPLEAGLRTAPLALVVVALNVAGLGAKLLEKLGIAMTIAVGMTLNAVGLAMVAVLGTPDRGFGGMLACLLVMGGGIAPAMPAMANAIMTSIPAEKAGAGAAVQGTVNQFGSGLGVAILGAVLNSRFAALLPIGLGAGAAGSLHEALLQARTPALQAQVRDAFAGGVRASELIGALAVVLGGMLAGMLLRRAARSEAHQAAWARPTIRLEAAPAPFTVDLR	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	106.10	gnl|BL_ORD_ID|2775|hsp_num:0	3280		
BGC0000136.1|Rifamycin_36 # 80000 # 80728 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=6bp;gc_cont=0.708	BGC0000136.1|Rifamycin_36 	80000	80728	+	Loose	400	50.447	tetR	30.43	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCAAACGGGCCTCGCAGCCCCGCGAGAGCGTGTGGCTTTCCCCGCGGCCGGCCCGCAAGCACCGGGCCGGCGAATCCGAGCTCGACCGCGAAAAGATCGTCGCCACCGCGGTCCGCGTCCTCGACGCCGAGGGCGACGCGAAGTTCTCGATGCGGCTGCTGGCCGAGGAACTCAACGTGACCCCGATGTCGGTGTACTGGTACGTCGCGAACAAGGACGACCTGCTCGAGCTGGCCCTCGATGCGGTGGCCGGCGAGATCGAGCTCCCGTCGCTCGACGACGGCAACGACTGGCGCGAGGACCTGCGCGCGCTCGCCCGCGCGTGGCGCCGCACGATGGTGGCCCACCCGTGGGCGATCCGCTGCTACGGCGAGTACCTGAACATCGGCCCGAGCAGCCTCCGCTTCACCGAGTGCGCCCAGGCGGTGATGGCGTGCTCACCGTTGCCGCTGAAGGACCGCTCGGCGGCGCTGAACGTGGTCTTCCAGTACGTCTACGGCTTCACGGCGACGGAGAGCCGCTGGCTGGAGCACCTCGCCGAAACGGGCCGCACGGCGGAGGAGTTCGCCGCCGAGGTGACGGGCAGCATGGCGGCGATGTCCTCGACGCTGGAGCAGGGCGGCCTGCTGGAGCGGGACGGCGACCAGTCGATGGAGCAGCTGCGGGACCGGGACTTCGACCGCGGGCTGAACTGGCTGTTCACCGGCATGGTCGCCGGCGGGTGA	MGKRASQPRESVWLSPRPARKHRAGESELDREKIVATAVRVLDAEGDAKFSMRLLAEELNVTPMSVYWYVANKDDLLELALDAVAGEIELPSLDDGNDWREDLRALARAWRRTMVAHPWAIRCYGEYLNIGPSSLRFTECAQAVMACSPLPLKDRSAALNVVFQYVYGFTATESRWLEHLAETGRTAEEFAAEVTGSMAAMSSTLEQGGLLERDGDQSMEQLRDRDFDRGLNWLFTGMVAGG	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	116.35	gnl|BL_ORD_ID|455|hsp_num:0	276		
BGC0000136.1|Rifamycin_37 # 80735 # 81235 # -1 # ID=1_37;partial=00;start_type=GTG;rbs_motif=GAGGGG;rbs_spacer=6bp;gc_cont=0.687	BGC0000136.1|Rifamycin_37 	80735	81235	-	Loose	750	26.9498	patA	56.25	3000024	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGACCTGAGCATGACCGAGAAGGAAGAGCAGGAGTTCCTGGCCGGCAAGCACATCGGCGTGCTGGCGGTGCACCGGCGAAGCGGCCCGCCGCTGGCGGTACCGATGTGGTACGGCTACTCCCCCGGCGGCGACGTGCTGTTGTGGACCGACGGCGAGGACACCTTGAAGGGCAGGCTGATCAAGAAGAACGGCGCCTTCACCTTGGTGGTCCAGAACGAGGATCCGCCCTACCGGTACGTTTCCGTGTCGGGTCCGGTGACGGCGTGGGAAGAAGCCACCGTCGAGGCCGCGTATTCGGTGGCGTCGCGGTACCTGCCAGAGCGGCAGGCGCGGGAGTTCGTCGAGGCGTTCAACGCGGGCCACGTGATCATCCGGATGACGCCGGACCGCTGGCGCAGCGTCGACTACGGCAAGACGTCGAACGTCCTCACCGACCGCGAAGGGACCCGGCTGCGGGAACACGTGCAGACGGCCCGGCGCGGGCGCGGGCGCGACTGA	MDLSMTEKEEQEFLAGKHIGVLAVHRRSGPPLAVPMWYGYSPGGDVLLWTDGEDTLKGRLIKKNGAFTLVVQNEDPPYRYVSVSGPVTAWEEATVEAAYSVASRYLPERQAREFVEAFNAGHVIIRMTPDRWRSVDYGKTSNVLTDREGTRLREHVQTARRGRGRD	MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK	29.43	gnl|BL_ORD_ID|1953|hsp_num:0	2081		
BGC0000136.1|Rifamycin_38 # 81320 # 82531 # -1 # ID=1_38;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=8bp;gc_cont=0.690	BGC0000136.1|Rifamycin_38 	81320	82531	-	Loose	600	25.7942	vanJ	31.67	3002914	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanJ membrane protein	TTGACGGAGACCGTCGCCTTCCCGCAAGACCGCACCTGCCCGTACCAGCCGGCGCCGGGTTACGAACCGCTCGCCGACCGGCGCCCGATCGCCGAGGTCACCCTCTACGACGGCCGCAAGGCCTGGGCGGTCACCGGGCACGAACTGGCCCGCAAGCTGCTGTGCGACCCGCGCATCTCCAGTGACCGGACCAATCCCGCGTGGCCGATGGTCAGCGCGGCCGCGGCCGTCGAGTTCACCGACGTCCAGCAGAAGGTCATCAAGCTGCTCACCGCGCTGGTGGGCGTCGACGGCCCGGCCCACCGGGCGCGGCGCAAGCTGGTGCAGGCGGGGTTCACGGTCAAGCGGATCGACTCCCTGCGGCCGAAGATCCAGGCGCTCGTCGACCGGCAGATCGACGAGATGATCGCCGAAGGCGCTCCGGTGGACCTGCTCAAGAAGTTCGCTTCGCCGGTGCCCCTGATCGCGTTGTGCGATCTGCTCGGCATCCCGCACGAGGACCAGGACTACTTCGAGAAGAAGGCGCACCAGATCCTGTTCGGGCCGGACGCCGGCGGGGCCTACGACGAGCTGATGGCCTACCTGACGAAGCTGATCGACAAGGCCGAGCAGAACCCGGGCGAAGAGGGGTTCCTGCAGGCCCTGCTCGCCGAGCGCGACCCGTCGAGCGACGTGGACCACGAGGAAATCCTGCAGATGTTCCTCATCGTGCTGGTGACCGGGCACGACACGACGTCGAGCTCGATCGGGCTCGGTGCCTTCACGCTGCTGCAGCACCCGGAACGGCTGGCCGAGCTGCGGGCGGACCCGTCGCTGATGCCCGCCGCGGTGGACGAGCTGACCCGGTTCGTGGTCGTCCCCGACGGCCTGCAGCGGGTGGCCGCGGACGACATCGAGGTCGACGCGGACACCACCATCCGCAAGGGCGACGGTGTGTTCTTCCTGTTCTCGCTCATCAACCGGGACGAGGAAGCCTACGAGGACGGCGACCGGCTGGATTGGCACCGCCCGACGTTCCGCGACCACCTGACCTACGGGTTCGGGACGCACCAGTGCGCGGGGATGAACCACGCGCGCGCCATCATGGAAATCGCTTTCCGGCGGCTGATCGACCGGCTGCCGGGATTGCGCCTGGCGGTCCCGGCCGACGAAGTCCGGGTCAAGCCGGGGGACGCGTTCCAAGGACTGGCCGAGCTGCCCGTCACTTGGTAG	MTETVAFPQDRTCPYQPAPGYEPLADRRPIAEVTLYDGRKAWAVTGHELARKLLCDPRISSDRTNPAWPMVSAAAAVEFTDVQQKVIKLLTALVGVDGPAHRARRKLVQAGFTVKRIDSLRPKIQALVDRQIDEMIAEGAPVDLLKKFASPVPLIALCDLLGIPHEDQDYFEKKAHQILFGPDAGGAYDELMAYLTKLIDKAEQNPGEEGFLQALLAERDPSSDVDHEEILQMFLIVLVTGHDTTSSSIGLGAFTLLQHPERLAELRADPSLMPAAVDELTRFVVVPDGLQRVAADDIEVDADTTIRKGDGVFFLFSLINRDEEAYEDGDRLDWHRPTFRDHLTYGFGTHQCAGMNHARAIMEIAFRRLIDRLPGLRLAVPADEVRVKPGDAFQGLAELPVTW	MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSVGSLVETFLPWFGLFVPVLAAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTARDLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDYGPLADTKPADVTMAGNRALRTTVATERGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWALGEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQILVRGVEPTGSWTLPATGSDHLPVAAGVSW	122.12	gnl|BL_ORD_ID|2082|hsp_num:0	2240		
BGC0000136.1|Rifamycin_39 # 82562 # 83827 # -1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.712	BGC0000136.1|Rifamycin_39 	82562	83827	-	Loose	1500	25.409	rphB	33.33	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGACCACCACTGCCGAGACTTCGGCCGAACCGGTCGACCTGTTCTCCCCGGAAGTGGTCGCCGACCCGTGGGGAGCGCACGCGGCGGTCCGCGAGGCGCCGACGCTGCAGATCGGCGGCTTCATGGGCGGGCCGCCGATGTACCTGGCCGCCCGCTACGAAGACGTCCGCCAGGTCCTGATGGACCAGCGGTTCCAGTGCAACCCGCTGGCCGATTCCCCCGCCGAGGACATCCGCAACGGCGTCTTCCGGCACCTGGACATGCCGGAGGAGCTGATCCCCTGGCTGAAGAACCTCATCAACGCCTCCGACGGCGAGGAGCACGCCCGGCTGCGCAAGCTGGTCTCCTACGCGCTCACCGCGCACCGGGTCGGCAAGTTCCGCCCCCGGGTCGAAGAGCTCACCGCGGAGCTGCTCGACAAGCTGGAAGCGGCGGGCGGTGACGGCACGCCGATCGACCTCGTCGAGTCGTTCTGCTACCCGCTGCCGGTCACCGTGATCTGCGAGCTGGTCGGCGTCGACCACGAAGACCGGCCGCAGTGGCGTGCGTGGAGCGACGCGATGGCCACCCTGGACGGCAAGCGGCTCCCGGAAGAAGTGCGCAAGACCCTCGCCGCCGCCCGCGGGATGATCGAGCGGCGCCGCGCCGAGCCGAAGGACGACATGGTCACCGCGCTCGTCGAGGCGCAGGCCAAGAACCCCGGCATCGCCACCGACGACGAGCTGGTCGGCGTCCTGTTCAGCCTGGTCACCGCCGGGCACCAGACGACCACCTACCTGATCGGCAACTCGGTGCTGGCCCTGCACGAGCACCCCGACCAGCTCGCGCGGCTCAAGGCCGACCCGTCGCTGTGGCCGCAGGCCGTGCGCGAACTGCAGCGCCTGGGCCCGATCCAGTTCGGGCAGCCGCGGTTCGCCACCGAGGACATCGAGGTGGGCGGCACGGTGATCCCGCGCGGCATGCCCGTGGTGCCGCTGATCATGGCCGCCAACAGCGACCCGCGGAAGTTCCCCGAGCCGGAGAAGCTGCAGATCGACCGGCTCGCCGTCGGCAGCGAGAGCCACCTCGGCTTCGGCAAGGGCATCCACCGCTGCCTCGGCCAGCACGTCGCCTACCTGGAGGCGGAAGTGGCCCTGCGCGGCCTGTACACCCGGTTCCCGGACATGACGCTGGCGGTGCCGCGCGAAGAGATCCCGTGGATCCTGCGGCCCGGCTTCACCCGGACCAAGGACCTCCCGGTGCGGCTCGCCCGGCCGGCGTCCTGA	MTTTAETSAEPVDLFSPEVVADPWGAHAAVREAPTLQIGGFMGGPPMYLAARYEDVRQVLMDQRFQCNPLADSPAEDIRNGVFRHLDMPEELIPWLKNLINASDGEEHARLRKLVSYALTAHRVGKFRPRVEELTAELLDKLEAAGGDGTPIDLVESFCYPLPVTVICELVGVDHEDRPQWRAWSDAMATLDGKRLPEEVRKTLAAARGMIERRRAEPKDDMVTALVEAQAKNPGIATDDELVGVLFSLVTAGHQTTTYLIGNSVLALHEHPDQLARLKADPSLWPQAVRELQRLGPIQFGQPRFATEDIEVGGTVIPRGMPVVPLIMAANSDPRKFPEPEKLQIDRLAVGSESHLGFGKGIHRCLGQHVAYLEAEVALRGLYTRFPDMTLAVPREEIPWILRPGFTRTKDLPVRLARPAS	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	47.62	gnl|BL_ORD_ID|2298|hsp_num:0	2528		
BGC0000136.1|Rifamycin_40 # 83901 # 85208 # -1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=10bp;gc_cont=0.683	BGC0000136.1|Rifamycin_40 	83901	85208	-	Loose	500	31.9574	OXA-364	24.05	3001551	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGTCGACTCAGCCCGATCGGACCTGCTGACGCAGGTTCGCGACTACCACGACGCCCAGTCCCCCGGGCCGGCGCCGTTCATCCCGGGGCAGACACCGATCCTGTCGTCCGGGGCGGTGCTGGACGCCGCCGACCGCGAAGCCCTGGTGGCCGCCGCGCTCGACCTGCGCATCGCCTCCGGCACCATCGCGACGAAGTTCGAGTCGTCCTTCGCCCGGAAACTCAAGCGGCGCAAGGCGGTGCTGACGAACTCCGGCTCGTCGGCGAACCTGCTGGCGCTGAGCACGCTGACGTCCCCGACGCTGGGCGACGAGCAGCTCAAGCCGGGCGACGAGGTCGTCACGGTCGCGGCCGGCTTCCCGACCACGGTGAACCCGATCCTGCAGAACGGCATGATCCCGGTGTTCGTCGACATCGAGCTCGGCACGTACAACACGACCGCCGAACGGGTCGAAGCGGCGATCTCCCCGCGCACGCGCGCCATCATGATCGCCCACACGCTGGGAAATCCTTTCCCGGTGGCGGAAATCGCCGAAATCGCCCAGCGCCACGGCTGCCACCTCATCGAGGACAACTGCGACGCCGTCGGCTCCACCTACCAGGGACAGCTCACCGGCACGTTCGGCCGGTTCTCGACGGTGTCCTTCTACCCAGCCCACCACCTGACCATGGGCGAGGGCGGCATGCTGCTGTCCTCGGACATCAAGCTGGCCAAGCTGGCGAAGTCGTTCCGCGACTGGGGCCGCGACTGCTGGTGCGAGCCCGGCGAGGACGACCGCTGCCTGAAGCGGTTCGACCTGCACCTCGGCACGCTGCCGGAGGCCTACGACCACAAGTACGTCTTCTCCGAGGTCGGCTACAACCTCAAGAGCACCGACATCCACGCCGCGCTCGGGCTGAGCCAGCTGGCGAAACTGCCGGACTTCGTCGACGCCCGCAAGCGCAACTGGCGTCAGCTGCGCGAAGGCCTCGACGGCCTGCCCGGGCTGATCCTGCCGGAGGCCACGCCGGGCAGCGACCCGAGCTGGTTCGGGTTCATCATCACGGTGAAACCCGACGCCGGCTTCGACGTCCCGGAGGTCGTCGAGTACCTCGAGGCGCGCAACATCCGCACCCGGCGGCTGTTCGCGGGCAACCTGACCCGCCACCCCGCCTACATCGGCAAGCCGCAGCGCATCGCCGGCCCGCTGACCAACAGCGACATCGTCACCGAGCGGACGTTCTGGATCGGCGTCTACCCGGGGATCACCACGGAGATGATCGAGTACGTGATCGGCACGCTCAAGGAGTTCGTCGCCACGCACTGA	MVDSARSDLLTQVRDYHDAQSPGPAPFIPGQTPILSSGAVLDAADREALVAAALDLRIASGTIATKFESSFARKLKRRKAVLTNSGSSANLLALSTLTSPTLGDEQLKPGDEVVTVAAGFPTTVNPILQNGMIPVFVDIELGTYNTTAERVEAAISPRTRAIMIAHTLGNPFPVAEIAEIAQRHGCHLIEDNCDAVGSTYQGQLTGTFGRFSTVSFYPAHHLTMGEGGMLLSSDIKLAKLAKSFRDWGRDCWCEPGEDDRCLKRFDLHLGTLPEAYDHKYVFSEVGYNLKSTDIHAALGLSQLAKLPDFVDARKRNWRQLREGLDGLPGLILPEATPGSDPSWFGFIITVKPDAGFDVPEVVEYLEARNIRTRRLFAGNLTRHPAYIGKPQRIAGPLTNSDIVTERTFWIGVYPGITTEMIEYVIGTLKEFVATH	MPLRLPLRALGAALSLFALAGAPASAAVLCTVVADAADGRIVFQQGTQAACAERYTPASTFKLPIALMGADAGILQGAHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVFARLLQDEKATRPNAGLRARDELLREWPAMADAPRQ	158.18	gnl|BL_ORD_ID|2141|hsp_num:0	3481		
BGC0000136.1|Rifamycin_41 # 85342 # 86556 # 1 # ID=1_41;partial=00;start_type=GTG;rbs_motif=GGAGA;rbs_spacer=12bp;gc_cont=0.707	BGC0000136.1|Rifamycin_41 	85342	86556	+	Loose	700	48.9062	oleD	25.91	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGATGGCCCCGGGCTTCTCCGTGGGCAAGCTGGAGCCGACCACGAGCCACCCCTGGGAGGACGATCTTGTGAAGGTTCTAAATCTCGCCGGGGTCGCCCCGTCGACGGTGTTCAGCCACGTCCCGCTCGCGAACGCCCTGCGCAACGCCGGGCACCAGGTGATGACCACGGCGTCGGTCGACGAGATGGTCGACACGATCGCCGGCGTCGGGCTGTCCGCGGTGCGGACCACGGCGCCGGGCGTCACCCCGCGGCAGGTCATCGCCGAAAGCGGCCTGACGCACGTGCCGGAAGACCCGGCAGAGCGCGAAGTCATGGCCGGCCGCTGGTACGCGCACATGGAGTACGTGACCCTGGACGCCTTGCTGGCGTTCAGCAAGGACTGGCGCCCGGACGTCATCGTCAGCGGCGTCACCTCCTACTCCGGCCCGCTGCTGGCCGCCCACCTCGGCGTGCCGTACGTGCGCCACGCCTGGGACATCCACACCCCGCGGCTGATGGATCAGGGTGCCGAGGACCAGCTGCGCGAGCAGCTGACGGAACTCGGCCTGGACGGCCTGCCCGAGCCCGCCATGACGATCGAGATCGCGCCGCCGAGCCTGCTGCCGGACGACCTCAAGGGCGGCCAGCCGATGCGGTGGATCCCCGGCAACTCGCAGTCGGTGCTGGAACCGTGGATGTACACCAAGAGCGCGGGCACCCGGATCGGCGTCACCATCGGCACCGGGGTCGCGAACTACAACCAGTACGACTTCCTGCAGGCCGTCGTCGAACAGGTCGCCACCCTGGACGCCGAAGTCGTCGTGGCCGTCACCGAAGACGCGGCGCCGGAACTGCGTGAGCGGCTGAAGAACGTGCGGGCGGGCTGGATCCCGCTGGACGTCGTCGCGCCGACCTGTGACGTCCTGGTGCACCAGACCGGCGGCAGCACGATGATGACGGGCCTGAGCTTCGGCGTGCCGCAGGTGCTGCTCCCGGACCCCAACCTCTTCCGCGCCAACGCGATGGCCCGCCGGCTCGCCGACACCGGCGCCGCGGTCGTGCTCTCGCCCGAGGAAGCCACGAGCGAGGTCATCGCGAAGACGTGCGGCGAGCTGGTCGCCGACCCGGCGTTCAAGGCGGCCGCGGGCGGGCTCGCCCGGGAGATCGCCGAGCTGCCCTCGCCGAACGAAGTGGCGCTGCGCATCGAGCAGCTCGTCCGGGAAGCGTCCTAA	MMAPGFSVGKLEPTTSHPWEDDLVKVLNLAGVAPSTVFSHVPLANALRNAGHQVMTTASVDEMVDTIAGVGLSAVRTTAPGVTPRQVIAESGLTHVPEDPAEREVMAGRWYAHMEYVTLDALLAFSKDWRPDVIVSGVTSYSGPLLAAHLGVPYVRHAWDIHTPRLMDQGAEDQLREQLTELGLDGLPEPAMTIEIAPPSLLPDDLKGGQPMRWIPGNSQSVLEPWMYTKSAGTRIGVTIGTGVANYNQYDFLQAVVEQVATLDAEVVVAVTEDAAPELRERLKNVRAGWIPLDVVAPTCDVLVHQTGGSTMMTGLSFGVPQVLLPDPNLFRANAMARRLADTGAAVVLSPEEATSEVIAKTCGELVADPAFKAAAGGLAREIAELPSPNEVALRIEQLVREAS	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	97.35	gnl|BL_ORD_ID|1284|hsp_num:0	1367		
BGC0000136.1|Rifamycin_42 # 86563 # 87207 # 1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000136.1|Rifamycin_42 	86563	87207	+	Loose	1200	25.7942	otr(A)	25.71	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGGTAGCGTCAGCACCCGCAGCATGACCGTTCAGCCGCTGGCCATCGACGGCGCACACGTGGTCACGTCCCAGTCGTTCGGCGACGAGCGCGGCGACTTCTTCGAGGTCTACCGCCAGGACGTGCTCACCGAGGCGCTCGGCTACCGGCCGCGGTTCCTGCAAACGAACGTCTCGACGTCGTGCCGCAACGTCGTGCGCGGCGTGCACGGGGCGATGACCCCGCCCGGCCTGGCGAAGTTCGTGACGTGCCTGCGCGGTTCGCTGCTCGACTTCGTCGTCGACGTGCGGACCGGTTCCCCGACGTTCGGCCAGTGGGACATGATCGTGCTCAACCAGCACGGCGGGACCGCGGTGTACGTCGAGGAAGGCCTCGGCCACGCGTTCGTGTCCCTCGAAGACGACACGTGCGTCCAGTACCTGCTGTCCGACCTCTACCGGCCGGCGGAGGTGCTCACCGTGCAGCCGCTGGACCCGGAAATCGGCCTCCCGCTGAACCTGCCGGGCGAGCCGATCCTGTCCGAGCGCGACGCGGCGGCGCCGACGTTGCGGGAGGCCGGCGAGCTGGGCCTGCTGCCGCGGTACGAGGAGTGCCTCGCGCTGCGGGAGGCGCGCGTGCGGCTCGAAGTGTCCGTGGCTTCCTGA	MGSVSTRSMTVQPLAIDGAHVVTSQSFGDERGDFFEVYRQDVLTEALGYRPRFLQTNVSTSCRNVVRGVHGAMTPPGLAKFVTCLRGSLLDFVVDVRTGSPTFGQWDMIVLNQHGGTAVYVEEGLGHAFVSLEDDTCVQYLLSDLYRPAEVLTVQPLDPEIGLPLNLPGEPILSERDAAAPTLREAGELGLLPRYEECLALREARVRLEVSVAS	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	32.28	gnl|BL_ORD_ID|1221|hsp_num:0	1273		
BGC0000136.1|Rifamycin_43 # 87270 # 88562 # -1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=15bp;gc_cont=0.742	BGC0000136.1|Rifamycin_43 	87270	88562	-	Loose	580	26.9498	ARL-2	24.21	3004735	protein homolog model	n/a	n/a	penam	antibiotic inactivation	ARL Beta-lactamase	ATGACCGTGCAGAAAGCGCCGTCCCAGCTGCTGGCGGCCAAGCTGCAGATCCCCCCGATCCCCTACAGCCACGCCGCCGGGTCCTGGGTGTACGCCTCCGACGGCACGCGCTACCTCGACGGCGCCAGCGGGATCGTCAACGTGAACATCGGCCACGCCCACCCCACGGTGGTCGCGGCCCTGCGGGACCAGGTCGGGATCTGCACCTACGCCAGCCCCGGCACGTTCGCGCCCGACCTGATGGAGCAGCTGGCCGCGGCCGCCGCCCGGGCGGTGCACCGCCCGGACGACCGGGTGATGTTCACCCCCACCGGCACGCACGCAACGGAATCCGCCATCGCGCTGGCCCGGCTGGTGCAGCGGGCCCGCGGCGAAGAGGGCAGGCACAAGATCCTGACCTCGACGCTGGGCTACCACGGCAACAGCGCGTTCGTGCTCGCCCTGTCGGGCCACCGGTCCCGGCGGCCGCACGAGGACGACAGCTTCGGCCTCGCTCCGGCGTTCAACCCGCCCTACCCCGGCCAGCACCTCGGCTGCCCGTTCGACGCCTGCCGGGTCGAGTGCGTGCGCGCGGTGCGCGACGCGATCGTCGCGGCCGGCCCGGAGAGCGTCGCCGCGGTGCTGATGGAGCCGGTCAACGGCACGACCGGCGGCGGGTACGTCCCGCCGGCGGGCTACCTGCGGGCGCTGCGCGAGGTCTGCGACGAGTTCGGCGTCCTCGTCATCCACGACGAGGTCCTCACCGGGCTGGGCCGCTGCGGGCTCCCGCTGGCCTCGCACCACACGCCGGGTTCGGCGGCGGACATCGTCACGCTGTCGAAGGGCCTCGGCGCGGGGTACGTCCCGCTGGCGGCCACGATGCTCTCGCCGGACCTGGCCGAGGACATCATGACCAGCGGCAAGTGGCTGCCGCTGATGGGCACGATGTCGGCGACCCCGCTGCAGGGCCGGGCCGGGCTGGCGGTGCTTTCGGTGCTGGAGGAGCTCGGCGCCCTCGACCGCGACGAAGTCCGCGGCGCGGCCCTCGGCCGGCTCGTGGCCGACGCCGTGCGCGGCCGGCAGGTGGTGACGGACGTCCGCGGGCTCGGGTACTTCTACGGCATCGAGCTGGCTCCCGGCACGCTCGGCGACGTCATGCGGATCACCCGGAGCCGGGGCCTGCTGCTGTACCCGTACGTCGGCTTCCGCCCCGACCGCACGGGCGAGGGCCTGCTGGTGGCCCCCCGCTCAACGCGACCGACGGCGATCTCGGCTTCCTCGGCGAGACGCTGGGCGCGGCACTGGACCAGCTGA	MTVQKAPSQLLAAKLQIPPIPYSHAAGSWVYASDGTRYLDGASGIVNVNIGHAHPTVVAALRDQVGICTYASPGTFAPDLMEQLAAAAARAVHRPDDRVMFTPTGTHATESAIALARLVQRARGEEGRHKILTSTLGYHGNSAFVLALSGHRSRRPHEDDSFGLAPAFNPPYPGQHLGCPFDACRVECVRAVRDAIVAAGPESVAAVLMEPVNGTTGGGYVPPAGYLRALREVCDEFGVLVIHDEVLTGLGRCGLPLASHHTPGSAADIVTLSKGLGAGYVPLAATMLSPDLAEDIMTSGKWLPLMGTMSATPLQGRAGLAVLSVLEELGALDRDEVRGAALGRLVADAVRGRQVVTDVRGLGYFYGIELAPGTLGDVMRITRSRGLLLYPYVGFRPDRTGEGLLVAPRSTRPTAISASSARRWARHWTS	MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFAYASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQSDNTASNIIMEQLGGLDQISSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHSLQQLLTTDAVAPQQRKFLQNLMFNNETGDSLIKKGVPDSYKVGDKSGQGTTYGTRNDVALIYPKHQTKPIVLVVFTKHQQQDAQPQDELVAQAARHAIHQLD	152.48	gnl|BL_ORD_ID|2469|hsp_num:0	3550		
BGC0000136.1|Rifamycin_44 # 88587 # 89579 # -1 # ID=1_44;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.725	BGC0000136.1|Rifamycin_44 	88587	89579	-	Loose	375	24.2534	vanXO	37.21	3002954	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	GTGGCCCCACTGCGCATCGGGATCATGGGCTGCGCGAGCATCGCCGTCCGGAAGGTGCTTCCCGCCATGGCCGCCTCGCCCCGCACGGAAATCACGGCGATCGCCAGCCGGAACCCCGGCAAGGCCGCGGAAATCGCGCACGCCTACGGGTGCCGCGCGGTCGAGGGCTATTCGGCGCTGCTGGACCTCGACGAGGTCGAGGCCGTCTACATCCCCCTGCCGAACGCCGCGCACGCGGGCTGGATCGAGCTGGCGCTGACCGCCGGCAAGCACGTGCTGGCCGAGAAACCGTTGACCACCAGCGTTTCCCGAACCTGTGAGCTGATCGCCGCGGCCGGTGCGGCCGGGCTCGTGCTGATGGAGAACGTCATGTTCCTCCACCACAGCCAGCACACGGCGGTCCGGGACCGGCTGGCCGGCGGCGCGATCGGCGAGCTGCGGGCGTTCCACGCCGCCTTCGCCGTGCCGGCCCGCCCAGCCGGCGACATCCGCCACCGCGCCGAGCTCGGCGGCGGTGCGCTGCTGGACACCGGCGTCTACCCGGTGCGCGCGGCGATGTCCTTCCTGGGCAGCGAAGTCGACGTCGTTTCGGCGGTGCTCACCCGGCGCCACGGCCGGCCCGTCGACTCCGCCGGGCAGGCGCTGCTGTGCACCGCCGACGGGGTGAGCGCGTCCGCGACCTTCGGGATCGACCACGCCTACCGCTCCGGATACGAACTTTGGGGCAGCGAAGGGCGGATCGTCCTCGACCACGCCTTCACCCCGCCCGCCGACCACCTCCCCGTGGTCCGCCTCGAACGGCGTTCGGGCGTCGACGAAATCCCGCTGCCGCCCGACGACCAGGTGGCGAACACGCTCACCGCCTTCGCCGCGGCCGTCCGTTCGGGACGGCTGCCCGACAACGACGACGTGGCCCGCCAAGCCGTGCTCGTCGACGACATCCGCACCAAGGCGAGGCTTTACGTCGATCACGCCCCCGAGCCGGTGGGCTGA	MAPLRIGIMGCASIAVRKVLPAMAASPRTEITAIASRNPGKAAEIAHAYGCRAVEGYSALLDLDEVEAVYIPLPNAAHAGWIELALTAGKHVLAEKPLTTSVSRTCELIAAAGAAGLVLMENVMFLHHSQHTAVRDRLAGGAIGELRAFHAAFAVPARPAGDIRHRAELGGGALLDTGVYPVRAAMSFLGSEVDVVSAVLTRRHGRPVDSAGQALLCTADGVSASATFGIDHAYRSGYELWGSEGRIVLDHAFTPPADHLPVVRLERRSGVDEIPLPPDDQVANTLTAFAAAVRSGRLPDNDDVARQAVLVDDIRTKARLYVDHAPEPVG	MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASLGFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGGAVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDCEWWHYTLKREPYPDVYFDFPIT	163.37	gnl|BL_ORD_ID|1602|hsp_num:0	1699		
BGC0000136.1|Rifamycin_45 # 89646 # 90611 # 1 # ID=1_45;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.690	BGC0000136.1|Rifamycin_45 	89646	90611	+	Loose	700	27.7202	EreA2	36.54	3002826	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	GTGGGCATCCCTCGTCCTGATAGCGCTCGCTGGTGGGAAAACCGGCCGGACAACCGGTCCGATGCTTGGTACTTTGCCGTTATGGCCACTGGGAGGAAGCCGTTCCGGTTCGGGGTCGACCTCATCACACCCGCACCGCGGCAGGCTTGGGTCGAAAGCTGCCGCAAGGCCGAGGATCTCGGCTACGACGTCATCGGGGTGGGTGACCACCTGGGCATGCCGGCGCCGTTTCCGGCGCTGGTGCTGGCCGCGGAGAACACCGAACGCGTCCGGCTCACGACGTTCGTGCTGAACGCCGGTTTCCACAATCCCGTGCTGCTCGCGCGGGAAGTCACCGGCACCGACCAGCTCACCGGCGGCCGGTTCGAACTCGGCCTCGGTGCGGGATACGTCGAAGCGGAATTCGAGGCCGCCGGAATTCCCTTTCCGACAGCCCGGCAACGGCTCGAGCACCTGGAACGGACGATCGAGCAGCTCAAGAAGAGCTACGCCGATCCGGCGCACCAGCCGCGGCCGGCGCAGCCGTCCGGCCCGCCGCTGCTGCTGGGCGGGCGCGGGAACGGCCTGCTCACCCTGGCCGCCGCGCACGCGGACACCATCGCGTTCATCGGCGCCACCGCTTCGCACAAGATGCTGCTGGCCGACGCCGCCGAGCTCGCCGACCGGGTCGGGTTCGCCAAGGCCGCGCTCGGCCCGCGGGCGGCCGAGGTCGAACTGAACGTCTTCGCCCACTACATCGACGTCACCGCCGATCGCCGGGCCGGCCTGGAAGCATTACACCGGCGGATGCCCGAGCGCACGGTCGACCAGCTCGCCGAACTGCCGACCGTGCTCGTCGGCACCGCCGCGCAGATCGCCGAACAGCTCGAAACCCACCGGGAGCGCTACGGGTTCAGCTACTTCACCGTGCTCGAGCACAACCTCGAAGCGCTTGCCCCGGTCATCGATCTCCTGCACGGGAAGTAG	MGIPRPDSARWWENRPDNRSDAWYFAVMATGRKPFRFGVDLITPAPRQAWVESCRKAEDLGYDVIGVGDHLGMPAPFPALVLAAENTERVRLTTFVLNAGFHNPVLLAREVTGTDQLTGGRFELGLGAGYVEAEFEAAGIPFPTARQRLEHLERTIEQLKKSYADPAHQPRPAQPSGPPLLLGGRGNGLLTLAAAHADTIAFIGATASHKMLLADAAELADRVGFAKAALGPRAAEVELNVFAHYIDVTADRRAGLEALHRRMPERTVDQLAELPTVLVGTAAQIAEQLETHRERYGFSYFTVLEHNLEALAPVIDLLHGK	MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERHDFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGELETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHLAEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKEDSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL	78.68	gnl|BL_ORD_ID|1429|hsp_num:0	1518		
BGC0000136.1|Rifamycin_46 # 90638 # 91708 # 1 # ID=1_46;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.698	BGC0000136.1|Rifamycin_46 	90638	91708	+	Loose	650	24.6386	vanN	44.44	3002912	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGGCGAACCGCCCGATGAAGTTCTCCACCTTCCACCTCTTCCACCAGTTCGCCGGGATGAGCGCGCCGGAGGTCTACGGCTACCACGTCGAGCTCGTCGAGCTGCTGGAGGAGCTCGGCTTCGACGGCGTGTGGCTGGCCGAGCACCACTTCCACGACTTCGGCACCGTGCCGAACACGCTCACCATGCTCGCCCACCTGGCGGCCCGCACCGAACGGCTGCGGCTCGGCACCGGGATCGTGGTGCTGCCGCTGCGCGACCCGATCCACGTGGCCGAGGAGGCCGCGATGGTGGACCTGCTCTCCGGCGGCCGGCTCGAGCTGGGCCTCGGCCGCGGCTACCAGAGCATCGAGTTCGAGAACTTCGGGCTCGACCTCGCCGAATCCCGCGACCGGTTCGACGAGTGCCTCGACGTGCTGCTCGGCCTCTTCACCACGGACGATTTCGAGTACCGGGGCCGGTTCCAGCAGACCACCCACCCGCTGACGCTGTGGCCCAAGCCGGTGCAGCGGCCGCACCCGCCGCTGCACGTCGCCGCCATCAGCCCCGAGACCGTGCGGAAGTACGCCGCCCGCGGCCTGCCGATCCTGGCCGACCCGGCTGCTCCTTTCGCGCGGATCGCCGAGGCCGCGGAGACCTGGCACAAGACCGCCGCCGGCCACGGCGTCGACGCGGGGGATGCCGAACTCGTCGCCAGCCGCGTGGTGTACGTCGCCGAGTCCGACGAGCGGGCCCGCGAAGAGCAGGCCCGGTTCGAGGCGGCGTTCGACCGGACCCGGGTCTTCCTGGCGGGCAACGCGCCGATCGACCTGAAGACCGGCGGGGCCGCGAGGAGCTACGAGTACCACCTGGAACGGCTCAAGGACCTCTCGGCCGAGAAGGACTTCGCCTGGAACCAGCTGGAAGTCATCGGCGACCCCGAGCGCGTCATCGGGCAGATCCGGTCCATTCAGGACATGGGCTACGGCAACCTCCTGTGCGACTTCGGCTCGACGCGGCAGATGCCGCTCGAGGAGATGAAGAAGCTGCTGAAGTTCTTCGCCGCCGAGGTCATGCCCGCGTTCCGCTGA	MANRPMKFSTFHLFHQFAGMSAPEVYGYHVELVELLEELGFDGVWLAEHHFHDFGTVPNTLTMLAHLAARTERLRLGTGIVVLPLRDPIHVAEEAAMVDLLSGGRLELGLGRGYQSIEFENFGLDLAESRDRFDECLDVLLGLFTTDDFEYRGRFQQTTHPLTLWPKPVQRPHPPLHVAAISPETVRKYAARGLPILADPAAPFARIAEAAETWHKTAAGHGVDAGDAELVASRVVYVAESDERAREEQARFEAAFDRTRVFLAGNAPIDLKTGGAARSYEYHLERLKDLSAEKDFAWNQLEVIGDPERVIGQIRSIQDMGYGNLLCDFGSTRQMPLEEMKKLLKFFAAEVMPAFR	MKKIALIFGGTSAEYEVSLKSAASVLSVLENLNVEIYRIGIASNGKWYLTFSDNETIANDLWLQDKKLNEITPSFDGRGFYDQAEKVYFKPDVLFPMLHGGTGENGTLQGVFECMQIPYVGCGVASSAICMNKYLLHQFAKSVGVMSTPTQLISSTDEQQVIKNFTELYGFPIFIKPNEAGSSKGISKVHTEAELTKALTEAFQFSQTVILQKAVSGVEIGCAILGNDQLLVGECDEVSLATDFFDYTEKYQMTTAKLTVPAKIPVATSREIKRQAQLLYQLLGCQGLARIDFFLTEAGEILLNEINTMPGFTNHSRFPAMMAATGITYQELISTLITLAEDK	103.79	gnl|BL_ORD_ID|148|hsp_num:0	164		
BGC0000136.1|Rifamycin_48 # 93305 # 94810 # -1 # ID=1_48;partial=00;start_type=TTG;rbs_motif=GAGG;rbs_spacer=5bp;gc_cont=0.734	BGC0000136.1|Rifamycin_48 	93305	94810	-	Loose	900	94.7449	iri	28.33	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	TTGACGGACACGGACGTCGTCATCGTCGGAAACGGCCCGATCGGCGCCACGCTGTCGGTGCTGCTCGCGCAACGCGGTTGGCGGGTGACGGTGCTCGAACGCCGGCCCCGGCCGTACAAGCTGCCGCGGGCGACCAGCTTCGACGGCGAGACGGCCCGGCTGCTGGCCGCCACCGGCATCGGCCCGGACCTCGGCCGGATCACCGCGCCGGCCAACGGCTACCAGTGGCAGACCGCCGACGGGCAGACGCTGCTCGACATCGCCTTCACCACAGACGGCCCGTACGGCTGGCCGGACGCCAACACCATGCACCAGCCCGCGCTCGAGGAGCTCCTCGCGGCCCGGGCGGCGGACCTGCCCGGGATCACCGTGCTGCGCGGGCACGAAGTCGTGGCCATCACCGACGGCGACTCGTTCGTCCAGGTGACCGCCACCGGCGAAGACGACGTTCCGCGGACGATCTCGGGCCGGTGGGTGGTCGGCTGCGACGGTGCCAACAGCTTCGTGCGCGAGCACCTCGACGTGCCGGTGACCGACCTCGGCTTCTCCTACGAGTGGCTACTCTGCGACGTCCGGCTGAACGAGCCGCGCGAGTTCGTGCCGACGAACGTGCAGATCTGCGACCCGGCCCGGCCCACCACGCTGGTGGGCAGCGGGCCCGGCCGCCGTCGCTGGGAGTTCATGCGCCTGCCGGGCGAAAACGCGGCGGAGCTCAACAAGGACGAGACGGCGTGGCGGCTGATGGCCCCCTTCGGCGTCACCCCCGAAACCGCCACCCTGCTGCGCAGCACCACCTACATCTTCCAGGCCCGCTGGGCCGACCGGTGGCGGGTGGGGCACGTCCTGCTCGCCGGCGACGCGGCGCACCTGATGCCGCCGTTCGCCGGGCAGGGCATGTGCTCCGGCATCCGCGACGTCACCAACCTGGCGTGGAAGCTCGACCTCACGCTCCGCGGCTTGGCTCCGGAGTCCCTTTTGGACAGCTACGGGGACGAGCGGCGCGAGCAGGCGCGCGAGGCCATCCTCGCGTCGGTCCAGCTGGGCCGGGTGATCTGCGTGACGGACCCGGCGGCCGCCGCCGAGCGGGACTCGACCGTGCTGGCCAACCGCCGCGGCAAGCCCGCGGGCCGGCCGGAACCGGCGAAGCCGCTCACCGGCGGGCTGCGCCACGAAAGCCCGGGCGCGGGCGTGGTGGTGCCGCAGGGCCGGGTGCAGGTCGGCGACGCCACCGGGCTCTTCGACGACGTCATCGGCCGGGGTTTCGTCCTGCTGACCACCGAGGAGACCCACTCGGACTTCCTCACCGAACTCGGAGCCCACGTCGTCCGGCTCGACGAGGGGGTGGACGTCGACGACGTCTACCGGCCGTTCCTGGCCCGGTTCGGGGCGGCTTCGGTGCTCGTGCGGCCGGACTACCACGTCTTCGGCACGGCCGGGCCGGGCGGGCTCGAAGCCCTGGTCGGCGCCCTGCGCGACCGGCTGCGCGCCGCGGTGCCCACCGGCTAG	MTDTDVVIVGNGPIGATLSVLLAQRGWRVTVLERRPRPYKLPRATSFDGETARLLAATGIGPDLGRITAPANGYQWQTADGQTLLDIAFTTDGPYGWPDANTMHQPALEELLAARAADLPGITVLRGHEVVAITDGDSFVQVTATGEDDVPRTISGRWVVGCDGANSFVREHLDVPVTDLGFSYEWLLCDVRLNEPREFVPTNVQICDPARPTTLVGSGPGRRRWEFMRLPGENAAELNKDETAWRLMAPFGVTPETATLLRSTTYIFQARWADRWRVGHVLLAGDAAHLMPPFAGQGMCSGIRDVTNLAWKLDLTLRGLAPESLLDSYGDERREQAREAILASVQLGRVICVTDPAAAAERDSTVLANRRGKPAGRPEPAKPLTGGLRHESPGAGVVVPQGRVQVGDATGLFDDVIGRGFVLLTTEETHSDFLTELGAHVVRLDEGVDVDDVYRPFLARFGAASVLVRPDYHVFGTAGPGGLEALVGALRDRLRAAVPTG	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	104.59	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0000136.1|Rifamycin_49 # 94826 # 96037 # -1 # ID=1_49;partial=00;start_type=GTG;rbs_motif=GGGAGG;rbs_spacer=6bp;gc_cont=0.729	BGC0000136.1|Rifamycin_49 	94826	96037	-	Loose	400	27.7202	Lactobacillus reuteri cat-TC	24.49	3002671	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	GTGACGCGAGCGGCTGTCCGGCGCGCGCTGGCGCCCAGCGAGAGCATCCACGCCGTGAAAGAGGCCTACATCGGGTACACCGTGCGTGCCGAGGGCCGGCTCGACCCCGAGGCGCTGACGACCGCGTTCGAAGCGGTCACTCGCGCCTACCCCCAGCTTTCGGCCTGCGTGGAGTTCACCGGCGAGGGCGCGGTGCTCGCCGAGTCCGACGCGCGGCCGGAGATCCGGTTCGCCGACGGCGATCCCGGCCGGCCACTCGAGGGATTGGACCTCGACCAGAGCCGTTCGCTGAGCGCGCTCAACGTCGTCCGCGACGGCGACGAAGCCAGTGTCTGCCTGGCGATCCAGCACAGTGTCGCCGACGCCCACCACGCCACCGCGATCCTCTCGGCGCTCTGGTCCTGCTACACCGACGTCATCGAGGGCGTGCCGCTCGACCTGGGCCGGCACCCGTACCCGCGGTCGCTGGAGGACCTGCTGGCCGAACGCGGCATCCACGCGAGCGTCCCGGCGGCGCCCTCGGTCCCACCGGCGGCACCGCCGCCCGCGTCCCGGCCGGACCCCGTCATCCGGCACGTCGTCCAGCACCGGCTGACCGAAGCCGAAACGACGGCGCTGGCGGAACTCGGCCACCGGGAGAAGGTGACGATCAACGGCCTGGTGTCGGGCGCGGTCCTGCTCGCCGAGGCCGAGATCCGTGACCTCCCGCTGACCGACCTCGTCTACCGGTACTCGGTGAACCTGCGCAGCAGGCTGACGCCCCCGGTCGGCGCGACCGAGGGCACGAACGTGCTGGACGGGGTCGGGTTCAAGGTGACGGACGGGATCGCGCACGACGCCGTCGCGATCGGCCGGGCCATCGGCGAGCAGCTGCGGGCCGGCCTCGCCGACGGGTCCGTGCAGCGCAGCATCCTGGACATGTTCGCCCGGCCCGCCGCCGCGAAACCGTGGGACCCGAAGCTCGCCCTCGCCGTGGTCAGCATCATGAACTGGGGCGTCGCCCCGCCGATGCGCACGCCGGACGGCCTGCGGCTGACCAACCTGCACTCGGCGTCGCGGATGCGGGAAACCCTCGCGCTCGGCGGTTACGTGATGAGCAGCTTCGGCGGCCGGGTGGGCCTCGACGTGGGCTGGCCCGAGGGCGATCCTTCGCTGCCGCAGCGGCTGGACTGCCTGCGCGAACGGCTGGCCCGCCTGACTCGTGACCTGTGA	MTRAAVRRALAPSESIHAVKEAYIGYTVRAEGRLDPEALTTAFEAVTRAYPQLSACVEFTGEGAVLAESDARPEIRFADGDPGRPLEGLDLDQSRSLSALNVVRDGDEASVCLAIQHSVADAHHATAILSALWSCYTDVIEGVPLDLGRHPYPRSLEDLLAERGIHASVPAAPSVPPAAPPPASRPDPVIRHVVQHRLTEAETTALAELGHREKVTINGLVSGAVLLAEAEIRDLPLTDLVYRYSVNLRSRLTPPVGATEGTNVLDGVGFKVTDGIAHDAVAIGRAIGEQLRAGLADGSVQRSILDMFARPAAAKPWDPKLALAVVSIMNWGVAPPMRTPDGLRLTNLHSASRMRETLALGGYVMSSFGGRVGLDVGWPEGDPSLPQRLDCLRERLARLTRDL	MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRVINSNTAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTSVKNDFKEFYDLYLSDVEKYNGSGKLFPKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIYLPLSLQVHHSVCDGYHAGLFMNSIRNCQIGLMTGFYNIDKPTVLFTVGFLMSLTCPLI	169.33	gnl|BL_ORD_ID|1527|hsp_num:0	1524		
BGC0000136.1|Rifamycin_51 # 96833 # 98101 # -1 # ID=1_51;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=5bp;gc_cont=0.704	BGC0000136.1|Rifamycin_51 	96833	98101	-	Loose	400	25.0238	MUS-2	29.11	3003842	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	ATGACCGCCACCGCCAAGCCTTCGGCCAAGCCGGTCGACCTGTTCTCACCGGAAGTGGTCGCCGACCCGTTCGGCTGGTACGCGCGGTTGCGCGAAGAACCGTTGCCGCACACCGGGACGCTGAACCTCGGCACCATGATGGGCGGGCCGGACATGTGGCTGGCCACCCGCTACGAGGACGTGCTCACGGTCCTCACCGACCCGCGCTTCCTCACCAACCCGCCCGCGGACTCGCCCCTGGCCGACATCCGCGACGGCGTCTTCAAGGCGATGAACTTCCCCGAAGACCTCATCCCGTGGATGGCCAACAAGCTCAACACCGCCGACGGCGAGGACCACACCCGGCTGCGCAAGCTGGTCTCGTACGCGCTGACCGCGCGCCGCGTCAACGCGCTGCGGCCGCGCGTCGAGAAGATCACCGAGGACCTGTTCGACCGGATGGCGGAACAGGGCAAGGACGGGTCGCCGGTCGACATCGTCGAGGAGTTCTGCTTCCCGCTGCCGGTGACGGTCATCTGCGAGCTGGTCGGCATCGACGAACCCGACCGCGCGGCCTGGCACGCCTGGGGCAACGCGATGGCGACCATGGACGGGCCGAAGATCCCGCCCGCGCTGCGCGAGTGCATCGCCCTCTCGCGCGAGCTGATGGCCCGACGGCGCGTCGAGCCGAAGGACGACCTGGTCACCGCCCTGGTGCAAGCCCAGGCCGACGACCCGGGCCGGGTGTCCGACGACGAGATCGTCGGCATCCTGTTCAGCCTCGTCACGGCCGGGCACCAGACGACGACCTACCTGATCGGGAACTCGGTGCTCTTCCTGCTCGAGCAGCCGGAGCAGCTCGCGCGGCTGAAGGCCGAGCCGGCGCTGTGGGCGCAGGCCGTGCGCGAGCTGCAGCGCCTGGGCCCGCTGCAGTTCACGCAGGCCCGCTTCCCGTCCGAGGACGTCGAGCTCGGTGGCGTCACGATCCCGCGGGGGACGCCGGTCGCGCCGCTGCTGCTGGCCGCCAACACCGACCCGCGCAAGTTCCCGGAGCCGGACAAGCTGGTCGTCGACCGGCTGAGCGTCGCCAACGAGATGCACCTTTCGTTCGGCAAGGGCATCCACCGCTGCCTGGGCCAGCACCTCGCCTACCAGGAGGCCGAGGTGGCGCTGCACGGGCTGTTCACCCGGTTCCCGGACCTGGCTCTGGCCGTGCCGCGCGACGAGATCCCGTGGATCCTCCGGCCGGCGTTCACCCGGACCAAGACGCTCCCCCTGAAGCTCGCTTAG	MTATAKPSAKPVDLFSPEVVADPFGWYARLREEPLPHTGTLNLGTMMGGPDMWLATRYEDVLTVLTDPRFLTNPPADSPLADIRDGVFKAMNFPEDLIPWMANKLNTADGEDHTRLRKLVSYALTARRVNALRPRVEKITEDLFDRMAEQGKDGSPVDIVEEFCFPLPVTVICELVGIDEPDRAAWHAWGNAMATMDGPKIPPALRECIALSRELMARRRVEPKDDLVTALVQAQADDPGRVSDDEIVGILFSLVTAGHQTTTYLIGNSVLFLLEQPEQLARLKAEPALWAQAVRELQRLGPLQFTQARFPSEDVELGGVTIPRGTPVAPLLLAANTDPRKFPEPDKLVVDRLSVANEMHLSFGKGIHRCLGQHLAYQEAEVALHGLFTRFPDLALAVPRDEIPWILRPAFTRTKTLPLKLA	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	171.54	gnl|BL_ORD_ID|2160|hsp_num:0	2328		
BGC0000136.1|Rifamycin_52 # 98368 # 99186 # 1 # ID=1_52;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=5bp;gc_cont=0.705	BGC0000136.1|Rifamycin_52 	98368	99186	+	Loose	600	36.965	emtA	26.27	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGACGAAGCCGACTCCGAACGAGATTGGTAAGGGCTACGACGCTTTCGCGGACCTGCTTGACCAGTTCTGGGGTGAAAACCTGCACCACGGATACTGGGACGACGAGTCCGCGACGCTCGAAGAGGCCACCACGCGGCTGACCGACCGGCTGGCCGGGATGCTCCCGCTGCGCGCCGGCGACCGGCTGCTCGACATCGGCTGCGGCAACGGCGAACCGGCGATCCGGATGGCCACCGCGAACGACGTCATGGTCACCGGCATCTCGATCAGCGAGAAGCAGGTGGAACGGGCGAACGACCGCGCGTACAAGGCCGACGTGGACGACCGGGTCGTCTTCGAGTACGCCGACGCGATGGAGCTGCCGTACCCGGACGCGTCGTTCGACGTCGTCTGGGCGCTGGAGTCCCTGCACCACATGCCGGACCGCTGGCACGTGATCCGCCAGGCGGCCCGGGTGCTGCGGCCGGGCGGCCGCCTGGCGCTCGGCGACTTCCTGCTCGTGCCGAGCCCGGCCGGCCTCGAGGCCGACGCCGAGCGCGTGCGCGAGGTGGGCAAGGGCGTGGTGGCGGTCGTCTCGCTCGACGAGTACCAGGCGCACCTGCGCGAGGCCGGGCTGGAGCCCGAATCCGCCGAGGACGTCAGCCAGTACACCCGGCCGTCGTGGACCAAGGCGGCGGAGCGGTTCGAAGGACTGCGGGAACAGGCCCTGCAGCACATCGAGGCCGCGCAGTTCGAGGTCACCCTCGGCCGGTTCCGCGCGTTCAGCGAGGAACCGTCGCTGGGGTACGTCCTGCTGACCGCGCGCAAGCCCGACTGA	MTKPTPNEIGKGYDAFADLLDQFWGENLHHGYWDDESATLEEATTRLTDRLAGMLPLRAGDRLLDIGCGNGEPAIRMATANDVMVTGISISEKQVERANDRAYKADVDDRVVFEYADAMELPYPDASFDVVWALESLHHMPDRWHVIRQAARVLRPGGRLALGDFLLVPSPAGLEADAERVREVGKGVVAVVSLDEYQAHLREAGLEPESAEDVSQYTRPSWTKAAERFEGLREQALQHIEAAQFEVTLGRFRAFSEEPSLGYVLLTARKPD	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	79.77	gnl|BL_ORD_ID|2272|hsp_num:0	3368		
BGC0000136.1|Rifamycin_53 # 99201 # 99893 # 1 # ID=1_53;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.716	BGC0000136.1|Rifamycin_53 	99201	99893	+	Loose	500	26.1794	mphO	35.29	3004543	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGCAGATGACCGAAGAGAACCTCCGCGGCCTGTTCGGCCGGATGACGGGGGACGAGAAGCACGGCTGGGCCGCGGCGTCGACATTGCACGCGATCTGGGTGCTCTACGAACGCGTGCTCAACGTGTCGCCGTCGAACATCGACGACCCCGGCCGGGACCGGTTCTACCTCTCCAAGGGACACGGCCCGATGGCCTACTACGCGGTGCTCGCCGCGAAGGGCTTCATCGAGCCGGAAACGCTGGACACCTGGCGGCAGTGGGGTTCGCCGCTGGGCATGCACCCGGACCGCAACCTGGCGCCCGGCGTGGAGATCAGCAGCGGCTCCCTCGGCCACGGGCTCCCGCTCGGCGTCGGCACCGCGCTCGGGCTGCGCGCCCAGGGCCGCGACGCCCGCGTGGTCGTCCTGATGGGCGACGGCGAGTTCGACGAGGGCAGCAACCACGAGACGATGGCGATCGCCGGACGGCTCGGGCTGGGCAGCCTCACCGCGGTCGTCATCGACAACAAGACGGCGAGCCTCGGCTGGCCGGGCGGCATCGCCGGGCGCTTCGAACAGGAGGGCTGGGCCGCCACCACGGTCGACGGCCGCGACCACGACGCGCTGGAGAAGGCGCTGACCGGGGAGACCGACGGGCGGCCGCGCGCGGTCATCGCGGAGATCCTCCCGATCGAGGAAGGGAGCACCGCATGA	MQMTEENLRGLFGRMTGDEKHGWAAASTLHAIWVLYERVLNVSPSNIDDPGRDRFYLSKGHGPMAYYAVLAAKGFIEPETLDTWRQWGSPLGMHPDRNLAPGVEISSGSLGHGLPLGVGTALGLRAQGRDARVVVLMGDGEFDEGSNHETMAIAGRLGLGSLTAVVIDNKTASLGWPGGIAGRFEQEGWAATTVDGRDHDALEKALTGETDGRPRAVIAEILPIEEGSTA	MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGEEEHRAAAAAALDPPDAD	72.56	gnl|BL_ORD_ID|2754|hsp_num:0	3219		
BGC0000136.1|Rifamycin_54 # 99890 # 100801 # 1 # ID=1_54;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=7bp;gc_cont=0.714	BGC0000136.1|Rifamycin_54 	99890	100801	+	Loose	550	28.1054	NmcR	33.96	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGACCGCCCAGGTGACCAGGAAGCAGATGCGGACCGTCTTCGCCGAGACGGTGATCGAGTCGCTGGCCACGGACCCGCGCGTGGTCATGCTGACCGCCGACATCTCGTCGTGGTTCTTCTGGGAGGTCAAGAAGGACTTCCCGGACCGCGTCCACAACTTCGGCATCCGCGAGCAGGCGATGATCGACATCGCCGGCGGCTTCGCGCTGGCCGGCCAGCGGCCGGTGGTGCACACGTACGCGCCGTTCCTGGTCGAGCGGCCGTTCGAGCAGATCAAGATCGGCCTCGGCCACCAGGACGTCGGCGCGGTGCTGGTCAGCGTGGGCGCCTCCTACGACGACCCGTCGTGGGGCCGCACCCACCAGGCCCCGGGCGACGTGGCGCTGCTGGACACGCTGCCGGGCTGGACGGTGCACGTCCCGGGCCACGAGGACGAGGTCGCGCCCCTGCTGAGCAAGGCCATCGCGGGTGACAACCGGGTCTACGTCCGGCTGTCCGAACGCGCGAACAGCGAAGCGGTGCCGGTGTCGGAGAAGTTCACGGTGCTGCGCCGGGGCAAGGCGGGCGTGGTGCTCGCGGTCGGCCCGGTGCTGGACCAGGTCCTGGCGGCCACGGCCACGGCGGACGTGACGGTGCTGTACGCCTCGACGATCCGCCCGTTCGACCACGCGGGCCTCCGGGAGGCGGTGGCCGCGGCGGCCCCGAACGTGGTGCTGGTCGACCCGTACCTGCGCGGGACGTCGGCGTTCGAGGTGACCGAGGCTCTGGGAGACGTCCCGCACCGCCTGCGCTCGTTCGGAACCTGGCGCGACCGCGAAGCCCGCGTCTACGGAACGCCCGAGGAACACGACCGCCTGTTCGGCGTGGACGCCGAGTCGCTGGCGGATTCGATCGCCCGCTTCGTCGGCTGA	MTAQVTRKQMRTVFAETVIESLATDPRVVMLTADISSWFFWEVKKDFPDRVHNFGIREQAMIDIAGGFALAGQRPVVHTYAPFLVERPFEQIKIGLGHQDVGAVLVSVGASYDDPSWGRTHQAPGDVALLDTLPGWTVHVPGHEDEVAPLLSKAIAGDNRVYVRLSERANSEAVPVSEKFTVLRRGKAGVVLAVGPVLDQVLAATATADVTVLYASTIRPFDHAGLREAVAAAAPNVVLVDPYLRGTSAFEVTEALGDVPHRLRSFGTWRDREARVYGTPEEHDRLFGVDAESLADSIARFVG	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	102.71	gnl|BL_ORD_ID|1951|hsp_num:0	2072		
BGC0000136.1|Rifamycin_55 # 101062 # 102312 # -1 # ID=1_55;partial=00;start_type=GTG;rbs_motif=AGTGA;rbs_spacer=8bp;gc_cont=0.706	BGC0000136.1|Rifamycin_55 	101062	102312	-	Loose	1100	27.335	tetA(46)	21.4	3004032	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCGAAAACGCGCCCAGCACCGAATCGCTGCGCTCACCACTCCCTCCGGAGTTCGTCCGGCGCGAAGACCCGTTCCACGTGCCGCCCGCTTTGGTGGCCGTCTCCGAACGGGGTCCCGTCGCCCGGGCGACACTGGCCGCCGGCGACCCGTTCTGGCTCGTGTCCGGGTACGAGGAAGCGCGCGCGGTGCTGTCGGACCCGCGCTTTTCCTCCGACCGGTTCCAGTACCACCCGCGGTTCAAGGAACTGTCGCCCGAATTCCGGGAGCGCCTGCGGGACGACAAAGCGCGCGCGGGGTCGTTCATCAACATGGACCCGCCGGAGCACACCCGGTACCGGAAACTGCTCACCGGGCAGTTCACCGTCCGGCGGATCCGCGAGCTCGGCGCCCGGATCGACGAGATCGTCGCCGGCCGGGTGGACGCCATGCTGGCCGGCGGGACCACCGCCGACCTGATGACCGAATTCGCGTTTCCGGCGCCTTCGCTGATGATCTGCGAGCTGCTCGGGGTGCGGTACGAGGACCGGGCGGAGTTCCAGCAGCGCGCGTCGGCCCTGCTGCAGATGAACGCCCCGGTCGCGGAGGCGGTGAAGAACGCCGACGCCCTGCGCGCGTTCATGCAGGCGCTGGTCACGGACAAGCGGGCGAACCCGGCGGGCGACATCATCTCCGGCCTGATCCACCACGCCGGCGCCGACCCCGCGCTCACCGACGACGAGCTGATCAACATCGCCAACCTGCTGCTCATCGCCGGCTACGACACCACGGCGAGCATGCTGGGGCTGGGCATCTTCGTGCTGCTGCAGCGCCCCGCCCAGCTCGCCACGCTGCGCGACGACCCGTCCCGCATCGCCGACGCGGTCGAAGGACTGCTGCGCTACCTGTCCGTGGTGAACCCGGGGATCTTCCGCTTCGCCAAGGAGGACCTGGAGTTCGCCGGCGAGCACATCCCGGCCGGTTCGACGGTGGTGGTCTCCGTGGTGGCGACCAACCGCGACGCGCGGCACTGGCCGGACCCGGACCTCGACCTGACCCGCCCCCGCGGCCCCCACCTGGCGTTCGGCCACGGCGTGCACCAGTGCCTCGGCCAGCAGCTGGCCCGGATGGAGATGCAGGCGGGCTACGCCGAGCTGCTGCGCCGCCTGCCGAACGTTCGCCTGGCGGTGCCGCCGGAGGAGGTTCCGCTGCGCAACGACATGCTGACTTACGGGGTGCACTCGCTTCCGATCGCCTGGGACGCTCCCTAA	MTENAPSTESLRSPLPPEFVRREDPFHVPPALVAVSERGPVARATLAAGDPFWLVSGYEEARAVLSDPRFSSDRFQYHPRFKELSPEFRERLRDDKARAGSFINMDPPEHTRYRKLLTGQFTVRRIRELGARIDEIVAGRVDAMLAGGTTADLMTEFAFPAPSLMICELLGVRYEDRAEFQQRASALLQMNAPVAEAVKNADALRAFMQALVTDKRANPAGDIISGLIHHAGADPALTDDELINIANLLLIAGYDTTASMLGLGIFVLLQRPAQLATLRDDPSRIADAVEGLLRYLSVVNPGIFRFAKEDLEFAGEHIPAGSTVVVSVVATNRDARHWPDPDLDLTRPRGPHLAFGHGVHQCLGQQLARMEMQAGYAELLRRLPNVRLAVPPEEVPLRNDMLTYGVHSLPIAWDAP	MIRAIWEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVLLVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTTDVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWQLTLISFIPMIFLVVSTYFLSRKQEEYVEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQKKTASLSKTGDKIASIQYSFGPLALLFIGFSTVLLLLFGGQSLASGQLSLGKLLALQLYLVFLIEPMWMMTDLILVYQTGQMSYKKLKEVIDETDDLEPDGTHYLEQIDSVEFKDYSFSYPGAERKSLSGIDWTIQRGQTVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEEKIGYVSQEHILFSKSIRENIALGKKGASQEDLMEAVAQAAFADDLERMSHGMDTLIGEKGVSVSGGQKQRISLARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVLDQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE	72.47	gnl|BL_ORD_ID|2370|hsp_num:0	2643		
BGC0000136.1|Rifamycin_56 # 102512 # 102967 # 1 # ID=1_56;partial=00;start_type=TTG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.721	BGC0000136.1|Rifamycin_56 	102512	102967	+	Loose	500	24.2534	FomA	25.25	3000423	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	Fom phosphotransferase family	TTGCCCGACGTCCTGCTGCTGAACGGTCCCAACCTGGGTGTGCTGGGCCGGCGCGAGCCCGAGATCTACGGCACCGACACGCTCGCCGACATCGAAAAGGCGGTCGCCGAGGAGGTGCGGCCCCGCGGCTGGACCGTCGTCCCGGTCCAGCGCGACGGCGAGGGCGAGCTGGTCGGCGCGATCCACCAGCACCGCGACACGACGGTCGGCGCGATCGTCAACCCCGGTGCGCTGATGATCGCCGGCTGGAGCCTGCGCGACGCGCTGGCCAGCTACGAGCCGCCGTGGATCGAGGTCCACCTGAGCAACGTGTGGGCGCGCGAGCAGTTCCGGCACGACTCGGTCATCGCCCCGCTGGCGAGCGGGGTGGTGGTCGGCCTCGGCGCCTTCGGCTACCGCCTGGCCGCACAGGCGTTGCTGCACCTGTCCGCCGAATCGCCGAATGGGCTCCGCTGA	MPDVLLLNGPNLGVLGRREPEIYGTDTLADIEKAVAEEVRPRGWTVVPVQRDGEGELVGAIHQHRDTTVGAIVNPGALMIAGWSLRDALASYEPPWIEVHLSNVWAREQFRHDSVIAPLASGVVVGLGAFGYRLAAQALLHLSAESPNGLR	MTPDFLAIKVGGSLFSRKDEPGSLDDDAVTPFARNFARLAETYRGRMVLISGGGAFGHGAIRDHDSTHAFSLAGLTEATFEVKKRWAEKLRGIGVDAFPLQLAAMCTLRNGIPQLRSEVLRDVLDHGALPVLAGDALFDEHGKLWAFSSDRVPEVLLPMVEGRLRVVTLTDVDGIVTDGAGGDTILPEVDARSPEQAYAALWGSSEWDATGAMHTKLDALVTCARRGAECFIMRGDPGSDLEFLTAPFSSWPAHVRSTRITTTASA	56.77	gnl|BL_ORD_ID|191|hsp_num:0	206		
BGC0000136.1|Rifamycin_57 # 103531 # 104808 # 1 # ID=1_57;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=11bp;gc_cont=0.703	BGC0000136.1|Rifamycin_57 	103531	104808	+	Loose	390	33.8834	evgA	27.45	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTGGACGTACCAAACTTGCAAATGCCATCGAATCCGTTCACCGGATTCGGGGACGATTTGATGCAGCGGTCCTGTGACACCGCTGGTTTCCTCCGCCGCTCGGCCTCGTCGTGGTTCAACGGGCGGCTCGACACGGGGTTGCACTGTGCCAGGGCAGCGGCCACGGGCAACCGCCGGGAATCCGACGAACTCAGCCAGCTGGCTCGGTTCTGGTACGTCGGGTTGCTGATCAAGGCCCGGGACCTCGACGCGGGCCGCCGGGTGCTCGAGTCGGCGGAGGCGGATCGGGGCGGGGCAGCCTCCGACCGCATGACCGCCGTCGAGCACAACGTGCGGGGCAGCCTGCTGTTCGCCATGGGCAGCGTCGACGACGCGATGGCGGAAATCAGCACCGGGCTGCGGATCGCCGAGCGCTGTGGTGACCGGTCGCTGCGGCCGCCCAGTTACGTCGTGCTGGCGCTGGGTGCCCTTCGCCGCGCGGACATGCGGGCGTGCCGCCACTTCGTCGACAAGCTGTCGGACGAAGCGCTGCTCGGTTACTTCGGGCAGGCGCCGGGAGCGTGGGTGGCCGCGCAGGCCGTGGAAGCCCGCAGCGGCGTGGAGAGCGCGGCGAGCCTGATCGCCGGGATCGTGACGAACCCGGTGGTGCTCCGGCAGCTGCTGGTGTCGGAACCGGCGGCGGCGTCCTGGCTGGTCCGCGCGTGCGTCAAGCTCGGCGCGCACGACCTGGCGAAGGCTTCGGCGGCGGAGTCCGCCGCGCTGGCCGCCGAGCAGCCGGAGTTCAGCGTGATCCGCGGCTCCGCCCTGCACGCGGCGGGCCTGCTGGAGCAGGACGCGGCCAAGCTCCACGAGGCGGCCGACATCCACCCCGACCGCTGGTGCGCGGCCTCGGCGCGCGAGGACCTGGCGAGCCTGCTGACCGTCCGGTGTTCCGAACGCGACCGGACGATCAGGATCCTCGAGTCGGTCCTGGACACGTACACGTCGGTGAGCGCCACCCGCGACTCGGCCCGGGTGGTGAACAAGCTCCGCGAGTACGGCGTCCGCCGCGGCACGACCCGGACGGTCGAGTGCGAAGGCACCGTCCCGCACGGGCTGACGAACACGGAGTTCGCGGTGGCGGAGCTGGTGAGCCAGGGCCACACCAACAACGAGGTGGGCCGGCAGCTGTTCATCTCCCGGCACACGGTGGCGTTCCACCTGAAGAAGGTGTTCCAGAAGATGAACCTCACCTCCAGGGTCGAGCTGGCGGCGGCGTGGAAGGTGTTCTCGTAG	MLDVPNLQMPSNPFTGFGDDLMQRSCDTAGFLRRSASSWFNGRLDTGLHCARAAATGNRRESDELSQLARFWYVGLLIKARDLDAGRRVLESAEADRGGAASDRMTAVEHNVRGSLLFAMGSVDDAMAEISTGLRIAERCGDRSLRPPSYVVLALGALRRADMRACRHFVDKLSDEALLGYFGQAPGAWVAAQAVEARSGVESAASLIAGIVTNPVVLRQLLVSEPAAASWLVRACVKLGAHDLAKASAAESAALAAEQPEFSVIRGSALHAAGLLEQDAAKLHEAADIHPDRWCAASAREDLASLLTVRCSERDRTIRILESVLDTYTSVSATRDSARVVNKLREYGVRRGTTRTVECEGTVPHGLTNTEFAVAELVSQGHTNNEVGRQLFISRHTVAFHLKKVFQKMNLTSRVELAAAWKVFS	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	208.33	gnl|BL_ORD_ID|958|hsp_num:0	1015		
BGC0000136.1|Rifamycin_58 # 105773 # 109276 # 1 # ID=1_58;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.668	BGC0000136.1|Rifamycin_58 	105773	109276	+	Loose	2300	1952.18	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin	82.2	3003283	protein variant model	D516G, H526T, L511R	A473T:90	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	TTGGCAGTCTCTCCCGCGAACCAGGCCACTGCTGCGACCACCTCGGCTGAATCTCGCTCGGAGGCCACGGGAATCCCCGGCGCGCCCAAGCGGGTTTCCTTCGCAAAGATTCGCGAACCCCTGAACACCCCCAACCTGCTCGACGTCCAGATCCAGTCGTTCCAGTGGTTCACCGGGGACGAAGCGTGGTTCCAGCGCCGTGTCGAGGAAGGTGAAGAGAACCCGGTCGGCGGCCTCGAAGAGGTCCTCAACGAGATCTCCCCGATCGAAGACTTCTCCGGTTCGATGTCCCTGTCCTTCTCCGCCCCGCGCTTCGACGAGGTCAAGGCCTCGATCGAGGAGTGCAAGGACAAGGACATGACGTACGCGGCCCCGCTGTTCGTCACGGCGGAGTTCGTCAACAACAACACGGGCGAGATCAAGAGCCAGACGGTCTTCCTGGGCGACTTCCCGGTGATGACCGACAAGGGCACCTTCGTCATCAACGGCACCGAGCGTGTCGTGGTGTCCCAGCTGGTCCGCTCGCCGGGCGTCTACTACTCCAAGGACATCGACAAGACGAGCGACAAGGACGTCTTCAGCGTCCGCGTCATCCCGAGCCGCGGTGCCTGGCTGGAGTTCGACGTCGACAAGCGCGACACCGTCGGCGTCCGCATCGACCGCAAGCGCCGCCAGCCGGTCACCGTGCTGCTGAAGGCGCTCGGCTGGACCACCGAGGCGATCCGCGAGCGCTTCTCCTTCTCGGAGACGCTGCTCGCCACCCTCGAGAAGGACCACACCGCCGGCACCGACGAGGCGCTGCTCGACATCTACCGCAAGCTCCGCCCGGGCGAACCGCCCACCAAGGAGAGCGCGCAGACCCTGCTGGAGAACCTGTTCTTCAAGGCGAAGCGCTACGACCTGGCCAAGGTCGGCCGGTACAAGGTCAACAAGAAGCTGGGCCTCTCGACCCCGATCGAGAACGGCACGCTGACCGAAGAGGACATCGTCACGATCATCGAGTACCTGGTCCGGCTGCACGCCGGCGAGGACAAGATGACCGCGGCGAACAACACCGAGATCCCGGTCGAGACCGACGACATCGACCACTTCGGCAACCGCCGGATCCGGACCGTCGGCGAGCTGATCCAGAACCAGATCCGGGTCGGCCTGTCGCGCACTGAGCGCGTCGTCCGCGAGCGCATGACCACGCAGGACGTCGAGGCGATCACCCCGCAGACCCTGATCAACATCCGCCCGATCGGCGCGGCGATCAAGGAGTTCTTCGGCACCTCGCAGCTGTCGCAGTTCATGCAGCAGACGAACCCGATCGACGGCCTGACCCACAAGCGCCGCCTCAACGCGCTGGGCCCGGGTGGTCTGTCGCGTGAGCGCGCCGGCATGGAGGTCCGCGACGTCCACCCGTCGCACTACGGCCGGATGTGCCCGATCGAGACGCCGGAAGGCCCGAACATCGGCCTGATCGGCTCGCTCTGCTCCTACGCGCGGGTCAACCCGTTCGGCTTCATCGAGACGCCGTACCGCAAGGTCGTCGAGGGCCGGGTCACCGACCAGATCGACTACCTGACCGCGGACGAAGAAGACCGGTTCGTCAAGGCCCAGGCCAACGCGCCGATCTCGGACGACGGCACCTTCATCGAAGACCGGGTCATGGCCCGCCGCAAGGGCGGCGAGGTCGAGCTGATCGACCCGCTCGACATCGACTACATGGACGTGTCGCCGCGGCAGATGGTCTCGATCGCGACGGCGATGATCCCGTTCCTCGAGCACGACGACGCGAACCGCGCGCTGATGGGCGCGAACATGCAGCGTCAGGCCGTGCCGCTGCTGCGCAGCCAGGCGCCGTACGTCGGCACCGGCGTGGAGCTGCGGGCCGCGATCGACTCCGGCGACATGCTGGTCGCCGAGCAGTCGGGCGTGGTGGAGGAGCTGTCGGCGGACCTGATCACGGTCATGCACGACGACGGCACGCGGAAGAGCTACAGCCTCTACAAGTTCCGCCGCTCGAACCACGGCACCTGCTTCAACCACCGCCCGATCGTCAACGAGGGCGACCGGATCGAAGCGGGCCAGGTCATCGCCGACGGCCCGTCCACCGAAAACGGTGAGGTGGCGCTCGGCAAGAACCTGCTGGTCGCGGTCATGCCGTGGGAGGGCCACAACTACGAGGACGCGATCATCCTCTCCGAGCGCCTGGTGCAGGACGACGTGCTGACGTCGATCCACATCGAGGAGCACGAGATCGATGCCCGCGACACGAAGCTGGGCGCCGAGGAGATCACCCGGGACATCCCGAACGTCTCCGAAGAAGTCCTGGCCGACCTCGACGAGCGCGGCATCATCCGGATCGGTGCCGAGGTCCGCGACGGCGACATCCTGGTCGGCAAGGTCACGCCGAAGGGCGAGACCGAGCTGACCCCGGAGGAGCGCCTGCTCCGCGCGATCTTCGGCGAGAAGGCCCGCGAGGTCCGCGACACCTCCCTGAAGGTGCCGCACGGCGAGACCGGCAAGGTCATCGGCATCCGGGTGTTCTCCCGCGAGGACGACGACGAGCTGCCCCCGGGCGTCAACGAGCTGGTCCGCGTCTACGTGGCCCAGAAGCGCAAGATCCAGCCGGGCGACAAGCTCGCCGGCCGGCACGGGAACAAGGGTGTCATCGGCAAGATCCTGCCGGTCGAGGACATGCCGTTCATGGAGGACGGCACCCCGGTCGACATCATCCTGAACACCCACGGTGTCCCGCGACGGATGAACATCGGCCAGATCCTCGAGCTGCACCTGGGCTGGCTGGCGTCGCAGGGCTGGACGATCGAGGGCGACCCCGACTGGGCGAAGAACCTGTCGGCCGAGCTCCGCGACGTCGCGCCCGGCACGAACACCGCCACCCCGGTGTTCGACGGCGCGAAGGAAGAGGAGCTCACCGGGCTGCTCAGCGCGACCAAGCCGAACCGCGACGGTGAGCGCATGGTCAAGGAGAACGGGAAGGCCAACCTGTTCGACGGCCGCTCGGGCGAGCCGTACCCGTACCCGGTCGCGGTCGGCTACATGTACATCCTGAAGCTGCACCACCTGGTCGACGACAAGATCCACGCCCGCTCCACCGGTCCGTACTCGATGATCACGCAGCAGCCGCTGGGTGGTAAGGCGCAGTTCGGTGGCCAGCGCTTCGGTGAGATGGAGTGCTGGGCGATGCAGGCGTACGGCGCTGCCTACACGCTGCAGGAGCTGCTGACGATCAAGTCGGACGACGTGGTCGGCCGCGTCAAGGTGTACGAGGCCATCGTCAAGGGGGAGAACATCCCCGAGCCGGGCATCCCGGAGTCGTTCAAGGTGCTCCTCAAGGAGCTCCAGTCGCTGTGCCTCAACGTCGAGGTGCTCTCCAGCGACGGCTCCTCGATCGAGATGCGCGACTCCGGCGACGAGGACCTCGAGCGCGCCGCGGCGAACCTCGGCATCAACCTGTCCCGCAACGAGTCGCCCTCGGTGGACGACGTCGTGCACTGA	MAVSPANQATAATTSAESRSEATGIPGAPKRVSFAKIREPLNTPNLLDVQIQSFQWFTGDEAWFQRRVEEGEENPVGGLEEVLNEISPIEDFSGSMSLSFSAPRFDEVKASIEECKDKDMTYAAPLFVTAEFVNNNTGEIKSQTVFLGDFPVMTDKGTFVINGTERVVVSQLVRSPGVYYSKDIDKTSDKDVFSVRVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTTEAIRERFSFSETLLATLEKDHTAGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKAKRYDLAKVGRYKVNKKLGLSTPIENGTLTEEDIVTIIEYLVRLHAGEDKMTAANNTEIPVETDDIDHFGNRRIRTVGELIQNQIRVGLSRTERVVRERMTTQDVEAITPQTLINIRPIGAAIKEFFGTSQLSQFMQQTNPIDGLTHKRRLNALGPGGLSRERAGMEVRDVHPSHYGRMCPIETPEGPNIGLIGSLCSYARVNPFGFIETPYRKVVEGRVTDQIDYLTADEEDRFVKAQANAPISDDGTFIEDRVMARRKGGEVELIDPLDIDYMDVSPRQMVSIATAMIPFLEHDDANRALMGANMQRQAVPLLRSQAPYVGTGVELRAAIDSGDMLVAEQSGVVEELSADLITVMHDDGTRKSYSLYKFRRSNHGTCFNHRPIVNEGDRIEAGQVIADGPSTENGEVALGKNLLVAVMPWEGHNYEDAIILSERLVQDDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSEEVLADLDERGIIRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGETGKVIGIRVFSREDDDELPPGVNELVRVYVAQKRKIQPGDKLAGRHGNKGVIGKILPVEDMPFMEDGTPVDIILNTHGVPRRMNIGQILELHLGWLASQGWTIEGDPDWAKNLSAELRDVAPGTNTATPVFDGAKEEELTGLLSATKPNRDGERMVKENGKANLFDGRSGEPYPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGSSIEMRDSGDEDLERAAANLGINLSRNESPSVDDVVH	MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIGSPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA	99.57	gnl|BL_ORD_ID|2005|hsp_num:0	1237		
BGC0000136.1|Rifamycin_59 # 109375 # 109527 # 1 # ID=1_59;partial=01;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=8bp;gc_cont=0.595	BGC0000136.1|Rifamycin_59 	109375	109527	+	Loose	1050	22.3274	carA	40.74	3002817	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGCTGGACGTCAACTTTTTCGATGAGCTCCGCATTGGTCTCGCCACGGCCGACGACATCCGTCAGTGGTCGTACGGCGAGGTCAAGAAGCCGGAGACCATCAACTACCGGACGCTCAAGCCCGAGAAGGACGGCCTCTTCTGCGAGAAGATC	MLDVNFFDELRIGLATADDIRQWSYGEVKKPETINYRTLKPEKDGLFCEKI	MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA	9.26	gnl|BL_ORD_ID|873|hsp_num:0	928		
